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Summary 
DNA single-strand breaks (SSB) are the most commonly occurring type of DNA damage arising 
in a cell and they are repaired by rapid repair pathways collectively termed single-strand break 
repair (SSBR).  Recently several rare hereditary neurodegenerative disorders with mutations in 
genes associated with SSBR, spinocerebellar ataxia and axonal neuropathy-1 (SCAN1), ataxia 
oculomotor apraxia-1 (AOA1) and microcephaly with early onset seizures and developmental 
delay (MCSZ), have been discovered.  A striking aspect that these disorders have in common is 
that they are all caused by mutations in end-processing factors.  The majority of SSBs that arise 
via endogenous damage have ‘dirty’ termini and require end-processing to restore DNA ends 
with conventional ‘ligatable’ chemistry.  Another common feature of these end-processing 
enzymes is their association with XRCC1, a scaffolding protein that is a core component of 
SSBR.  Complete loss of XRCC1 is embryonically lethal and the conditional deletion of XRCC1 in 
the developing mouse brain leads to persistent DNA damage, cerebellar interneurons loss and 
abnormal hippocampal function resulting in behavioural abnormalities such as seizures and 
episodic epilepsy.  Taken together these observations suggest that neural cells are exquisitely 
sensitive to defects in chromosomal SSBR.  In my thesis, I will describe biochemical and cellular 
data on lymphoblastoid and fibroblast cell lines derived from patients with mutations in the 
end-processing factors aprataxin (APTX is mutated in AOA1).  I will include data showing that 
aprataxin is required for the short-patch SSBR of abortive ligation intermediates in vitro and 
that repair arrests in AOA1 cell lines due to insufficient levels of non-adenylated DNA ligase. 
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1.1 DNA damage and repair 
The DNA in our cells is under constant attack from DNA damaging agents which are a 
continuing threat to genomic integrity (Lindahl, 1993, Ward, 1998).  Maintenance of genomic 
integrity is of fundamental importance to the continuing survival of the cell and without the 
multitude of DNA repair pathways that exist, the cell would very quickly accumulate lethal 
DNA aberrations and would cease to function.  A large variety of DNA damage can occur from 
three main sources.  The first common source of DNA damage is environmental.  Ultraviolet 
(UV) radiation that is a component of sunlight is a major source of exogenous DNA damage 
and induces bulky lesions, such as cyclobutane pyrimidine dimers (CPD) and 6-4 photoproducts 
((6-4)PP) that distort the DNA double helix (Hoeijmakers, 2001).  Exogenous genotoxic agents, 
such as polycyclic aromatic hydrocarbons that can be found in cigarette smoke and 
heterocyclic amines found in over-cooked foods, can also damage DNA and induce bulky 
adducts (Hoeijmakers, 2001).  A third source of exogenous DNA damage is ionising radiation 
(IR) in the form of either γ-rays or X-rays which induce DNA breaks, both DNA single – strand 
breaks (SSB) and double – strand breaks (DSB), and base damage via the production of 
hydroxyl (OH) radicals (Ward, 1975, Ward et al., 1987, Ward, 1998).  A large source of naturally 
occurring ionising radiation is radon, a radioactive gas that emanates from uranium-containing 
soil and porous rock (Al-Zoughool and Krewski, 2009, Bissett and McLaughlin, 2010).   
 
The second source of DNA damage are endogenous (by)products of cellular metabolism.  
Reactive oxygen species (ROS) such as superoxide anions, OH radicals and hydrogen peroxide 
can induce a staggeringly large variety of oxidative DNA lesions (Cadet et al., 2003, Sander et 
al., 2005, Beckman and Ames, 1997, Evans, 1997).  Endogenous ROS are generated during a 
number of cellular processes such as during the electron transfer chain, when “leaked” 
electrons encounter oxygen, in the immune response, when phagocytic cells produce an 
oxidative burst to kill virally or bacterially infected cells and during lipid peroxidation in 
peroxisomes (Evans, 1997, Cooke et al., 2003).   The large amount of ROS generated by the cell 
means that a high level of oxidative DNA damage can be measured in normal tissues at any 
time.   
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A third source of DNA damage is the tendency of some chemical bonds in DNA to 
spontaneously disintegrate under physiological conditions.  Nucleotide residues can hydrolyse, 
leading to abasic (AP) sites and the spontaneous deamination of cytosine, adenine, guanine or 
5-methylcytosine can result in uracil, hypoxanthine, xanthine and thymidine respectively 
(Lindahl, 1993).   
 
The consequences of unrepaired DNA lesions are generally deleterious.  DNA replication or 
transcription can become blocked as polymerases are unable to bypass bulky DNA lesions 
caused by exposure to UV light or polycyclic aromatic hydrocarbons.  The accumulation of 
unrepaired bulky adducts can lead to cell-cycle arrest and/or cell death.  Some DNA lesions are 
particularly mutagenic, such as oxidative 8-hydroxyguanine (8-oxo-G) which can pair with 
cytosine or adenine with equal affinity, potentially resulting in a GC →TA point mutation 
(Shibutani et al., 1991, Akbari and Krokan, 2008).  The accumulation of damage-induced point 
mutations is a driving factor in oncogenesis as it can lead to deregulation of the cell cycle as 
the result of either the loss of tumour-suppressor genes or the untimely activation of 
oncogenes (Hoeijmakers, 2001, Kastan and Bartek, 2004, Stratton et al., 2009).  DSBs are 
considered to the most genotoxic lesion that can arise and if left unrepaired or repaired 
inappropriately can lead to a variety of chromosomal aberrations and/or mis-segregation of 
chromosomes during mitosis (Hoeijmakers, 2001).  SSBs, although not considered to be 
genotoxic themselves, can be converted into DSBs by collision with a replication or 
transcription fork (Kuzminov, 2001, Hoeijmakers, 2001, Kouzminova and Kuzminov, 2006).  
 
The examples briefly discussed here show that a variety of adverse outcomes can result from 
DNA damage and serve to highlight the importance of the accurate repair of DNA for cell 
survival.  As there is a very large variety of DNA lesions that can arise, there are also numerous 
over-lapping DNA response and repair pathways that have evolved in all organisms to maintain 
genome stability.  The ultimate function of these genome maintenance pathways is the 
accurate transmission of genetic information to subsequent generations.   
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1.2 DNA Single Strand Breaks 
DNA single-strand breaks (SSB) are discontinuities in one strand of the DNA sugar phosphate 
backbone and are the most commonly occurring type of DNA lesion in the cell.  It has been 
estimated that as many as 10,000 SSBs can arise in a single cell per day (Lindahl and Nyberg, 
1972, Lindahl, 1993, Sander et al., 2005, Ward, 1998, Caldecott, 2001, Beckman and Ames, 
1997).  Although SSBs are not considered to be particularly genotoxic themselves, if left un-
repaired and allowed to convert into DSBs via collision with replication or transcription 
machinery, the sheer volume of breaks would quickly overwhelm the DSBR capacity of the cell 
(Kuzminov, 2001, Deckbar et al., 2007).  As a consequence of this cells have evolved rapid and 
efficient repair pathways collectively single-strand break repair (SSBR) (Reviewed in detail in 
(Caldecott, 2008)).   
 
There are a number of different sources of endogenous SSBs.  SSBs can arise directly from the 
disintegration of oxidized sugars following attack on the sugar-phosphate backbone of DNA by 
ROS (Ward et al., 1987, Ward, 1998).  This is the biggest source of SSBs owing to the creation 
of large amounts of ROS during normal cellular metabolism (Beckman and Ames, 1997, Evans, 
1997, Cadet et al., 2003, Sander et al., 2005).  SSBs created in this manner are usually 
associated with a single nucleotide gap resulting from base loss and typically possess 
“damaged” DNA termini.  These are termini that have different chemistry from the 
conventional 3’-hydroxl and 5’-phosphate moieties that are required for DNA ligation.  It has 
been estimated that ~70% of 3’ termini of ROS induced SSBs possess a 3’-phosphate and ~30% 
possess a 3’-phosphoglycolate (Ward, 1998, Caldecott, 2001).  The 5’ termini of these SSBs 
usually contain an undamaged 5’ – phosphate although a small percentage possess a 5’-
hydroxyl.   
 
SSBs can also arise indirectly as the result of the enzymatic processing of damaged bases 
during the base excision repair pathway (BER).  Base damage is another consequence of ROS 
induced DNA damage and it is thought that up to 20% of the total DNA damage induced by 
ionising radiation is comprised of oxidized bases (Von Sonntag, 1987, Demple and DeMott, 
2002).  Indeed over 70 types of oxidative base and sugar products can be generated (Sander et 
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al., 2005).  8-hydroxyguanine (8-oxo-G) is a commonly occurring oxidative lesion and is the 
most frequently used marker for oxidative base damage (Figure 1.1A) (Kasai et al., 1984, 
Lindahl, 1993, Sander et al., 2005).  As mentioned above this oxidative lesion is particularly 
mutagenic as adenine can be inserted opposite an 8-oxo-G lesion with the same frequency as 
cytosine during DNA replication and can result in a GC →TA point mutation (Figure 1.1B) 
(Shibutani et al., 1991).  
 
Alkylation of DNA is another important source of base damage (Sedgwick et al., 2006).  S-
adenosylmethionine (SAM) is the donor of methyl groups during cellular enzymatic 
methylation events (Figure 1.2A) (Sedgwick et al., 2006, Barrows and Magee, 1982).  SAM has 
a very high transfer potential and is a source of spontaneous DNA methylation.  It has been 
shown that SAM induces the same base adducts as the alkylating agent methyl 
methanosulfonate (MMS) (Rydberg and Lindahl, 1982).  Two noteworthy products arising from 
the methylation of DNA are 7-methylguanine (7meG) and 3-methyladenine (3meA) (Figure 
1.2B).  3meA is considered to be genotoxic as it blocks both RNA and DNA polymerase activity 
(Sedgwick et al., 2006). 
 
A third source of base damage is the spontaneous deamination of cytosine to uracil which can 
result in the mis-incorporation of adenine and can result in a CG→TA point mutation (Figure 
1.3).  It has been estimated that spontaneous cytosine deamination events can occur 60-500 
times in a cell per day (Krokan et al., 2002, Barnes and Lindahl, 2004).  Additionally cytosine 
deamination can be caused by ROS induced oxidative damage resulting from ionising radiation 
(Bjelland and Seeberg, 2003).  Apurinic/apyramidinic sites (AP) sites result from the intrinsic 
instability of DNA in aqueous solution and are a major source of endogenous SSB.  It has 
estimated that in each cell per day 2000-10000 depurination events occur (Lindahl and Nyberg, 
1972, Lindahl, 1993).   
 
A final source of endogenous SSBs is via the abortive action of the enzyme topoisomerase 1 
(Top1).  Top1 relaxes supercoiled duplex DNA during transcription and DNA replication by 
nicking one strand of the DNA double helix and allowing it to unwind (Roca, 1995, Wang, 
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2002).  A transient cleavage complex is formed, in which Top1 becomes covalently linked via a 
3’ phosphotyrosyl bond to the DNA, before the nick is resealed.  These nicks are usually 
resealed rapidly and are not a source of endogenous SSBs.  However if a DNA or RNA 
polymerase collides with Top1 before the nick is resealed, then the cleavage complex can 
become trapped as a Top1-SSB, probably due to the misalignment of the 5’-OH, and the SSB 
cannot just be religated (Pommier et al., 2003).  The Top1 inhibitor camptothecin (CPT) 
increases the half-life of the cleavage complexes and is used to experimentally increase the 
level of Top1-SSBs (Pourquier et al., 1997).  Top1-SSBs can also become trapped if the cleavage 
complex occurs in the close proximity of another DNA lesion (Pourquier et al., 1997).     
 
1.3 DNA single strand break repair 
As described above SSBs can either arise directly from the fragmentation of damaged sugars, 
indirectly during the removal of damages bases in base excision repair (BER) or as the result of 
abortive Top1 activity.  However, despite the variety of ways SSBs can occur, they are all 
repaired in overlapping repair pathways collectively termed single-strand break repair (SSBR) 
(reviewed in (Caldecott, 2008)).  Most SSBR pathways proceed through four stages of repair; 
detection of the break, end-processing of damaged termini, gap-filling and DNA ligation (Figure 
1.4, 1.5 and 1.6).   
 
1.3.1 Detection 
Detection of direct SSBs is achieved by the enzyme poly(ADP-ribose) polymerase 1 (PARP1) 
(D'Amours et al., 1999, Kim et al., 2005) (Figure 1.4).  PARP1 has a very high affinity for DNA 
breaks and upon binding it catalyses the polymerisation of long branched chains upon itself 
and other target molecules (Benjamin and Gill, 1980, Weinfeld et al., 1997, Bramson et al., 
1993).  Once autoribosylated the PARP1 molecule disassociates from the break (Ferro and 
Olivera, 1982, Zahradka and Ebisuzaki, 1982) and is rapidly targeted by the enzyme poly(ADP-
ribose) glycohydrolase (PARG) which catalyses the degradation of the poly(ADP-ribose) 
polymers, allowing PARP1 to be recycled (Cortes et al., 2004, Fisher et al., 2007).   
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PARP1 has been shown to have an important role in stimulating rapid SSBR as the depletion, 
deletion or inhibition of PARP1 results in decreased rates of repair of global SSBs (Fisher et al., 
2007, Le Page et al., 2003, Godon et al., 2008).  Importantly depletion of PARG imparts a 
similar SSBR defect (Fisher et al., 2007).  One way in which PARP1 could be facilitating rapid 
SSBR is by stimulating the rapid accumulation of downstream SSBR factors.  PARP1 is known to 
interact with, and is required for the rapid accumulation of foci at sites of oxidative damage, of 
the core SSBR protein X-ray cross complementing protein 1 (XRCC1) (Caldecott et al., 1996, El-
Khamisy et al., 2003, Masson et al., 1998).  XRCC1 does not appear to have any enzymatic 
activity but has an essential role in cells, as evidenced by the fact that Xrcc1-/- mice do not 
survive past embryonic day 6.5 (Tebbs et al., 1999, Tebbs et al., 2003).  Additionally four 
Chinese hamster ovary cell lines (CHO) that harbour mutations in XRCC1 display 
hypersensitivity to DNA damaging agents and exhibit global SSBR defects (Caldecott, 2003b).   
 
XRCC1 contains three domains; an N-terminal domain and two BRCT domains, and also 
contains putative PAR binding motifs (Caldecott, 2003b).  It interacts with numerous 
components of SSBR and it is thought that it helps facilitate rapid repair by acting as a 
molecular scaffold for the various repair factors involved and helps to organise the 
downstream steps of SSBR (Figure 1.4) (Caldecott, 2003b, Caldecott, 2003a).  Confirmed 
partners of XRCC1, other than PARP1, include DNA polymerase β (Polβ) (Caldecott et al., 1996, 
Kubota et al., 1996, Luo et al., 2004), polynucleotide kinase phosphatase (PNK) (Whitehouse et 
al., 2001, Luo et al., 2004), aprataxin (APTX) (Clements et al., 2004, Luo et al., 2004), AP 
endonuclease 1 (APE1) (Vidal et al., 2001) and DNA ligase IIIα (LigIIIα) (Caldecott et al., 1994, 
Caldecott et al., 1995, Nash et al., 1997).  XRCC1 has also been shown to stimulate the 
activities of a number of its interacting partners (Whitehouse et al., 2001, Mani et al., 2007, Lu 
et al., 2010, Marsin et al., 2003, Campalans et al., 2005). 
 
Detection of base damage is achieved in a different manner to direct SSBs.  Altered bases 
cause minor perturbations in the DNA helix which are recognised and cleaved by distinct DNA 
glycosylases (Figure 1.5).  Ten DNA glycosylases have been identified to date and each 
recognises and excises specific damaged bases (Reviewed in (Robertson et al., 2009)).  There 
are two types of glycosylase; mono-functional and bi-functional glycosylases (Figure 1.7) (a list 
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of known DNA glycosylases and their substrates is presented in Table 1.1).  Both types catalyse 
the cleavage of an N-glycosidic bond, releasing the damaged base and creating an AP site 
(Lindahl, 1974).  AP sites generated by mono-functional glycosylases are then cleaved by AP 
endonuclease I (APE1) to produce a SSB with a 3’-OH and a 5’-dRP (Demple et al., 1991).  Bi-
functional glycosylases possess an additional AP lyase activity and cleave the abasic site 
themselves in either a β elimination or βδ elimination reaction, resulting in SSBs containing 
single nucleotide gap with a 5’-P and a 3’-αβ unsaturated aldehyde or 3’-P respectively 
(McCullough et al., 1999, O'Connor and Laval, 1989, Hegde et al., 2008).  
 
PARP1 has been seen accumulating at sites of base damage, although it is not thought that 
PARP1 plays the same role in the repair of indirect SSBs produced during BER as it does in the 
repair of direct SSBs (Durkacz et al., 1980).  XRCC1 has been shown to interact with the DNA 
glycosylases OGG1, NEIL1, NEIL2 and MPG as well as APE1 (Vidal et al., 2001, Marsin et al., 
2003, Campalans et al., 2005, Das et al., 2006) and it is thought that SSBs arising during the 
initial stages of BER are simply relayed to the next step in SSBR and would not require the 
action of PARP1 to be detected.  It is also not currently clear whether PARP1 plays a role in the 
detection of TOP1-SSBs.   
 
1.3.2 End – processing 
As mentioned previously, the majority of SSBs possess “damaged” termini.  For successful DNA 
ligation to occur the conventional 3’-OH and 5’-P chemistries have to be restored and as a 
consequence a large variety of DNA end-processing factors have evolved to repair the different 
chemistries arising at damaged DNA breaks (the structures of the different chemistries that 
arise at the termini of damaged SSBs are shown in Figures 1.8 and 1.9, and the enzymes that 
are involved in processing them are detailed in Table 1.2).  DNA breaks with damaged termini 
are considered to be cytotoxic as they could lead to the production of collapsed replication or 
transcriptions forks.  Repair of the 3’ terminus is also thought to be particularly crucial as a 
damaged 3’ terminus would not support DNA polymerase activity if left unrepaired and could 
lead to the continued blockage and prevention of replication fork restart.  The importance of 
DNA end-processing is highlighted by the observation that three human neurological disorders 
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associated with mutations in SSBR proteins have been discovered to be caused by defects in 
end-processing factors.  These three factors are APTX, TDP1 and PNK as and are mutated in 
ataxia oculomotor apraxia 1 (AOA1), spinocerebellar ataxia with axonal neuropathy 1 (SCAN1) 
and microcephaly, early-onset, intractable seizures and developmental delay (MCSZ) 
respectively (Date et al., 2001, Moreira et al., 2001, Takashima et al., 2002, Shen et al., 2010)  
 
An end-processing factor that is particularly worthy of attention is PNK, a bi-functional protein 
that possesses both 3’ phosphatase and 5’ kinase activity (Jilani et al., 1999, Karimi-Busheri et 
al., 1998, Whitehouse et al., 2001, Bernstein et al., 2005b).  PNK contains an N-terminal FHA 
domain, through which it interacts with CK2 phosphorylated XRCC1 and XRCC4, and 
phosphatase and kinase catalytic domains (Loizou et al., 2004, Whitehouse et al., 2001, 
Bernstein et al., 2005b).  PNK is considered to be a critical protein in SSBR due to the sheer 
volume of SSBs possessing a 3’P that can potentially arise in a cell per day.  3’-P termini, which 
is a major substrate for PNK, arises at approximately 70% of direct SSBs induced by ROS (Figure 
1.4), at SSBs created indirectly via the excision and cleavage of base damage by a bi-functional 
DNA glycosylase in a βδ elimination reaction (Figure 1.5 and 1.7) and following TDP1 activity 
during the repair of TOP1-SSBs (Figure 1.6) (Caldecott, 2001, Ward, 1998, O'Connor and Laval, 
1989, Interthal et al., 2001).  This critical role is further underlined by the observation that 
mutations in PNK result in the human developmental disorder MCSZ (Shen et al., 2010).   PNK 
also acts to repair termini harbouring a 5’-OH, which can also arise as the result of ROS 
induced sugar fragmentation or following TDP1 activity although it is not thought that the 5’ 
kinase activity of PNK plays as large a role in SSBR as its 3’ phosphatase activity (Ward, 1998, 
Caldecott, 2001, Interthal et al., 2001).  In support of this PNK has both a higher affinity for and 
a greater activity on 3’-phosphorylated substrates than on DNA substrates with a 5’-OH 
(Dobson and Allinson, 2006).   
 
APE1 is an important SSBR factor that is involved in the repair of both direct and indirect SSBs 
(Figure 1.4 and 1.5). In addition to its AP lyase activity, it has also been shown to repair 3’PG 
termini (Demple et al., 1991, Chen et al., 1991, Demple and Harrison, 1994, Winters et al., 
1992, Winters et al., 1994), and to a lesser extent, 3’P termini  (Chen et al., 1991, Demple and 
Harrison, 1994, Izumi et al., 2000).  SSBs possessing 3’-PG termini are another common type of 
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lesion that requires processing.  3’-PG arise at approximately 30% of direct SSBs induced by 
ROS (Ward, 1998, Caldecott, 2001).  APE1 is essential in mammalian cells and Ape1-/- mice do 
not survive past embryonic day 4-5 (Xanthoudakis et al., 1996, Izumi et al., 2005).  Studies have 
also demonstrated that conditional inactivation of APE1 in living cells leads to an accumulation 
of both SSBs and AP sites (Izumi et al., 2000, Izumi et al., 2005, Mitra et al., 2007). 
 
Polβ is a member of the X-family of polymerases and is an important end-processing factor in 
the repair of indirect SSBs.  It is contains two separate domains; a small N-terminal dRP lyase 
domain and a larger polymerase domain and as mentioned previously it forms an interaction 
with XRCC1 (Beard and Wilson, 2000, Marintchev et al., 2000, Breslin and Caldecott, 2009).  AP 
sites cleaved by APE1 possess 5’dRP termini which are repaired by the AP lyase activity of Polβ 
in a reaction mechanism that involves the production of a Schiff base intermediate, a reaction 
intermediate in which an active site lysine becomes covalently attached to the DNA (Piersen et 
al., 1996, Sobol et al., 2000, Matsumoto and Kim, 1995).   This AP lyase activity has been 
shown to be the critical activity for Polβ as the hypersensitivity of Polβ-/- MEFs to DNA 
alkylating agents can be rescued by expression of only the N-terminal dRP lyase domain (Sobol 
et al., 2000).   
 
APTX is a member of the Hint-like histidine triad (HIT) superfamily (Brenner, 2002, Kijas et al., 
2006).  APTX interacts with CK2 phosphorylated XRCC1 and XRCC4 via a N-terminal FHA 
domain as shown by yeast-two hybrid analysis and co-immunoprecipitation (Sano et al., 2004, 
Clements et al., 2004, Luo et al., 2004, Date et al., 2004, Gueven et al., 2004).  It has been 
shown that APTX and PNK bind to the same CK2 phosphphorylated cluster on XRCC1, 
S518/T519/T523, and are present in two mutually exclusive complexes (Luo et al., 2004).  APTX 
has also been reported to co-immunoprecipitate with PCNA (Hirano et al., 2007), PARP1 and 
p53 (Gueven et al., 2004).   
 
APTX catalyses the release of AMP groups covalently linked to 5’-phosphate termini of a DNA 
SSB or DSB (Ahel et al., 2006, Rass et al., 2008).  Release of the 5’-AMP is achieved via a two-
step reaction in which the AMP becomes transiently linked to a histidine residue within the 
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active site (Rass et al., 2008).  Adenylated nicks are produced as a normal intermediate during 
ligation by an ATP-dependant DNA ligase, and an stable abortive ligation intermediate can 
arise if a ligase has prematurely attempted to ligate a SSB with a 3’ terminus other than a 3’OH 
(the reaction mechanism of mammalian ligases is described in detail later in section 1.3.4.1).  
Mutations in APTX result in the neurodegenerative disorder AOA1, which suggests that 
abortive ligations could be occurring at sufficient frequency within a cell to cause problems if 
left unrepaired (Date et al., 2001, Moreira et al., 2001). It has also been proposed that APTX 
can remove 3’P and 3’PG, although this activity is orders of magnitude less efficient than the 
adenylate hydrolysis activity (Takahashi et al., 2007b).   
 
TDP1 is the end-processing factor that is responsible for the repair of abortive TOP1-SSBs 
(Figure 1.6) (Interthal et al., 2001, El-Khamisy et al., 2005).  TDP1 has tyrosyl-DNA 
phosphodiesterase activity and cleaves the phosphodiester bond linking the active site 
tyrosine residue of TOP1 with the 3' terminus of DNA in TOP1-SSBs in a reaction mechanism 
that involves the transient formation of a covalent enzyme-DNA intermediate (Interthal et al., 
2001).  Removal of the TOP1 results in a DNA nick possessing a 3’-P and a 5’-OH and therefore 
requires further processing by PNK.  It should also be noted that TDP1 has been reported as 
being able to repair a 3’-PG (Zhou et al., 2005, Inamdar et al., 2002).  A single mutation in TDP1 
has been shown to be the cause of the neurodegenerative disorder SCAN1 (Takashima et al., 
2002).  This is intriguing as defects in both APTX and TDP1 result in neurodegeneration and 
both are involved in the repair of DNA damage arising from abortive enzymatic activity.   
 
1.3.3 Gap – filling 
As the majority of SSBs are associated with a missing base, a gap-filling step usually follows 
end-processing.  At this stage of SSBR the pathway splits into two sub-pathways; short-patch 
repair, in which a single nucleotide is incorporated into the gap (Dianov et al., 1992), and long-
patch repair, in which a repair patch of 2-12 nucleotides is synthesised, displacing a 5’ single-
stranded flap which is cleaved by flap endonuclease 1 (Frosina et al., 1996, Klungland and 
Lindahl, 1997, Kim et al., 1998, Mosbaugh and Linn, 1983, Singhal et al., 1995). 
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Early studies involving the reconstitution of short-patch repair of damaged bases using 
recombinant human proteins and cell-free extracts from Polβ-/- MEFs suggested an important 
role for Polβ in short-patch repair (Singhal et al., 1995, Sobol et al., 1996, Nealon et al., 1996, 
Kubota et al., 1996, Klungland and Lindahl, 1997, Karimi-Busheri et al., 1998, Fortini et al., 
1998, Winters et al., 1999, Fortini et al., 1999, Dianov et al., 1999, Whitehouse et al., 2001, 
Podlutsky et al., 2001b, Pascucci et al., 2002, Dianova et al., 2004, Vens et al., 2007).  
Quiescent Polβ-/- MEFs exhibit sensitivity to γ-irradiation, although this sensitivity is not evident 
in cycling Polβ-/- MEFs (Vermeulen et al., 2007b, Vermeulen et al., 2008). 
 
It is important to note that there is some Polβ independent short-patch repair seen in the Polβ-
/- MEF extracts showing that there is functional redundancy at the level of DNA polymerase 
choice in short-patch repair (Braithwaite et al., 2005b).  DNA polymerase λ (Polλ), also a 
member of the same X-family of polymerase, has significant sequence homology with Polβ and 
also has 5’dRP lyase activity (Garcia-Diaz et al., 2000, Nagasawa et al., 2000, Garcia-Diaz et al., 
2001, Garcia-Diaz et al., 2002). It has been shown that Polλ can carry out single nucleotide 
incorporation during short-patch repair in the absence of Polβ (Garcia-Diaz et al., 2001, 
Braithwaite et al., 2005a, Braithwaite et al., 2005b, Braithwaite et al., 2010).  Another potential 
polymerase that could add to the functional redundancy within short-patch repair is Pol ι, a 
member of the Y- family of polymerases.  The Y-family polymerases are low-fidelity 
polymerases which are involved in the bypass of DNA lesions during translesion synthesis 
(Reviewed in (Prakash et al., 2005)).  Like both Polβ and Polλ, Polι has 5’dRP lyase activity and 
can also carry out single nucleotide incorporation in the absence of Polβ (Bebenek et al., 2001, 
Prasad et al., 2003, Vens et al., 2007).  Additionally Polι depleted human fibroblasts are 
hypersensitive to hydrogen peroxide (Petta et al., 2008).   
 
A number of polymerases have been implicated in long-patch repair.  It has been suggested 
that Polβ can carry out strand displacement synthesis during long-patch repair in a reaction 
that is stimulated by the presence of PARP1 and FEN1 (Dianov et al., 1999, Prasad et al., 2001, 
Prasad et al., 2000, Liu et al., 2005, Balakrishnan et al., 2009).  On the other hand it has also 
been suggested that Polβ is only responsible for the initiation of synthesis and other 
polymerases carry out the strand displacement reaction (Parlanti et al., 2004, Podlutsky et al., 
35 
 
2001a, Dianov et al., 2001, Dianov et al., 1999).  Experiments using extracts from Polβ-/- MEFs, 
however, show that Polβ is not the only polymerase that can operate in long-patch repair and 
it has been shown that the replicative polymerases DNA polymerase δ and ε (Polδ/ε) can also 
carry out strand displacement synthesis in a reaction that is dependent on the presence of 
proliferating cell nuclear antigen (PCNA) (Dresler and Lieberman, 1983a, Dresler and 
Lieberman, 1983b, DiGiuseppe and Dresler, 1989, Frosina et al., 1996, Klungland and Lindahl, 
1997, Stucki et al., 1998, Fortini et al., 1998, Pascucci et al., 1999, Matsumoto et al., 1999, 
Dogliotti et al., 2001, Parlanti et al., 2004, Parsons et al., 2007).  Additionally it has also been 
suggested that Polλ also operates during long-patch repair which adds further potential 
redundancy to long-patch repair (Brown et al., 2011).   
 
It is thought that it is the nature of the DNA lesion which determines which sub-pathway of 
SSBR is used.  An example of this is in the presence of a reduced AP site that is resistant to the 
AP lyase activity of Polβ which is repaired by a FEN1 dependent long-patch repair pathway as 
short-patch repair would be unable to repair the lesion (Matsumoto et al., 1994, Matsumoto 
and Kim, 1995, Klungland and Lindahl, 1997, Miller and Chinault, 1982b, Miller and Chinault, 
1982a).  Another observation that has been made is that in vitro different sub-pathways are 
utilised depending on the glycosylase that initiates BER (Fortini et al., 1999).  Finally it has also 
been proposed that cellular concentrations of ATP could also determine sub-pathway choice in 
a mechanism that is regulated by XRCC1 and LigIIIα (Petermann et al., 2003, Petermann et al., 
2006).  In this model short-patch repair would be favoured in conditions with lower levels of 
cellular ATP.   
 
1.3.4 DNA Ligation 
Following gap-filling, the final stage of SSBR is DNA ligation.  This is achieved in mammalian 
cells by two DNA ligases; DNA Ligase III α (LigIIIα) and DNA Ligase I (LigI) (Figure 1.10) 
(Reviewed in (Ellenberger and Tomkinson, 2008a)).  LigIIIα is the ligase that is predominantly 
associated with short-patch repair (Brookman et al., 1994, Caldecott et al., 1994, Caldecott et 
al., 1995, Cappelli et al., 1997, Winters et al., 1999, Sleeth et al., 2004).  LigIIIα is one of three 
polypeptides that is generated by the LIG3 gene; which include the nuclear version that 
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interacts with XRCC1 (LigIIIα), a mitochondrial version of LigIIIα (mtLigIIIα), which differs to the 
nuclear version only with the presence of an N-terminal mitochondrial localisation signal 
(MLS), and a germ-line specific isoform that lacks the C-terminal BRCT that is generated by an 
alternative splicing event called LigIIIβ which lacks the C-terminal BRCT domain (Lakshmipathy 
and Campbell, 1999, Perez-Jannotti et al., 2001, Mackey et al., 1997). 
 
The nuclear LigIIIα protein consists of two distinct DNA binding modules.  The first is comprised 
of an N-terminal ZnF motif and an internal DNA binding domain and the second contains the 
catalytic core (Cotner-Gohara et al., 2008).  The ZnF domain allows LigIIIα to act as a nick 
sensor and, although dispensable for simple nick ligation, is required for the efficient repair of 
SSBs in the presence of abnormal secondary structure of DNA or other DNA lesions (Caldecott 
et al., 1996, Mackey et al., 1999, Taylor et al., 2000b).  The second module consists of the 
nucleotidyltransferase (NTase) domain and oligonucleotide binding (OB-fold) domain and a C-
terminal BRCT domain.  The BRCT motif of LigIIIα forms a constitutive interaction with the 
second BRCT domain of XRCC1, and although recombinant LigIIIα is stable in vitro, this 
interaction is required for stability of the ligase in vivo (Caldecott et al., 1994, Caldecott et al., 
1995, Nash et al., 1997, Taylor et al., 1998, Dulic et al., 2001).  LigIIIα also has the ability to 
ligate DSBs, which requires both the N-terminal ZnF and the catalytic core (Cotner-Gohara et 
al., 2008).  
 
While LigIIIα is usually associated with short-patch repair, LigI is thought of as the ligase that is 
involved in long-patch repair (Karimi-Busheri et al., 1998, Matsumoto et al., 1999, Pascucci et 
al., 1999, Prasad et al., 1996, Winters et al., 1999, Sleeth et al., 2004).  An interaction between 
LigI and PCNA has also been shown to be crucial to its role in long-patch repair (Levin et al., 
1997, Levin et al., 2000).   Aside from its role in SSBR, LigI also has an essential role in the 
maturation of Okazaki fragments during DNA replication (Waga and Stillman, 1998).  Like 
LigIIIα, LigI has a central region consisting of a DNA binding domain, an NTase domain and an 
OB-fold, however the ZnF and BRCT domains are unique to LigIIIα which likely reflect the 
different roles of the ligases.   It is important to note that the roles of the two ligases in the 
different sub-pathways has largely been demonstrated using in vitro repair assays and two 
recent studies have in which XRCC1 and LigIIIα were inactivated in the mouse nervous system 
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has challenged the current dogma of which ligases are involved in short-patch and long-patch 
repair (Simsek et al., 2011, Katyal and McKinnon, 2011, Gao et al., 2011).  In these studies it 
was shown that the essential function of LigIIIα was its role in mitochondrial repair and LigI 
was implicated as the main DNA ligase in XRCC1-mediated SSBR.  Indeed, LigIIIα-deficient cells 
were found to exhibit normal or near-normal rates of SSBR following oxidative DNA damage 
while LigI-deficient cells exhibited delayed rates of SSBR (Gao et al., 2011).  It is likely that the 
simple model of different ligases functioning seperately in short-patch repair and long-patch 
repair is untrue and that the roles of LigIIIα and LigI in SSBR are more overlapping than 
previously thought. 
  
1.3.4.1 Reaction mechanism of mammalian ligases 
DNA ligases are nucleotidyltransferases (NTases) that utilise a high energy cofactor to catalyse 
phosphodiseter bond formation in a universal three-step reaction mechanism that includes an 
intermediate in which the 5’ terminus of the nick becomes adenylated (Figure 1.11) (Olivera et 
al., 1968, Harvey et al., 1971, Weiss et al., 1968b, Gumport and Lehman, 1971, Lehmann, 
1978).  Under certain circumstances, such as a premature attempt to ligate a SSB with a 
damaged 3’ terminus, the ligation reaction will stall and a stable abortive ligation intermediate 
will persist (Shuman, 1995, Sriskanda and Shuman, 1998c, Ahel et al., 2006).  The discovery of 
the neurodegenerative disorder AOA1, a disease caused by mutations in APTX, suggests that 
adenylated SSBs could be physiologically relevant lesions in cells (Date et al., 2001, Barbot et 
al., 2001).   
 
All eukaryotic ligases use ATP as a cofactor and contain six highly conserved NTase motifs.  
Details of the reaction mechanism have been elucidated from extensive functional and 
structural studies using the DNA ligase of the Chlorella Virus PBCV-1 (CV Lig) (Ho et al., 1997).  
This is the smallest known eukaryotic ATP-dependant DNA ligase and although it consists of 
only the catalytic core it can almost fully compensate the loss of both S.cerevisiae DNA ligases, 
Cdc9p and Lig4p, in vivo making it an appropriate model system for studying DNA ligation 
(Sriskanda et al., 1999).   
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In the first step of DNA ligation, the ligase reacts with ATP to form a ligase-adenylate 
intermediate in which AMP is covalently linked to the active-site lysine via a phosphoamide 
bond (Olivera et al., 1968, Harvey et al., 1971, Weiss et al., 1968b, Gumport and Lehman, 1971, 
Lehmann, 1978).  This reaction is very energetically favourable and the ligase-adenylate 
intermediate is stable in the absence of a DNA substrate.  The majority of DNA ligases, 
including LigIIIα, have a significantly higher affinity for a nicked or broken DNA duplex than an 
intact duplex (Sekiguchi and Shuman, 1997, Caldecott et al., 1996, Sriskanda et al., 1999).  This 
is described as nick sensing and the covalent lysine-AMP adduct is a crucial part of this as the 
AMP forms contacts with the 5’P termini of a nick, allowing a ligase adenylate to bind tightly to 
broken DNA (Sekiguchi and Shuman, 1997, Sriskanda and Shuman, 1998a, Odell et al., 2000, 
Odell et al., 2003, Nair et al., 2007b).  Mutations in the critical active site lysine that forms the 
covalent bond with AMP abolishes both ligase adenylation and nick sensing, whereas 
mutations that preserve ligase adenylation but prevent the downstream stages of ligation do 
not affect nick sensing (Sriskanda and Shuman, 1998a).   
 
This mechanism ensures that only an adenylated ligase primed for ligation will bind to a DNA 
nick and will prevent competition with a non-adenylated ligase.  It has also been shown that a 
ligase will not bind to an un-ligatable nick with a 5’OH, allowing the ligase to possess a degree 
of proof-reading ability for the suitability of a nick (Sekiguchi and Shuman, 1997, Sriskanda and 
Shuman, 1998a, Odell et al., 2000, Odell et al., 2003, Tomkinson et al., 2006, Nair et al., 
2007b).  This ability to proof-read the suitability of a nick is, however, not perfect as a ligase 
will still adenylate a 5’dRP and does not seem to be able to differentiate between this and a 
5’P (Rass et al., 2007a).   
 
The second step of ligation is the activation of the 5’P by adenylation of the DNA (Olivera et al., 
1968, Harvey et al., 1971).  During this step the oxygen of the 5’P attacks the phosphorus of 
the AMP, dispelling the lysine and transferring the adenylate group onto the 5’P, forming an 
AMP-DNA intermediate (Odell et al., 2003, Nair et al., 2007b).  This is facilitated by a 
conformational change in the ligase and a possible reconfiguration of metal ions in the active 
site (Odell et al., 2003, Nair et al., 2007b).  It has been proposed that the 3’-OH participates in 
binding of the catalytic metal ions required for the reaction and that this could act as another 
39 
 
checkpoint to dissuade the ligase from prematurely adenylating an un-ligatable nick (Nair et 
al., 2007b). 
 
The final step of ligation is the reformation of the phosphodiester backbone (Lehmann, 1978).  
During this step the non-adenylated ligase catalyses the nucleophilic attack of the 5’AMP by 
the 3’OH, displacing the AMP and joining the two polynucleotides by formation of a 
phosphodiester bond (Odell et al., 2000, Sriskanda and Shuman, 2002b, Sriskanda and 
Shuman, 2002a, Crut et al., 2008, Nair et al., 2007b).  This step is very rapid, and the rate of 
phosphodiester resynthesis is much faster than the adenylation of the DNA (Crut et al., 2008).  
Less data is available about this step of ligation as it is so rapid and the only crystal structure of 
a non-adenylated ligase bound to adenylated DNA used nick with a 3’dideoxynucleoside rather 
than a 3’OH to block phosphodiester formation and could have disrupted metal ion 
coordination in the active site (Pascal et al., 2004).     
 
1.3.5 Replication-coupled single strand break repair 
The SSBR pathways described above are very rapid and seem to operate throughout the cell 
cycle and are therefore described as ‘global SSBR’ (Reviewed in (Caldecott, 2008)).  However 
there is some evidence that alternate SSBR pathways operate at different times throughout 
the cell cycle, specifically during S-phase.  It has been shown that XRCC1 co-localises with PCNA 
at replication foci (Fan et al., 2004) and a complex consisting of APE1, UNG2, XRCC1 and Polβ 
replicative Polα, Pol δ /ε and DNA ligase 1 co-associates with DNA replication proteins in 
human cycling cells (Parlanti et al., 2007, Otterlei et al., 1999).   Additionally it has been shown 
that the BRCT domains within XRCC1 have a role in the repair of SSBs during S-phase (Taylor et 
al., 2000a).  It is possible that a core SSBR complex associates with the replication fork during 
S-phase and deals with any SSBs that are encountered.  This hypothetical pathway has been 
termed replication-coupled SSBR (RC-SSBR) (Figure 1.12) (Caldecott, 2008, Caldecott, 2001, 
Caldecott, 2003b).  It is considered likely that this hypothetical pathway would resemble long-
patch repair due to the fact that many of the proteins involved in long-patch repair, such as 
Polδ/ε, PCNA, FEN1 and LigI, are also core components of the replication machinery.  It has 
also been suggested that this pathway could operate in conjunction with the double-strand 
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break repair pathway homologous recombination (HR) due to the fact that SSBs converted into 
DSBs upon collision with the replication fork are substrates for HR (Kouzminova and Kuzminov, 
2006, Kuzminov, 2001).  This also raises the possibility that the structure specific nucleases 
that operate during HR could also play a role in RC-SSBR.  One of the attractions of this 
hypothetical pathway is that the presence of this pathway could explain the lack of cancer 
predisposition in SSBR defective disorder as any unrepaired SSBs encountered by the 
replication fork would be repaired by RC-SSBR and would not become a permanent block to 
replication.   
 
1.3.6 SSBs and Transcription 
The survival of the cell depends on not just the accurate replication of the genome, but also on 
the unperturbed transcription of the many coding and regulatory regions within the genome 
and therefore DNA lesions located within these transcribed regions of the genome can result 
in a number of deleterious effects.  Transcribing past the damage can result in mutations due 
to base misinsertions opposite the lesion, the presence of the lesion can affect the rate of 
transcription, altering the expression level of the damaged gene, and finally transcription can 
be completely blocked, leading to loss of the transcript (Zhou and Doetsch, 1994, Saxowsky 
and Doetsch, 2006, Tornaletti, 2009). 
 
 The role of dedicated repair pathways, such as transcription-coupled repair (TCR) in the 
recognition and repair of specific transcription blocking lesions, such as cyclobutane 
pyrimidines (CPD) and intrastrand crosslinks, is already well established and is described later 
in Section 1.6 (Tornaletti, 2009, Nouspikel, 2009, Lagerwerf et al., 2011).  Indeed there are 
human disorders, such as the microcephalic cockayne syndrome, which are associated with 
defects in the repair of DNA lesions in transcribed genes, highlighting the cytotoxicity of 
unrepaired transcription-blocking lesions (Lehmann, 2003).  There is evidence that SSBs can 
also block RNA polymerases and that SSBR has a role in protecting against transcription 
blocking DNA damage, although this is not as well established as TCR.   
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It is known that collision with transcription machinery converts Top1 cleavage complexes into 
abortive Top1-SSB (Kroeger and Rowe, 1989, Bendixen et al., 1990, Wu and Liu, 1997).  Indeed 
a significant portion of the accumulating abortive Top1-SSBs seen in TDP1-defective cell lines 
following incubation with camptothecin (CPT), a Top1 poison that increases the half-life of 
Top1 cleavage complexes, is dependent on the presence of active transcription as shown by 
their disappearance upon incubation with the RNA polymerase inhibitor α-amanitin (Miao et 
al., 2006, El-Khamisy et al., 2005).  Additionally, CPT-induced SSBs still accumulate in TDP1-
defective cell lines in the presence of the replication inhibitor aphidicolin showing that TDP1 
dependent SSBR has a role in protecting the cell against transcription blocking lesions (Miao et 
al., 2006, El-Khamisy et al., 2005).  The DNA glycoslysase NEIL2 has also been shown to 
associate with RNA polymerase II and to preferentially repair oxidised bases within transcibed 
genes, further supporting a role for SSBR in the repair of transcription-blocking lesions 
(Banerjee et al., 2011).   
 
1.4 DNA Double Strand Breaks 
DNA double strand breaks (DSB) are discontinuities in both strands of the DNA double helix 
and can arise from both endogenous and exogenous sources.  Although rare lesions, it is 
estimated that only 10 spontaneous DSBs arise per cell per day based on experiments 
performed on early passage primary human fibroblasts (Lieber et al., 2003, Lieber and 
Karanjawala, 2004, Martin et al., 1985), DSBs are considered to be particularly genotoxic 
lesions and a single unrepaired DSB can be sufficient to induce apoptosis (Rich et al., 2000).  
Failure to repair the breaks correctly can lead to chromosomal rearrangements, including 
translocations and deletions, chromosomal miss-segregation during mitosis and/or cell death 
(Hoeijmakers, 2001).    
 
Like SSBs, DSBs can be generated directly if the attack of free radicals on the sugar-phosphate 
backbone of the DNA double helix, results in the disintegration of two closely located oxidised 
sugars on anti-parallel strands of the DNA double helix (Ward et al., 1987, Ward, 1998).  
Ionising radiation is a major source of DSBs as the IR particles create localised clusters of ROS 
as they pass through the cell, predominantly from water, increasing the chance that two 
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closely spaced lesions will arise.  Indeed, unlike hydrogen peroxide which induces one DSB for 
every ~2000 SSBs, IR generates one DSB for every 25 - 40 SSBs (Friedberg EC et al., 2006, Ward 
et al., 1987, Ward, 1998).   
 
Endogenous DSBs can arise from a number of sources; as the result of the abortive activity of 
type II DNA topoisomerases which transiently nick both strands of the duplex, by the collision 
of a replication fork with a SSB during DNA replication, forming a one ended DSB, or from 
mechanical stress on chromosomes such as during chromosomal segregation in mitosis 
(Adachi et al., 2003, Friedberg et al., 2006, Kuzminov, 2001, Hoeijmakers, 2001, Kouzminova 
and Kuzminov, 2006). 
 
1.5 Double strand break repair 
The accurate repair of DSBs is vital to the survival to the cell and an intricate network of 
signalling cascades and double-strand break repair (DSBR) pathways have evolved to ensure 
unrepaired breaks do not persist to threaten genomic stability.  Mammalian cells have evolved 
two major double-strand break repair (DSBR) pathways to deal with DSBs; non-homologous 
end-joining (NHEJ), an efficient DSBR pathway that operates throughout the cell cycle but is 
particularly importance during the G1 and early S phases of the cell cycle, and homologous 
recombination (HR), a repair pathway that predominantly operates during late S –phase and 
G2 (Reviewed in (Hartlerode and Scully, 2009, Lieber, 2010).  In addition there are a number of 
DSB sensors that can detect and signal the presence of a DSB to facilitate its rapid repair.  In 
this section I will discuss the two main DSBR pathways, NHEJ and HR, and detail DSB signalling 
by the protein kinase ataxia telangiectasia mutated (ATM).   
 
1.5.1 Non-homologous end-joining 
NHEJ is an efficient error-free DSBR pathway that aims to accurately religate the ends of a DSB 
with no loss of genetic information (Figure 1.13) (Hartlerode and Scully, 2009, Mahaney et al., 
2009, Lieber, 2010).   As NHEJ does not require a homologous sequence for accurate repair it 
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operates throughout the cell cycle and is of particular importance during G0, G1 and early S-
phase when a sister chromatid is not available for use as a donor template (Takata et al., 1998, 
Sonoda et al., 2006, Delacote and Lopez, 2008).   
 
NHEJ is initiated by the rapid binding of the Ku70/80 heterodimer to both ends of the DSB.  
Upon binding to the DSB, Ku70/80 forms a ring-like structure that encircles the DNA and 
translocates inwards, making the ends of the DNA accessible to other DNA repair factors such 
as DNA dependent protein kinase (DNA PK) (Walker et al., 2001, Yoo and Dynan, 1999).  The 
recruitment of the catalytic subunit of the DNA PK (DNA PKcs) then occurs in the presence of 
both Ku and DNA to for the active holoenzyme DNA PK (Jin et al., 1997, Uematsu et al., 2007, 
Suwa et al., 1994).  The activated DNA PK then loads onto the exposed DNA termini on both 
sides of the DSB and interacts across the break to form a ‘synaptic complex’ (DeFazio et al., 
2002).  This ‘synaptic complex’ acts to tether the ends of the DSB to each other and to offer 
protection against unwanted processing by nucleases.  The assembly of the DNA PKcs/Ku/DSB 
synaptic complex also stimulates the kinase activity of DNA PK, resulting in the disassociation 
of DNA-PK from the break and allowing access of other repair factors to the DNA ends (Meek 
et al., 2007).  The poly (ADP) ribose polymerase protein PARP3 also has a role in DSB signalling 
and is activated upon induction of a break, ribosylating itself and other substrate proteins such 
as histones (Rulten et al., 2011, Rulten et al., 2008, Iles et al., 2007).   
 
The next stage of NHEJ is the processing of the DNA termini at the ends of the DSB to restore 
conventional ligatable 3’OH and 5’P.  Like SSBs, DSBs can have a multitude of different 
chemistries and structures at the DNA ends, depending on the source of the damage, and 
therefore require a diverse set of end-processing enzymes to repair.  Artemis is key NHEJ end-
processing factor that is reported to possess a number of different repair activities, including 5’ 
→ 3’ exonuclease and 3’PG processing activity and the ability to resolve DNA hairpins (Ma et 
al., 2002, Ma et al., 2005, Povirk et al., 2007).  Artemis is recruited to DSBs via an interaction 
with DNA PKcs, and it seems likely that Artemis is involved in multiple aspects of NHEJ (Ma et 
al., 2002).   
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Another processing factor that is likely to have a role in NHEJ is PNKP.  As discussed in section 
1.3.2, PNKP plays a very important role in SSBR in the processing of SSBs induced by a variety 
of DNA damaging agents aided by an interaction with XRCC1 (Jilani et al., 1999, Karimi-Busheri 
et al., 1998, Whitehouse et al., 2001, Bernstein et al., 2005b).  PNKP also interacts with CK2 
phosphorylated XRCC4 and it is believed that it performs a similar role in the processing of 
DSBs during NHEJ (Ward, 1998, Chappell et al., 2002, Bernstein et al., 2005a, Koch et al., 2004, 
Karimi-Busheri et al., 2007, Mani et al., 2010, Segal-Raz et al., 2011).  Similarly, APTX is another 
end-processing factor that interacts with both CK2 phosphorylated XRCC1 and XRCC4 and has 
been shown to remove adenylate groups from the 5’ termini of both SSBs and DSBs, and has 
also been implicated in DSBR (Clements et al., 2004, Rass et al., 2007a).   
 
Another end-processing factor that has a potential role in NHEJ is tyrosyl-DNA 
phosphodiesterase 2 (TDP2), a protein that resolves damage arising from abortive 
topoisomerase 2 (Top2) activity.  Top2 induces DSBs in a reaction mechanism that involves an 
intermediate in which the topoisomerase becomes covalently linked to the 5’termini of the 
break via a phosphotyrosyl bond (Wang, 2002, Nitiss, 2009b, Nitiss, 2009a).  Normally this is a 
very transient intermediate and the DSB is rapidly resealed in the final stage of the reaction, 
but under certain circumstances, such as in the presence of Top2 poisons, a stable DSB with 
Top2 linked to the 5’ termini can form which requires processing to resolve.  Tdp2 is a recently 
identified phosphodiesterase that cleaves 5’ - phosphotyrosyl bonds and has been shown to 
repair Top2 – DSBs (Zeng et al., 2011, Cortes Ledesma et al., 2009).  Tdp2 generates clean 
ligatable DNA ends and it is very likely that it functions during NHEJ to promote the error-free 
repair of abortive Top2 – DSBs.  Finally Ku has also been reported to possess 5’-dRP/AP lysase 
activity, suggesting a role in the processing of DNA ends in addition to its main role in NHEJ 
(Roberts et al., 2010).   
 
Often the processing of DSBs leads to the creation of DNA gaps, which require the action of a 
DNA polymerase to repair.  The DNA polymerase X family of polymerases have been implicated 
in carrying out gap-filling during NHEJ, including polymerases μ and λ, which interact with Ku 
and XRCC4/LigIV,  and terminal deoxyribonucleotidyltransferase (TdT), which interacts with Ku, 
(Nick McElhinny and Ramsden, 2004, Mueller et al., 2008).   
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Once the DNA termini have been processed, and any gaps have been filled, the final stage of 
NHEJ is DNA ligation.  Ligation of the DSB is carried out by DNA LigIV in a complex with XRCC4 
(Critchlow et al., 1997, Grawunder et al., 1997, Sibanda et al., 2001, Grawunder et al., 1998a, 
Grawunder et al., 1998b).  Like XRCC1, XRCC4 has no enzymatic activity but has a critical role in 
NHEJ, acting as a scaffolding protein to facilitate the recruitment of repair factors to the site of 
the break (Mari et al., 2006).  The recruitment and stability of XRCC4-LigIV at the DSB is 
mediated by interactions with Ku70/80, DNA PK and the ADP-ribose binding protein, aprataxin 
and PNK- like factor (APLF) (Mehrotra et al., 2011, Rulten et al., 2011, Rulten et al., 2008, 
Macrae et al., 2008, Iles et al., 2007, Mari et al., 2006, Costantini et al., 2007, Nick McElhinny 
et al., 2000).  XRCC4 –like factor (XLF) is another factor that is recruited to DSBs via an 
interaction with Ku70/80 and functions to stimulate NHEJ (Ahnesorg et al., 2006, Yano et al., 
2008).  XLF is similar in structure to XRCC4 and facilitates rapid end-joining by stimulating the 
DNA ligation and promoting the re-adenylation of LigIV following end-joining (Gu et al., 2007, 
Tsai et al., 2007, Lu et al., 2007, Wu et al., 2007, Riballo et al., 2009, Hammel et al., 2011).   
 
1.5.2 Homology directed repair 
A series of pathways in operation in cells that use a homologous sequence from an undamaged 
donor template to repair a DSB are collectively called homology directed repair (HDR) (Figure 
1.14) (Paques and Haber, 1999, Hartlerode and Scully, 2009).  These pathways are of particular 
importance during the late S-phase and G2 phases of the cell cycle owing to the existence and 
close proximity of sister chromatids (Delacote and Lopez, 2008, Sonoda et al., 2006).   
 
The Mre11-Rad50-NBS1 (MRN) complex plays a critical role in the early response to DSBs 
during HDR (Williams et al., 2007).  Amongst its many roles it is thought that two MRN 
complexes carry out a similar function during HDR to the DNA PKcs/Ku/DSB synaptic complex 
in NHEJ by tethering the ends of a DSB together via homodimerisation of the Rad50 subunit 
(Hopfner et al., 2002, Williams et al., 2008, Lavin, 2007).  Following detection of the break, the 
DNA ends are resected in a 5’ → 3’ direction to generate 3’ ssDNA overhangs with a 3’OH.  
MRN, in co-operation with CtIP, has been shown to initiate DNA resection by trimming of the 
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DNA ends (Sartori et al., 2007, Huertas and Jackson, 2009, You et al., 2009b, Nicolette et al., 
2010a, Paull, 2010b, Coleman and Greenberg, 2011, Mimitou and Symington, 2008).  The bulk 
of end resection is then carried out by two nucleases, DNA2 and EXO1, in combination with the 
helicase BLM (Nimonkar et al., 2011, Cejka et al., 2010, Zhu et al., 2008, Mimitou and 
Symington, 2008).  Another factor which has been implicated in the regulation of DNA 
resection is BRCA1 (Coleman and Greenberg, 2011).   
 
The ssDNA generated by resection is rapidly bound by the ssDNA binding protein RPA which 
melts the DNA’s secondary structure (Sung and Klein, 2006).  RPA is then displaced from the 
ssDNA by the Rad51 recombinase with the help of the mediator proteins BRCA1/BARD1 and 
BRCA2/DSS1 to form a Rad51 nucleofilament which carries out the strand invasion and 
homology search steps of HDR (Sy et al., 2009, Zhang et al., 2009, Wong et al., 1997, Pellegrini 
et al., 2002, San Filippo et al., 2006).  Strand invasion occurs by the capture of the intact duplex 
by the Rad51 nucleofilament which forms a D-loop intermediate, where the 3’ termini of the 
invading strand is primed for DNA synthesis.  It is at this stage that various hypothesised 
pathways of HDR diverge (Figure 1.14).   
 
In the synthesis-dependent strand-annealing model (SDSA), following DNA synthesis and D-
loop migration, the newly synthesised invading strand is displaced and anneals back to the 
second resected end of the break (West, 2003, Paques and Haber, 1999, Hartlerode and Scully, 
2009).  In the homologous recombination (HR) pathway, the resected second DNA end is 
captured by the migrating D-loop, forming double holiday-junctions (HJ) (Paques and Haber, 
1999, Hartlerode and Scully, 2009).  These double HJs are then resolved enzymatically by a 
number of structure – specific endonucleases (Wu and Hickson, 2003, Chen et al., 2001, Rass 
et al., 2010, Svendsen and Harper, 2010).  Depending on the orientation of resolution this can 
lead to either a crossover or non-crossover in event (Paques and Haber, 1999, Hartlerode and 
Scully, 2009).   
 
Single-strand annealing (SSA) is an error prone HDR pathway that can occur when a DSB arises 
between two direct repeats (Paques and Haber, 1999, Hartlerode and Scully, 2009).  Resection 
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of the DNA ends uncovers the repeats, generating two complementary single strands that 
anneal together.  The resulting DNA flaps generated are excised and the DNA nicks are ligated.  
Finally break – induced recombination (BIR) occurs when a one-ended DSB invades the intact 
duplex, forming a recombination induced replication fork (Paques and Haber, 1999, Hartlerode 
and Scully, 2009).  This could be a particularly important repair pathway during DNA 
replication as a way of restarting a collapsed replication fork caused when an elongating fork 
collides with a SSB (Kuzminov, 2001).   
 
1.5.3 ATM dependent DNA double strand break signalling 
Ataxia telangiectasia mutated (ATM) is a member of phosphatidylinositol 3-kinase-related 
kinases (PIKK) family of serine/threonine protein kinases, which includes DNA PK, and plays a 
critical role in the coordination of events that take place during DSB sensing and repair (Figure 
1.15).  ATM is rapidly recruited to DSBs and immediately phosphorylates serine 139 on the 
histone variant H2AX to produce γH2AX (Burma et al., 2001).  The ATM activity is partially 
dependent on the presence of MRN, another DSB sensor that rapidly accumulates at sites of 
damage, and it is thought that these two DSB sensors act in concert to promote a complete 
and efficient DNA damage response and repair (Uziel et al., 2003, Lavin, 2007, Williams et al., 
2007).   
 
Following the formation of γH2AX, the adaptor protein mediator of DNA damage checkpoint 
protein 1 (MDC1) is recruited to the break via its BRCT repeats and is phosphorylated by ATM 
(Stucki and Jackson, 2004, Lukas et al., 2004).  MDC1 binds to the phosphorylated histone and 
is thought to act as a protein platform to help stabilise DDR proteins at the break.  It also helps 
to propagate the spreading of the γH2AX signal, recruiting more ATM to the break via its FHA 
domain, which in turn phosphorylates H2AX further away from the break (Lou et al., 2006).  
H2AX phosphorylation can spread for up to 1-2 megabases around the DSB, which is important 
for sustaining the DDR (Celeste et al., 2002, Harper and Elledge, 2007). 
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A cascade of ubiquitin modification at sites of DSBs adds another layer to the DNA damage 
response (DDR).  The E3 ubiquitin ligase ring finger protein 8 (RNF8) interacts with 
phosphorylated MDC1 at the break and ubiquitinates H2A and γH2AX at the site of the break 
(Huen et al., 2007, Kolas et al., 2007, Mailand et al., 2007).  A second and third E3 ligase are 
then recruited to the break, RNF168 via a ubiquitin interacting motif, binds to the ubiquinated 
histones and, HERC2, interacting with the FHA domain of RNF8, to stimulate further 
ubquitination around the break (Doil et al., 2009, Stewart et al., 2007, Bekker-Jensen et al., 
2010).  The spreading of the ubiquitin chains leads to the recruitment of RAP80, BRCA1 and 
53BP1 (Huen et al., 2007, Kolas et al., 2007, Lavin, 2008).  53BP1 plays an important that role in 
the DNA damage response, although precisely what that role is has yet to be discerned.   
 
1.6 Nucleotide excision repair 
Nucleotide excision repair (NER) is one of the most versatile DNA repair pathways within 
mammalian cells (Figure 1.16) (Nouspikel, 2009).  It recognises and repairs a wide range of 
DNA lesions, including bulky DNA adducts that result in the distortion of the DNA double helix.  
Bulky, helix distorting adducts can be caused by exposure to UV light, in particular UVB 
radiation which is a component of sunlight, resulting in the formation of photodamage within 
DNA (Cadet et al., 2005a, Douki and Cadet, 2001).  Cyclobutane pyrimidines (CPD) and (6-4) 
pyrimidine photoproducts ((6-4)PP) are the most commonly occuring type of lesion (Figure 
1.17) (Cadet et al., 2005b).  Other types bulky DNA adducts that are repaired by NER include 
DNA lesions induced by polycyclic aromatic hydrocarbons which are commonly found in air, 
food and drinking water as well as in tobacco smoke (Perera et al., 2005).   
  
NER achieves its versatility by excising a short patch of DNA surrounding the lesion, bypassing 
the need for specific DNA repair enzymes.  There are two pathways that operate within NER; 
global genome NER (GGR), which recognises and repairs DNA adducts that cause major 
distortions of the double helix anywhere in the genome, and transcription coupled repair 
(TCR), which repairs transcription blocking lesions (Gillet and Scharer, 2006, Tornaletti, 2009, 
Nouspikel, 2009).   
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There are two major damage detection complexes involved in GGR.  The XPC complex is 
involved in the recognition of lesions that cause major distortions in the double helix, such as 
(6-4)PPs (Kusumoto et al., 2001, Sugasawa et al., 2001, Araki et al., 2001).  However the XPC 
complex is unable to recognise lesions which only cause small distortions in the double helix, 
such as CPDs and recognition of these lesions is performed by the XPE complex (also known as 
the DDB complex) (Kim et al., 1995, Payne and Chu, 1994).  In TCR, the lesion is only 
recognised when it is encountered by an elongating RNA polymerase, which causes stalling of 
the transcription bubble (Payne and Chu, 1994).  CSA and CSB are two proteins that are 
recruited to the site of the stalled transcription complex and are required for efficient TCR (Tu 
et al., 1997, Tijsterman et al., 1997, Tu et al., 1998, Tantin, 1998).  Following detection of the 
lesion, the GGR and TCR pathways converge and are mechanistically identical.   
 
The next stage of NER is the unwinding of the DNA helix to form a bubble around the lesion.  
This is carried out by the transcription factor TFIIH, a large complex consisting of 10 subunits, 
including the two ATP-dependent DNA helicases XPB and XPD, which have opposing 3’ → 5’ 
and 5’ → 3’ helicase activities respectively  (Tapias et al., 2004, Tantin, 1998, Drapkin et al., 
1994).  It is at this stage that the proteins XPA, XPG and the ssDNA binding protein RPA are 
recruited via interactions with TFIIH (Araujo et al., 2001, Volker et al., 2001).  XPA is absolutely 
essential for NER to take place although its precise role has not yet been determined (Tanaka 
et al., 1990, Gillet and Scharer, 2006, Park and Choi, 2006).  One potential role it could perform 
is damage verification to ensure that RPA coats only the undamaged DNA strand, allowing 
proper assembly of the pre-incision complex (Hermanson-Miller and Turchi, 2002, Sugasawa et 
al., 1998).  The coating of RPA on the undamaged DNA strand is essential for the incision and 
repair synthesis stages (Mu et al., 1995, Coverley et al., 1992, Guzder et al., 1995).  The final 
protein to be recruited to the pre-incision complex is ERCC1-XPF via an interaction with XPA (Li 
et al., 1995a, Saijo et al., 1996, Park and Sancar, 1994, Nagai et al., 1995, Li et al., 1994).   
 
Following formation of the denaturation bubble and assembly of the pre-incision complex, 
dual incisions are made at the 3’ and 5’ ends of the bubble at the ssDNA-dsDNA junction by the 
structure-specific endonucleases XPG and ERCC1-XPF respectively (O'Donovan et al., 1994, 
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Sijbers et al., 1996, Park et al., 1995, Matsunaga et al., 1995).  Following excision, the gap is 
filled by the replicative polymerases Pol δ and Pol ε in association with PCNA, and the 
remaining nick is ligated by the XRCC1-LigIII complex (Popanda and Thielmann, 1992, Shivji et 
al., 1992, Moser et al., 2007).   
 
1.7 Mismatch repair 
Canonical Watson-Crick base pairing, in which A pairs with T and G pairs with C, is an inherent 
feature of the structure of double stranded DNA and allows for the error-free duplication and 
maintenance of genetic information (Watson and Hayes, 1953).  However, alternative 
configurations of base-pairing, called DNA mismatches can occur.  DNA mismatches can 
involve non-Watson-Crick combinations of bases, including G-T, A-C, A-A, G-G, A-G, C-T, C-C 
and T-T, the pairing of undamaged bases with damaged bases, such as of 8-oxo-G with A or 
O6meG with C, mismatches arising loops from small nucleotide insertions or deletions or 
mismatches arising between undamaged bases and uracil (Li, 2008, Kunz et al., 2009).  DNA 
mismatches that arise as the result of base damage are generally repaired by specific DNA 
glycosylases during BER (Table 1.1) while other types of DNA mismatch are recognised and 
repaired by a highly conserved repair pathway called DNA mismatch repair (MMR) (Figure 
1.18) (Li, 2008, Kunz et al., 2009).   
 
In human MMR, recognition of base-base mismatches post replication is achieved via the 
activity of the two heterodimers, MSH2-MSH6 and MSH2-MSH3 (Kunkel and Erie, 2005).  Once 
a base mismatch is recognised, this leads to the recruitment of the MLH1/PMS2, resulting in 
the formation of a ternary complex which is crucial for the completion of MMR in human cells 
(Kunkel and Erie, 2005).  It is thought that PCNA also plays a role in the recruitment of MMR 
proteins in the vicinity of a replication fork via interactions with MSH6 and MSH3 (Hsieh and 
Yamane, 2008).  An essential aspect of MMR is that the nascent DNA strand containing the 
mismatch can be discriminated from the parental strand which contains the correct base.  Post 
replication, a newly synthesised DNA strand contains discontinuities due to the presence of 
DNA primer ends and unprocessed Okazaki fragments and in eukaryotes MMR is directed 
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towards whichever strand contains discontinuities in the proximity of the mismatch (Hsieh and 
Yamane, 2008, Li, 2008, Kunz et al., 2009).   
 
Once the MMR machinery has been assembled at the site of damage, a nick is introduced 5’ to 
the mismatch in a PCNA dependent manner by PMS2, then the nicked strand is degraded by 
the 5’ → 3’ exonuclease EXO1 (Hsieh and Yamane, 2008, Genschel et al., 2002).  The single-
stranded gap is then rapidly bound by RPA, which helps facilitate Polδ or Polε dependent DNA 
synthesis, and finally the resulting DNA nick is ligated by DNA Ligase I (Zhang et al., 2005, Li, 
2008).   
 
1.8 DNA Damage Response and Human Genetic Disease 
As described above, the large variety of DNA lesions that can arise in cells are repaired by over-
lapping DNA response and repair pathways that function to maintain genome integrity.  The 
importance of these pathways in the maintenance of human health is highlighted by the 
existence of human genetic diseases which are caused by defects in many of these pathways 
(Table 1.3).  There are three main classes of symptoms that are associated with defective 
responses to DNA damage, including pre-disposition to cancer and deficiencies of the immune 
system and  nervous system (Jackson and Bartek, 2009, Hoeijmakers, 2001, Hoeijmakers, 2007, 
McKinnon, 2009, McKinnon and Caldecott, 2007).   
 
Cancer is a disease that is fundamentally linked to genomic instability (Negrini et al., 2010).  
DNA damage that results in mutations, either by faulty repair or replication errors, can lead to 
the loss of tumour-suppressor genes or the improper activation of oncogenes, triggering 
uncontrolled cellular proliferation and the development of malignant cells (Stoler et al., 1999, 
Hoeijmakers, 2001, Stratton et al., 2009).  In fact many lymphoid tumours are linked with 
specific chromosomal translocations involving proto-oncogenes (Schlissel et al., 2006).  
Furthermore, defects in DNA repair pathways or the deregulation of DNA damage response 
pathways can contribute to a ‘mutator phenotype’ in which enhanced mutation rates speed 
the progression of malignancy, such as the link between inherited defects in MMR and 
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predisposition to colorectal and endometrial carcinomas (Hoeijmakers, 2001, Jiricny, 2006).  
Indeed the fact that most carcinogens are DNA damaging agents further highlights the link 
between cancer and DNA damage (Hoeijmakers, 2001).   
 
Defects in many other DNA damage signalling and repair pathways have also been linked with 
cancer.  Mutations in BRCA1 and BRCA2, which impart defects in the homologous 
recombination DSBR pathway, strongly predispose to breast cancer (Venkitaraman, 2002).  
Defective NER, in particular the global genome NER pathway, leads to pronounced UV-
sensitivity and a very high incidence of skin cancer.  Additionally mutations in proteins that 
form part of the DNA DSB signalling cascade, such as ATM and Nbs1, also impart susceptibility 
to cancer (Chun and Gatti, 2004, Varon et al., 1998). 
 
The link between immunodeficiency and defects in DNA repair pathways arises due to 
essential roles specialised DNA repair pathways have in the development of the vertebrate 
immune system (Dudley et al., 2005).  Core members of the NHEJ pathway perform direct roles 
in the production and diversification of the antigen receptors expressed on B- and T- 
lymphocytes in a pathway called V(D)J recombination (Hartlerode and Scully, 2009).  
Consistent with this role, various immunodeficient human disorders are caused by mutations 
in proteins involved in DSB signalling and repair.  Deficiencies in Ku70/80, LigIV, Artemis, 
RNF168, ATM, Mre11 and XLF all lead to disorders associated with  severe immunodeficiency 
(Gu et al., 1997, Zhu et al., 1996, Moshous et al., 2001, Stewart et al., 2007, Bohgaki et al., 
2011, Stewart et al., 2009, Stewart et al., 1999, Chun and Gatti, 2004, Buck et al., 2006a).  
Additionally multiple DNA repair pathways are also thought to be involved in class switch 
recombination, another specialised DNA repair pathway involved in the production of 
antibodies (Dudley et al., 2005).   
 
Finally, defective DNA repair can also lead to disorders of the nervous system.  There are two 
main types of neuropathology presentation that is linked to defective DNA repair; primary 
microcephaly and progressive neurodegeneration (McKinnon, 2009, O'Driscoll and Jeggo, 
2008).   Primary microcephaly is a clinical term which is used to describe reduced head size, 
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defined as head circumference 3 standard deviations below the mean, which presents from 
birth (O'Driscoll and Jeggo, 2008).  The underlying cause of the reduced head circumference is 
a reduction in total brain volume, as the outward pressure of the developing brain is the 
driving force for the expansion of the head and skull.  An early period of rapid proliferation of 
neuronal progenitor cells in the ventricular (VZ) and subventricular zones (SVZ) that line the 
ventricles of the developing brain is critical for the development of the huge amount of 
neurons that comprise the mature nervous system (Bayer et al., 1991, Chan et al., 2002).  Once 
these neuronal progenitors have replicated, cells destined to become neurons exit the cell 
cycle, differentiate and migrate away from the VZ and SVZ towards the cortical plate (Bayer et 
al., 1991, Chan et al., 2002, Carmichael and Woods, 2006).  Due to the rapid proliferation that 
the neuronal progenitors undergo, they are likely to be heavily reliant on DNA repair pathways 
to prevent replication-associated DNA damage (Barnes et al., 1998, Gao et al., 1998).  
Additionally, these neuronal progenitors also seem to have a low threshold of DNA damage 
that is required to induce apoptosis (Hoshino and Kameyama, 1988, Narasimhaiah et al., 2005, 
Hoshino et al., 1991).  Therefore defects in DNA repair could lead to an increased rate of 
apoptosis in the proliferating progenitors due to high levels of replication stress, resulting in a 
reduction in the total numbers of neurons in the developing brain, and consequently giving 
rise to microcephaly (Gatz et al., 2011).  Microcephaly is common feature amongst defective 
DNA repair disorders, with defects in NHEJ, NER, SSBR, and MRN dependent DSB signalling all 
resulting in microcephalic disorders (Shen et al., 2010, Varon et al., 1998, O'Driscoll et al., 
2001, Buck et al., 2006a, Reed et al., 1965, Mimaki et al., 1986, Jaspers et al., 2007, Lehmann, 
2003).   
 
The other type of neuropathology that can arise from defective DNA repair is the progressive 
neurodegeneration of the adult brain.  Neurodegenerative disorders usually present after birth 
and are typically associated with the progressive degeneration of specific regions of the brain 
such as the cerebellum (Date et al., 2001, Moreira et al., 2001).  The progressive degeneration 
of the adult brain is thought to be due to the accumulation of DNA lesions in post mitotic 
lesions.  Neurons are highly active cells and generally exhibit high levels of mitochondrial 
respiration, and also have a reduced capacity to neutralise reactive oxygen species, leading to 
elevated levels of oxidative DNA damage in neurons (Weissman et al., 2007, Barzilai, 2007).  
Additionally, the adult brain also has a limited capacity for cellular regeneration and post 
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mitotic neurons, being in G0, would lack the DNA repair pathways that operate during S-phase 
and G2, such as HR (Rass et al., 2007b).  Therefore, due to the increased oxidative stress, the 
adult brain would be sensitive to the loss of any the remaining DNA repair pathways, which 
could lead to the gradual accumulation of unrepaired DNA lesions.  The accumulating DNA 
lesions could potentially interfere with the transcription machinery, leading to cell dysfunction 
or apoptosis (Ljungman and Lane, 2004).  Defects in ATM and Mre11 dependent DSB signalling, 
SSBR and NER can all result in disorders characterised by progressive neurodegeneration of the 
cerebellum (Chun and Gatti, 2004, Taylor et al., 2004, Date et al., 2001, Moreira et al., 2001, 
Stewart et al., 1999).  
 
1.8.1 Ataxia Telangiectasia/Ataxia Telangiectasia – Like Disorder 
Ataxia telangiectasia (A-T) is a rare, autosomal recessive disorder characterised by progressive 
cerebellar ataxia, neurodegeneration, radiosensitivity, cell-cycle checkpoint defects, genome 
instability and a predisposition to cancer (Boder and Sedgwick, 1958).  Ataxia is characterised 
by a lack of coordination of muscle movement that affects movement, speech and balance and 
is typically caused by dysfunction of the cerebellum.  AT was discovered to be caused by 
mutations in the gene ataxia-telangiectasia mutated (ATM), named after the disorder (Savitsky 
et al., 1995).  As described earlier in section 1.5.3, ATM is a serine/threonine protein kinase 
that plays a critical role in DSB sensing and repair (Kastan and Lim, 2000).  A-T is considered to 
be the archetypal DDR-defective disorder as it provided one of the first direct links between 
DNA damage and neurodegeneration.  
 
The primary symptom of A-T, and the most debilitating aspect of the disease, is early onset, 
progressive neurodegeneration which results in prominent ataxia and dysarthria, which are 
symptoms of cerebellar dysfunction (Boder and Sedgwick, 1958).  Indeed by the age of 10, 
magnetic resonance imaging of A-T patients reveal that the cerebellum has lost much of its 
volume and the patients are usually wheelchair bound by this age (Tavani et al., 2003, Chun 
and Gatti, 2004).  It has been shown that ATM is required for DNA damage induced apoptosis 
in the nervous system which suggests that ATM functions to eliminate neurons that possess 
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DNA damage and the absence of ATM may result in the persistence of DNA lesions eventually 
resulting in cell loss and neurodegeneration (Lee et al., 2000, Sekiguchi et al., 2001).   
 
Ataxia-telangiectasia like disorder (A-TLD) is caused by hypomorphic mutations in Mre11 and 
has a neuropathological presentation which is very similar to A-T, although with a delayed 
onset and lacking the symptoms of telangiectasia and cancer predisposition (Stewart et al., 
1999).  The clinical overlap between these two syndromes could be explained by the 
overlapping roles that ATM and MRN play in sensing and signalling DSBs.  ATM activity is 
partially dependent on the presence of the MRN complex and it is believed they act in concert 
to promote an efficient DDR (Uziel et al., 2003, Lavin, 2007, Williams et al., 2007).  In contrast, 
mutations in NBS1, another component of the MRN complex, result in Nijmegen breakage 
syndrome (NBS), which presents with microcephaly and lacks the neurodegenerative 
symptoms common to A-T and A-TLD (Varon et al., 1998).  How two different clinical 
presentations can arise from mutations in two proteins within the same complex could be 
potentially be explained due to the ATM-independent roles that MRN performs, such as the 
involvement of NBS1 in ATR signalling and HR (Stiff et al., 2005, Hopfner et al., 2002, Williams 
et al., 2008, Lavin, 2007, Nicolette et al., 2010a, Paull, 2010b).  Therefore mutations in Mre11 
that lead to A-TLD could be the result of a defect in the ATM-dependent role of MRN, while 
mutations in NBS1 could cause deficiencies in ATR signalling and/or HR.   
 
1.9 DNA single strand break repair disorders 
1.9.1 Ataxia oculomotor apraxia 1 
AOA1 is the most common form of autosomal recessive ataxia in Japan and the second most 
common in Portugal.  It clinically presents with early onset ataxia, oculomotor apraxia, 
cerebellar atrophy and axonal motor neuropathy (Figure 1.19) (Date et al., 2001, Moreira et 
al., 2001, Shimazaki et al., 2002a, Le Ber et al., 2003, Sekijima et al., 2003, Tranchant et al., 
2003, Amouri et al., 2004, Criscuolo et al., 2004, Habeck et al., 2004, Criscuolo et al., 2005, 
Duquette et al., 2005, Ito et al., 2005, Mahajnah et al., 2005, Quinzii et al., 2005, Tsao and 
Paulson, 2005, Palau and Espinos, 2006, Shahwan et al., 2006, Baba et al., 2007, Ferrarini et al., 
2007, Zuhlke et al., 2007, D'Arrigo et al., 2008, Liu and Narayanan, 2008, Salvatore et al., 2008, 
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Sugawara et al., 2008, Yoon et al., 2008, Anheim et al., 2010, Tada et al., 2010).  As mentioned 
above, ataxia is characterised by a lack of coordination of muscle movement affecting 
movement, speech and balance, while oculomotor apraxia is an inability to control eye 
movements, both of which result from cerebellar dysfunction.  Onset of AOA1 occurs between 
early childhood and adolescence and patients can be severely disabled and wheel chair-bound 
by later life (Aicardi et al., 1988, Barbot et al., 2001, Tachi et al., 2000, Gascon et al., 1995).  An 
interesting feature of this disorder is that although it shares a number of neurological 
symptoms with other DNA repair defective disorders, such as ataxia-telangiectasia, it lacks any 
of the other extraneurological features such as immunodeficiency or cancer pre-disposition 
(Table 1.3).  As mentioned previously it is caused by mutations in the gene APTX,  a member of 
the Hint-like histidine triad (HIT) superfamily which consist of adenosine 5’-
monophosphoramide hydrolyases (Brenner, 2002, Bieganowski et al., 2002a, Krakowiak et al., 
2004a, Seidle et al., 2005, Kijas et al., 2006).  APTX also possess a divergent zinc finger motif 
(ZnF) and an amino-terminal fork-head associated domain that has homology with the amino-
terminus of PNK (Barbot et al., 2001). 
 
The in vitro substrate for APTX has been discovered and well characterised.  APTX catalyses the 
release of adenylate groups covalently linked to 5’-P termini of a DNA SSB or DSB (Ahel et al., 
2006, Rass et al., 2007a, Rass et al., 2008).  Cell-free extracts prepared from APTX-/- DT40 cells 
or APTX-/- mouse cortical astrocytes lack the ability to repair a 5’AMP-SSB indicating that this 
activity is unique to APTX in mammalian cells (Ahel et al., 2006).  Also cell-free extracts 
prepared from APTX-/- mouse cortical astrocytes are defective in full repair assays which 
measure short patch SSBR of an adenylated SSB in vitro (Ahel et al., 2006).  Adenylated nicks 
are produced as a normal intermediates during ligation by an ATP-dependant DNA ligase, and 
an stable abortive ligation intermediate can arise if a ligase has attempted to ligate a SSB with 
a 3’ terminus other than a 3’OH.  Thus APTX has been proposed to play a role in SSBR as a way 
of resetting an abortive ligation and allowing repair to continue.   
 
Consistent with its association with SSBR and DSBR machinery overexpressed EGFP-tagged 
APTX has also been shown to co-localise with XRCC1 at sites of heavy ion-induced damage and 
laser irradiation (Gueven et al., 2004, Jakob et al., 2005, Harris et al., 2009, Gueven et al., 
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2007).  Heavy-ion irradiation introduces complex localised DNA damage and it is very likely 
that both SSBs and DSBs are present at the sites of damage.  It has also been reported in a 
number of different studies that APTX defective cells exhibit sensitivity to DNA damaging 
agents.  Transformed lymphoblastoid cell lines (LCL) and primary fibroblasts have been 
reported to show sensitivity to treatment with the alkylating agent MMS and the oxidising 
agent H2O2, although this was very mild in the case of the fibroblasts (Gueven et al., 2004, 
Clements et al., 2004).  In the same study Clements et al demonstrated that the AOA1 primary 
fibroblasts showed a mild sensitivity to X-rays while the LCLs were not sensitive to -ionising 
radiation in the Gueven et al study (Gueven et al., 2004, Clements et al., 2004).  siRNA 
mediated knock-down of APTX in HeLa cells has also been shown to confer sensitivity to MMS 
(Luo et al., 2004).   
 
AOA1 primary fibroblasts were also reported to show sensitivity to buthionine-(S,R)-
sulfoximine (BSO), an inhibitor of the synthesis of the ROS scavenger glutathione (Hirano et al., 
2007).  This sensitivity is rescued by addition of the anti-oxidants decylubiquinone or all-trans-
retinol (Hirano et al., 2007).  Importantly it has been shown that deleting Hnt3, the 
saccharomyces cerevisae homolog of APTX, in an apn1 apn2 (3’ end-processing factors) or a 
rad27 (FEN1) background conferred sensitivity to H2O2 and MMS.   Taken together these data 
provide support for an important role for APTX in the promotion of cellular survival following 
alkylating or oxidative damage (Daley et al., 2010). 
 
The evidence for a global SSBR defect in AOA1 cell lines, however, has proved somewhat 
inconsistent.  Several studies have reported that APTX defective cell lines show normal rates of 
SSBR upon treatment with H2O2 or MMS when measured by comet assay or NAD(P)H depletion 
assay (Gueven et al., 2004, Reynolds et al., 2009, El-Khamisy et al., 2009).  A single study has 
reported that AOA1 cell lines show reduced repair of CPT lesions by comet assay but as CPT 
treatment would result in the increase in SSBs containing a non-adenylatable nick with a 5’OH 
it is again unclear how this fits in with the role of APTX in SSBR (Mosesso et al., 2005).  It is 
possible that this defect is due to a 3’ processing defect but in the presence of highly efficient 
3’ phosphatase activity of PNK this seems unlikely (Takahashi et al., 2007b).   
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Additionally two studies have reported an increased level of oxidative damage persists in AOA1 
cells.  They demonstrated that there is an elevated level of 8-oxo-G staining in AOA1 cells 
compared to a control cell lines using an anti-8-oxo-G antibody (Hirano et al., 2007, Harris et 
al., 2009).  They also attempted to show elevated levels of 8-oxo-G staining in a post-mortem 
slice from an AOA1 patients cerebellum compared to an unrelated age-matched control 
(Hirano et al., 2007).  However it is unclear how the loss of APTX leads to an increase in 8-oxo-
G as this is type of DNA damage has not been shown to be a substrate for APTX.  The 
processing of any potential abortive ligations would be downstream of the recognition and 
excision of 8-oxo-G by OGG1.   
 
Interestingly, a genetic approach in which APTX-/- TDP1-/- double knockout mice where 
generated, showed that APTX-/- TDP1-/- astrocytes exhibited a synergistic decrease in rates of 
global SSBR compared to either of the single mutants (El-Khamisy et al., 2009).  This was 
observed for the repair of both hydrogen peroxide and MMS induced damage.  It is possible 
that in the APTX-/- single mutant, the level of unrepaired adenylated breaks could be too small 
to detect.  The increase in blocked 3’ termini due to the loss of TDP1 in the double mutant may 
result in the increase of abortive ligations above the threshold level of detection.  Another 
possibility is that APTX-independent pathways that use the 3’ terminus, such as long-patch 
repair, could function to repair the adenylated SSBs in APTX-/- cells and could be blocked in the 
double mutant.   
 
APTX has been proposed to play a role in SSBR following DNA damage as a way of resetting an 
abortive ligation and allowing repair to continue.  This offers a possible explanation for the 
clinical presentation of AOA1 as unrepaired adenylated SSBs could accumulate in post-mitotic 
neurons leading to blocked transcription and eventually cell death.   
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1.9.2 Spinocerebellar ataxia with neuronal neuropathy 1 
The neurodegenerative disorder SCAN1 was discovered to be caused by a mutation in TDP1 
(Figure 1.20) (Takashima et al., 2002).  SCAN1 is an adult onset autosomal recessive ataxia 
which is characterised by spinocerebellar ataxia and, intriguingly, like AOA1 lacks any 
extraneurological features.  SCAN1 has a later age-of-onset than AOA1 and seems to have a 
milder clinical presentation.  To date nine SCAN1 patients, from a single family, have been 
discovered, each possessing the same H493R point mutation (Takashima et al., 2002).   
 
TDP1 is phosphodiesterase that can selectively hydrolyse a phosphotyrosyl linkage at the 3’ 
termini of DNA SSBs or DSBs (Yang et al., 1996, Interthal et al., 2001).  In eukaryotic cells these 
linkages arise as the result of abortive topoisomerase 1 activity which leads to DNA breaks 
with a TOP1 peptide covalently linked to the 3’ terminus of a SSB (Pommier et al., 2003).  The 
H493R mutation found in SCAN1 patients resides within one of the HKD catalytic active sites 
within the phosphodiesterase domain and results in an approximately 25-fold reduction in 
activity as well as causing the accumulation of the TDP1-DNA covalent intermediate (Interthal 
et al., 2005, Walton et al., 2010).  Thus the combination of accumulating TDP1-DNA adducts 
together with unrepaired Top1-SSBs would interfere with replication and transcription, 
potentially leading to progressive neuronal cell death and neurodegeneration. 
 
SCAN1 cell lines have been shown to accumulate more DNA breaks in the presence of the Top1 
inhibitor camptothecin than WT control cells using the alkaline comet assay (El-Khamisy et al., 
2005) .  Levels of these breaks did not decrease when subsequently incubated in drug – free 
media (El-Khamisy and Caldecott, 2006).  Interestingly only half of these breaks where 
dependent on replication, suggesting that collision with the transcription machinery was 
responsible for as many abortive Top1-SSBs as with collision with replication machinery (El-
Khamisy and Caldecott, 2006).  This is important as the clinical presentation of SCAN1 is 
restricted to post-mitotic neurones which are highly transcriptionally active and could 
potentially possess a high level TOP1-SSBs and therefore a higher dependence on TDP1 than 
other cell types (Flangas and Bowman, 1970, Sarkander and Uthoff, 1976).  
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SCAN1 cell lines also displayed defective SSBR of oxidative damage induced by hydrogen 
peroxide and γ-rays (Katyal et al., 2007, El-Khamisy et al., 2007, El-Khamisy et al., 2005).  This 
could either reflect an increase in abortive topoisomerase activity due to the close proximity of 
oxidative DNA lesions to the cleavage complex or it could reflect a defect in the processing of 
oxidative DNA breaks as TDP1 has been shown be able to process a 3’-PG and a number of 
other 3’ adducts (Zhou et al., 2005, Inamdar et al., 2002).   
 
Importantly TDP1-/- mice display a progressive decrease in cerebellar size which is consistent 
with the clinical presentation of the disease although the mice do not seem to exhibit any 
obvious ataxic phenotype (Katyal et al., 2007).  SCAN1 is a relatively late onset disorder and it 
is possible that the mice do not live long enough to display these symptoms.  Alternatively the 
ataxia in SCAN1 individuals could be due to the extra TDP1-SSBs that are generated as a result 
of the neomorphic H493R mutation (Interthal et al., 2005).  Together the data provides strong 
evidence for the critical role of TDP1 in SSBR in maintaining neuronal integrity and preventing 
cerebellar degeneration.   
 
1.9.3 Microcephaly, early-onset, intractable seizures and developmental delay 
Very recently a third human neurological disorder associated with defective SSBR has been 
discovered.  MCSZ is a developmental disorder characterised by microcephaly, infantile-onset 
seizures, developmental delay and variable behavioural problems, especially hyperactivity, and 
is caused by mutations in PNK (Figure 1.21) (Shen et al., 2010).  It is striking that mutations 
arising in PNKP result in a developmental defect presenting with severe microcephaly while 
mutations in APTX and TDP1 result in a progressive cerebellar degeneration.  Additionally 
MCSZ does not seem to display any neurodegeneration, although like the other disorders it 
also lacks any extraneurological symptoms.  It is also important to note that this is the first 
human disorder associated with defective DNA repair that presents with seizures, which is 
intriguingly close to the pathology of mice that have a targeted deletion of XRCC1 (Lee et al., 
2009).    
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Seven families with individuals suffering from MCSZ have been discovered so far.  These 
individuals harbour four different mutations in PNK (Shen et al., 2010).  L176F and E326K are 
point mutations within highly conserved residues of the phosphatase domain and T424Gfs48X 
and exon15Δfs4X are mutations within the kinase domain that produce truncated PNKP due to 
premature stop codons resulting from frameshifts.  The frameshift within T424Gfs48X is the 
result of 17bp duplication within exon14 in the kinase domain, resulting in a 471 amino acid 
polypeptide of which the last 48 residues are out of frame. The frame-shift within exon15Δfs4X 
mutation arises due to a 17bp deletion within intron 15 that leads to mRNA transcript lacking 
exon 15, and resulting in a polypeptide of 436 amino acids of which the last 4 residues are out 
of frame (Shen et al., 2010).  All of the mutations resulted in at an approximately 10-fold 
reduction in total levels of PNK protein.  Importantly lymphoblastoid cell lines (LCL) derived 
from MCSZ patients displayed reduced rates of SSBR of both hydrogen peroxide and 
camptothecin induced DNA damage, consistent with previous data using a stable PNK knock 
down in human cells (Shen et al., 2010, Rasouli-Nia et al., 2004).   
 
As mentioned previously PNK is a particularly important protein in SSBR due to its role in the 
repair of 3’-P termini.  SSBs harbouring 3’-P termini arise at the majority of direct SSBs induced 
by ROS and this could provide an explanation for the differences in the clinical presentations of 
MCSZ with AOA1 and SCAN1 (Ward, 1998).  It is thought that abortive ligations and TOP1-SSBs 
arise only rarely and therefore may not accumulate to sufficient levels to interfere with the 
developing nervous system.  However oxidative lesions that require processing by PNK arise 
thousands of times per cell per day (Ward et al., 1987).  Defective PNK activity would therefore 
present the rapidly dividing neuronal stem cell progenitors in developing brains with a huge 
quantity of unrepaired SSBs which would rapidly be converted into DSBs and would ultimately 
lead to cell death.   
 
1.9.4 DNA Ligase I Deficiency 
Mutations in DNA ligase I have been discovered within an individual suffering from stunted 
growth, sun-sensitivity and severe immunodeficiencies was discovered to possess mutations 
within DNA Ligase I alleles (Barnes et al., 1992).  So far this has been the only documented case 
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of a Ligase I deficiency.  This individual possessed two point mutations in different alleles of 
Ligase I, E566K and R771W, both of which reside within the active site of the protein 
intermediate and seem to disrupt the formation of the ligase-adenylate intermediate (Barnes 
et al., 1992).  A fibroblast cell line established from the patient, 46BR, was shown to be 
hypersensitive to a wide range of DNA damaging agents including alkylating agents, cross-
linking agents, ionising radiation, PARP inhibitors and UV (Simmonds et al., 1982, Squires and 
Johnson, 1983, Teo et al., 1983a, Teo et al., 1983b, Henderson et al., 1985, Lehmann et al., 
1988, Lonn et al., 1989).   
 
The types of DNA lesions induced by these chemically unrelated DNA damaging agents would 
require different DNA repair pathways to correct, implicating ligase I in pathways as diverse as 
BER, SSBR, NER, and interstrand crosslink repair (Caldecott, 2008, Nouspikel, 2009, Deans and 
West, 2011).  In conjunction with its role in DNA repair, DNA ligase I also has a core role in DNA 
replication in the maturation of Okazaki fragments (Waga and Stillman, 1998).  Consistent with 
this role, the 46BR cell line exhibits a reduced rate of joining of Okazaki fragments (Henderson 
et al., 1985, Lehmann et al., 1988, Lonn et al., 1989).  Although DNA LigI is implicated in SSBR, 
the symptoms associated with ligase I deficiency are unlikely to be caused by the loss of any 
one pathway but instead a combination of defects in DNA replication and the repair of a 
variety of DNA lesions.   
 
1.9.5 SSBs and Neurological Dysfunction 
The existence of three human disorders associated with defective repair of SSBs, AOA1, SCAN1 
and MCSZ, suggest that the SSBR has a crucial role in the maintenance of human health (Shen 
et al., 2010, Date et al., 2001, Moreira et al., 2001, Takashima et al., 2002).  A striking similarity 
between the disorders is that they are all caused by mutations in DNA end-processing 
enzymes.  APTX removes an adenylate group from the 5’ of DNA, TDP1 cleaves the phosphor-
tyrosyl linkage between the 3’ terminus of DNA and a top1 peptide and PNKP repairs SSBs with 
3’-phosphate and 5’-hydroxly termini (Ahel et al., 2006, Interthal et al., 2001, Takashima et al., 
2002, Jilani et al., 1999, Karimi-Busheri et al., 1998, Whitehouse et al., 2001, Bernstein et al., 
2005b).  The end-processing stage of SSBR is enzymatically diverse as a large number of 
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different chemistries can arise at SSBs depending on the source of damage, requiring a number 
of mechanistically distinct activities to repair (Section 1.3.2).  Thus there is likely to be less 
redundancy amongst the components of end-processing than during gap-filling or DNA 
ligation, as the later stages of SSBR utilise a number of DNA repair enzymes that possess 
similar mechanistic activities.  This means that SSBR is potentially more susceptible to the loss 
of an end-processing factor, particularly if the defective protein possesses a unique activity.   
 
Another striking similarity between the disorders is the presentation of pronounced 
neuropathology in the absence of extraneurological symptoms that are common to other DNA 
repair defective disorders, such as cancer predisposition and immunodeficiency.  This suggests 
that neurons are exquisitely sensitive to defects in SSBR.  The absence of extraneurological 
symptoms present in these three disorders could be due to a combination of factors.  There is 
evidence for a hypothetical role S-phase specific role for XRCC1 in the repair of SSBs 
encountered by the replication fork, in the  replication-coupled SSBR  pathway, and it has been 
suggested that this pathway could operate in conjunction with HR and therefore involve the 
structure specific nucleases that operate during HR (Figure 1.12) (Caldecott, 2008, Caldecott, 
2001, Caldecott, 2003b).  The presence of this pathway could explain the lack of cancer 
predisposition in SSBR defective disorder as any unrepaired SSBs encountered by the 
replication fork would be repaired by RC-SSBR and would not become a permanent block to 
replication.  Finally there is no evidence for a role of SSBR in development of the vertebrate 
immune, explaining the lack of immunodeficiency in AOA1, SCAN1 and MCSZ.   
 
There is, however, a very important difference between the neuropathologies that present in 
AOA1, SCAN1 and MCSZ.  While both AOA1 and SCAN1 are neurodegenerative disorders that 
are associated with progressive degeneration and atrophy of the cerebellum after birth, MCSZ 
presents with primary microcephaly from birth, but exhibits no evidence of subsequent 
degeneration.  The different presentations likely reflects that the loss of APTX and TDP1 
primarily effect post-mitotic neurones while mutations in PNKP have a greater impact upon 
the developing brain.   
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The sensitivity of post-mitotic neurons to the loss of APTX and TDP1 could be due to a number 
of factors.  This first is that post-mitotic neurones could be more dependent on APTX and TDP1 
dependent SSBR due to the absence of alternate end processing factors or redundant repair 
pathways.  For example, long-patch repair, which could function in the absence of APTX to 
repair adenylated SSBs, is thought to be attenuated in post-mitotic neurones due to the down-
regulation of replication factors (Cam et al., 2004).  Additionally homologous recombination 
and other DNA repair pathways that operate during S-phase and G2 would not be in operation 
in the G0 phase of post-mitotic neurons (Delacote and Lopez, 2008, Sonoda et al., 2006, 
Caldecott, 2008, Rass et al., 2007b). 
 
Another possibility is that post-mitotic neurones are exposed to a higher level of oxidative 
stress than other tissue types due to the high oxygen demand of the nervous system.  Neurons 
are highly active cells and exhibit high levels of mitochondrial respiration together with a 
reduced capacity to neutralise reactive oxygen species, which will lead to high levels of 
oxidative DNA damage (Weissman et al., 2007, Barzilai, 2007).  This would place a higher load 
on the SSBR pathways in post-mitotic neurones that repair oxidative DNA damage.   Post 
mitotic neurones are also highly transcriptionally active which, in combination with the high 
level of oxidative stress, could mean that post-mitotic neurones possess a high level of 
transcription associated DNA damage and would, again, be more dependent on the SSBR 
pathways than other cell types (Flangas and Bowman, 1970, Sarkander and Uthoff, 1976).  The 
accumulation of unrepaired SSBs and collapsed transcription forks in AOA1 and TDP1 could 
ultimately lead to a higher occurrence of neuronal cell death in individuals suffering from the 
disease.  Finally the nervous system has a very limited regenerative capacity which would 
mean that it would be highly sensitive to progressive cell death and any brain tissue lost 
through degeneration would not be replaced.  
 
Together these factors provide a potential explanation for why post-mitotic neurones are 
sensitive to mutations in APTX and TDP1.  However, in contrast, MCSZ presents with severe 
microcephaly from birth and there is no evidence of any subsequent neurodegeneration (Shen 
et al., 2010).  As described earlier, the generation of the huge numbers of neurons that 
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comprise the adult brain is dependent on a critical period of proliferation of neuronal stem cell 
progenitors (Bayer et al., 1991). 
 
Due to the highly metabolic status of the developing brain, oxidative DNA damage induced by 
ROS produced by cellular metabolism would be a very significant source of DNA damage, a 
large proportion if which would be substrates for PNK.  Therefore the proliferating neuronal 
stem cells are likely to be heavily dependent on PNK-dependent SSBR and defects in PNK could 
lead to a significant increase in the numbers of unrepaired oxidative SSBs and DSBs in the 
rapidly replicating neuronal progenitors, and in combination with the low threshold for 
undergoing apoptosis, leading to an increased rate of apoptosis.  This would result in a 
reduction in the total numbers of neurons in the developing brain, and could consequently 
give rise to microcephaly.  Indeed this has been suggested to also be the case for the incidence 
of microcephaly linked to defective repair of DSBs via the non-homologous end-joining 
pathway (O'Driscoll et al., 2001, Buck et al., 2006b, Gatz et al., 2011).    
 
The absence of microcephaly in AOA1 and SCAN1 could reflect the potential rarity of the DNA 
lesions that APTX and TDP1 repair.  It is possible that these rare lesions would not accumulate 
in enough numbers to impact upon the neuronal progenitors in the VZ and SVZ of the 
developing brain, whereas PNKP substrates would be amongst the most commonly arising 
DNA lesions.  However the absence of neurodegeneration in MCSZ is more difficult to explain, 
as PNKP-dependent SSBR would also be defective in post-mitotic neurons which are subject to 
a high oxidative load.  This could potentially be explained by the observation that post-mitotic 
neurons are much less sensitive to DNA damage that the neuronal progenitors in the VZ and 
SVZ of the developing brain (Hoshino and Kameyama, 1988, Narasimhaiah et al., 2005, 
Hoshino et al., 1991).  As MCSZ cell lines have residual levels of PNKP, approximately 5-10%, 
there could be a low level of PNKP activity that is sufficient for the post-mitotic neurons, which 
can tolerate more DNA damage, but which is insufficient for the neuronal progenitors which 
are very sensitive to damage (Shen et al., 2010).   
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1.10 General aim of thesis 
The first major aim of this thesis was to further investigate the short-patch repair defect of 
adenylated SSBs exhibited by APTX defective cell extracts in vitro.  Prior to this study it has 
been shown that APTX defective cell extracts are unable to repair adenlyated SSBs in vitro, 
however the precise nature of this defect has not been shown.  Additionally it has not been 
clear whether a DNA strand defect is responsible for the AOA1 disease as conflicting data 
exists for the presence of a chromosomal SSBR defect in APTX defective cells.  To attempt to 
provide an answer for why this discrepancy exists between the biochemical and cellular data, it 
was the aim of this study to determine the precise stage at which the repair of abortive 
ligation intermediates AOA1 extracts failed in vitro and what the nature of the failure was.  
This was carried out using in vitro repair assays with a combination of recombinant DNA repair 
proteins and whole cell extracts prepared from AOA1 cell lines.  The second major aim of this 
thesis was to use this knowledge to investigate whether APTX – independent repair pathways 
existed for the resolution of abortive ligation intermediates in living cells, and thereby 
proposing a hypothesis for the lack of a consistent DNA repair defect in AOA1 cells.  To test 
this, the polymerase inhibitor aphidicolin was used investigate the impact of inhibiting Polδ 
and Polε dependent long-patch repair on the rates of SSBR in AOA1 cells following oxidative 
DNA damage.   
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CHAPTER TWO 
Materials and Methods 
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2.1 General Chemicals and Equipment 
All chemicals were obtained from VWR, Fisher Scientific or Sigma unless otherwise stated.  All 
enzymes were obtained from Roche or New England Biolabs unless otherwise stated.  All cell 
culture media was obtained from Gibco® Invitrogen Cell Culture and cell culture flasks, dishes 
and cryovials from Nunc.   
 
All centrifugation steps, with the exception of cell culture, were carried out using a Beckman 
GS – 15R centrifuge using S4180, F0630 and F24020H rotors or a Sigma 1-13 micro centrifuge.  
All cell culture centrifugation steps were carried out using a Denley B5400 centrifuge or a 
Hettich Rotina refrigerated centrifuge.   
 
2.2 Preparation of Plasmid DNA Constructs 
2.2.1 DNA constructs 
The sources of all bacterial expression plasmid DNA constructs used in this thesis are detailed 
in table 2.1.   
 
2.2.2 Preparation of Plasmid DNA 
Plasmid DNA was prepared by first transforming chemically competent DH5α E.coli cells with 
0.2μg - 2μg of the appropriate plasmid.  Plasmid DNA was incubated with 50μl of chemically 
competent DH5α cells for 30min on ice before heat shocking for 45 seconds at 42°C and then 
cooling on ice for 5 min.  1ml of LB was added to the transformation mixture which was 
incubated at 37°C for 1 hour with shaking at 220rpm.  The transformation mixture was plated 
onto LB agar plates containing 50μg/ml ampicillin or kanamycin and incubated at overnight at 
37°C.  Single colonies were picked and used to inoculate 5ml (mini-preparation) or 100ml (midi 
preparation) LB containing 50μg/ml of the appropriate antibiotic.  These cultures were then 
incubated overnight at 37°C on a shaker at 220rpm.  Plasmid DNA was then extracted by 
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alkaline lysis according to manufacturer’s specifications using Quiagen DNA extraction kits 
(QIAprep® Miniprep Kit and QIAGEN® Plasmid Midi Purification Kit).   
 
2.2.3 Quantification of DNA concentration in solution 
The concentration of DNA in solution was quantified by measuring the absorbance at 260 and 
280nm in quartz cuvettes.  The ratio of 260/280 absorbance was used to determine the purity 
of the DNA solution.  A ratio of 1.8 or greater indicated that the preparations were free from 
contaminations.  The concentration was confirmed in parallel by analysing the DNA solution by 
DNA agarose gel electrophoresis and comparing to a linear DNA molecule of known 
concentration.   
 
2.2.4 DNA agarose gel electrophoresis 
Agarose gels (0.8 – 1% w/v) were prepared by dissolving Ultrapure Electrophoresis Grade 
Agarose (Invitrogen) in 1xTAE buffer (0.4M Tris Acetate and 1mM EDTA pH8.0).  2μg/ml 
ethidium bromide was added to the agarose gel mix and the gel was poured.  DNA samples 
were loaded onto the agarose gel in type II loading buffer (1 x concentration:  0.04% w/v 
bromophenol blue, 0.04% w/v xylene cyanol FF, 2.5% w/v ficoll (Type 400 from Pharmacia)) in 
distilled water.  DNA was subjected to electrophoresis at 80V for 45min.  1 Kb Plus DNA Ladder 
(Invitrogen) was electrophoresed in parallel and used as a size marker.  DNA was visualised by 
UV illumination (The Imager UV Transilluminator Appligene Inc QBiogene).   
 
2.2.5 Restriction enzyme digestion of DNA 
DNA of the appropriate concentration (0.5μg - 5μg) was incubated with 1-2U of appropriate 
restriction enzyme for 1 hour at 37°C.  Complete digestion of the DNA determined by 
comparison to an undigested control sample by agarose gel electrophoresis.   If appropriate, 
DNA fragments were purified using Qiagen QIAquick® Gel Extraction Kit and the DNA 
concentration was quantified as described above.   
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2.2.6 DNA ligation 
Prior to ligation, digested vector DNA was dephosphorylated with 1U calf intestine alkaline 
phosphatase for 1 hour at 37°C and purified using the Qiagen QIAquick® Gel Extraction Kit.  
DNA ligation reactions were set up according to Sambrook and Russell (Sambrook and Russell, 
2001) at vector to insert ratios of 1:0, 1:1 and 1:3.  Reactions were incubated with 1U of T4 
DNA ligase (Roche) overnight at 16°C in a total volume of 10μl.  5μl of the ligation reaction was 
transformed into chemically competent DH5α as described above in section 2.2.3.  Plasmid 
DNA was extracted by alkaline lysis according to manufacturer’s specifications using Quiagen 
DNA extraction kits (QIAprep® Miniprep Kit).  The presence of the insert and correct 
orientation was confirmed by digestion of the plasmid by restriction digest and analysis by 
agarose gel electrophoresis.   
 
2.2.7 DNA sequencing 
Plasmid DNA was sequenced by GATC Biotech using standard primers or gene-specific primers.   
 
2.3 Analysis of cellular extracts and recombinant protein by SDS-PAGE 
and immunoblotting 
 
2.3.1 SDS- Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
10% resolving (10ml final volume:  4ml ddH2O, 3.3ml 30% acrylamide/bisacrylamide (37.5:1) 
mix (Flowgen), 2.5ml  1.5M Tris pH 8.8, 0.1ml 10% SDS, 0.1ml 10% APS, 4μl TEMED) and 5% 
stacking (4ml final volume:  2.7ml ddH2O,  0.67ml 30% acrylamide/bisacrylamide (37.5:1) 
(Flowgen) 0.5ml, 0.5ml 1M Tris pH6.7, 40μl 10% SDS, 40μl 10% APS, 4μl TEMED) 
polyacrylamide gels (PAGE) were prepared according to Sambrook and Russell (Sambrook and 
Russell, 2001).  Protein samples (purified recombinant protein, bacterial and mammalian cell 
extract ) were denatured by incubating in SDS loading buffer (1x concentration:  50mM Tris 
pH8.0, 2% w/v SDS, 10% w/v glycerol, 0.1% w/v bromophenol blue 200mM DTT) at 94°C for 
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5min.  The denatured samples were briefly centrifuged at full speed and aliquots were 
separated on SDS-PAGE using Precision Plus Protein Prestained Duel Colour Standards (BioRad) 
as markers.  Electrophoresis was carried out using Mini Protean 3 apparatus (BioRad) in 1x 
running buffer (25mM Tris, 250mM glycine, 0.01% w/v SDS) at 150V for 60min.  Total protein 
was visualised by staining in coomassie brilliant blue solution (0.25% w/v coomassie brilliant 
blue G-250 (BioRad, 50% v/v methanol, 10% v/v acetic acid) for 30min and destaining (10% v/v 
methanol, 10% v/v acetic acid) and dried.   
 
2.3.2 Immunoblotting of proteins 
Total protein was transferred from polyacrylamide gels to nitrocellulose membrane (H-Bond C 
Extra Membrane GE Healthcare) by wet transfer using Protean 3 Mini Trans-Blot Cell (BioRad) 
in 1x Towbin buffer (20mM Tris, 150mM glycine, 10% v/v methanol) at 100V for 90min or 10V 
for 999min.  Successful transfer was determined by non-permanent staining of total protein on 
the membrane with 0.1% w/v Ponceau S in 5% acetic acid.  The stain was removed by washing 
in 1x TBST (10mM Tris, 140mM sodium chloride, 0.1% v/v Tween 20, pH 7.9).  Membranes 
were blocked by incubation with 5% (w/v) non-fat milk in 1xTBST for 1 hour and then washed 
briefly in 1xTBST.  Membranes were then incubated in primary antibody under the appropriate 
conditions (Table 2.2), washed in 1xTBST (1x 15min, 1x 10min and 2x 5min) and finally 
incubated in the appropriate secondary antibody (Table 2.3).  The membranes were washed 
again as described for the primary antibody and incubated in enhanced chemiluminescence 
(ECL) western blotting detection reagent (GE Healthcare) for 1 minute and developed on 
autoradiography blue sensitive film (GRI) using Xograph Compact 4 automatic X-ray film 
processor.   
 
2.4 Overexpression and purification of recombinant human proteins 
from E.coli  
 2.4.1 Overexpression of recombinant proteins in E.coli strain BL21 (DE3) 
The appropriate bacterial expression vector was transformed into chemically competent BL21 
(DE3) E.coli cells.  0.2μg - 2μg plasmid DNA was incubated with 50μl of chemically competent 
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BL21 (DE3) cells for 30min on ice before heat shocking for 45 seconds at 42°C and then cooling 
on ice for 5min.  1ml of LB was added to the transformation mixture which was subsequently 
incubated at 37°C for 1 hour with shaking at 220rpm.  The transformation mixture was plated 
onto LB agar plates containing 50μg/ml ampicillin or kanamycin and incubated at overnight at 
37°C.  Single colonies were picked and used to inoculate 10ml starter culture consisting of LB 
containing 50μg/ml of the appropriate antibiotic and the culture was incubated overnight at 
37°C on a shaker at 220rpm.   
 
The starter culture was centrifuged at 4,800 rpm for 20 min, resuspended in fresh LB media 
and diluted into a large scale 500ml culture to a final OD600 0.01.  The culture was incubated at 
30°C until OD600 0.6 was reached and a 1ml pre-induction sample was taken for analysis.  For 
the expression of proteins using the pET16b vector, 1mM IPTG was added and the culture was 
incubated for a specified time and temperature (details of the appropriate incubation 
conditions for different proteins are contained in Table 2.4).  A 1ml post induction sample was 
taken for analysis and the culture was harvested by centrifugation at 5,000 rpm for 20min.  
The pellet was washed once in PBS and stored at -20°C.  Aliquots of the 1ml pre- and post- 
induction samples were analysed by SDS-PAGE. 
 
The ORF of human Pol was contained within the heat- inducible expression vector pLW11 and 
protein expression was induced by incubation of E.coli containing the bacterial expression 
vector at 42C for 4 hours (Sobol et al, 1996).  Pre- and post- induction samples were obtained 
and analysed as described above.   
 
2.4.2 Preparation of clarified cell extract from E.coli 
Bacterial cell pellets containing overexpressed recombinant were resuspended in 20ml 
sonication buffer (25mM Tris-HCl (pH7.0), 0.5M NaCl, 10% glycerol, 1mM DTT, 1mM imidazole 
(pH8.0) and 1mM PMSF).  Crude cell extract was prepared by sonicating the resuspended cell 
pellet at 30% power for ten times 30 seconds bursts followed by a 30 second cooling period.  
The soluble and insoluble material was separated by spinning at 14,000 rpm for 20min at 4°C.  
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The supernatant was retained, snap frozen in liquid nitrogen and stored at -80°C.  100μl 
aliquots of the soluble and insoluble material were retained for anaylsis by SDS-PAGE.   
 
2.4.3 Purification of His-tagged APTX, PNK and LigIIIα proteins from E.coli  
Human recombinant Histidine-tagged APTX, PNK and LigIIIα were purified from E.coli extract 
using the method below. 
 
2.4.3.1 Purification of His-tagged APTX, PNK and LigIIIα by immobilised metal affinity 
chromatography (IMAC) 
Human recombinant His-tagged APTX, PNK and LigIIIα were overexpressed in BL21 (DE3) E.coli 
cells as described (section 2.4.1) using the expression vectors pB352-hAPTX, pET16b-hPNK and 
pET16b-hLigIIIα respectively (Table 2.4).  The first purification step was immobilised metal 
affinity chromatography (IMAC) on Ni-NTA agarose beads (first described in Porath et al. 
1975).  In IMAC, metal ions (Ni2+) are bound to a metal chelating group (NTA) immobilised on 
agarose beads.  The Ni2+ ions form interactions with imidazole side-chains present within 
histidine residues, retaining any histidine containing proteins on the beads.  To take advantage 
of this proteins are fused to tags consisting of six or ten histidine residues, allowing the 
recombinant protein to bind to the Ni2+ on the column with high affinity.  Proteins are eluted 
from the beads with a buffer containing an excess of free imidazole, which out-competes the 
interaction of the histidine side chains with the column.   
 
A Ni-agarose column with a 5.0ml bed volume was prepared by loading 1ml Ni-NTA Agarose 
resin (Qiagen) onto a Bio-Rad PolyPrep column and washing with 10 column volumes of 
sonication buffer (25mM Tris-HCl, 0.5M NaCl, 10% glycerol, 1mM DTT, 1mM imidazole 
(pH8.0)).  20ml clarified E.coli extract containing His-tagged recombinant protein was loaded 
onto the Ni-NTA agarose column at 4°C.  All subsequent steps were also carried out at 4°C.  
The column was washed three separate times with 10 column volumes of sonication buffer 
containing 20mM, 40mM and 80mM imidazole respectively.  His-tagged protein was then 
eluted with 5 column volumes of sonication buffer containing 250mM imidazole and 0.5ml 
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elution fractions were collected.  Aliquots of the column load, flow through, washes and 
elution fractions were analysed by SDS-PAGE.   
 
2.4.3.2 Purification of His-tagged APTX, PNK and LigIIIα by cation exchange chromatography 
IMAC elution fractions containing either His-APTX, His-PNK or His-LigIIIα were subsequently 
purified by cation exchange chromatography using a 1.6-ml POROS column on a BioCAD ® 
Sprint Perfusion Chromatography System (Applied Biosystems, United Kingdom).  The column 
was washed with 20 column volumes of ice cold high salt buffer (25mM Tris-HCl, 1M NaCl, 10% 
glycerol, 1mM DTT) and then 20 column volumes of ice cold low salt buffer (25mM Tris-HCl, 
0.1M NaCl, 10% glycerol, 1mM DTT).  Prior to washing, the high and low salt buffers were 
filtered through a 0.22μm filter unit.  pH strongly affects the charge characteristics of a protein 
and the affinity of the target protein for the column.  This effect is expressed by the isoelectric 
point (pI) of a protein, which describes the pH at which a molecule has a net charge of zero.  
The purification of different proteins was carried out at different pH to optimise the yield 
(Table 2.5).  All buffers and protein solutions were kept on ice.   
 
Peak elution fractions from IMAC (section 2.4.3.1) were pooled, loaded onto the cation 
exchange column and washed with 10 column volumes low salt buffer.  His-APTX was eluted 
with a salt gradient from 0.1M NaCl to 1M NaCl over 15 column volumes.  1ml elution fractions 
were collected.  Aliquots of the column load, flow through and elution fractions were analysed 
by 10% SDS PAGE and peak fractions were dialysed into storage buffer (25mM Tris-HCl, 
150mM NaCl, 10% glycerol, 1mM DTT) using a D-Tube™ Dialyzer (Novagen).  The protein 
concentration of the final dialysed fractions was quantified by the Lowry method using the DC 
Protein Assay (BioRad) with BSA used as a protein standard.  The dialysed fractions were 
aliquoted, snap frozen in liquid nitrogen and stored at -80°C.   
 
2.4.4 Purification of Polβ from E.coli by cation exchange chromatography 
Recombinant Polβ was purified by cation exchange chromatography using 1.6-ml POROS 
cation and anion exchange columns on a BioCAD ® Sprint Perfusion Chromatography System 
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(Applied Biosystems, United Kingdom).   Consecutive anion and cation exchange columns were 
set up in a circuit and washed with 20 column volumes of ice cold high salt buffer (25mM Tris-
HCl, 1M NaCl, 10% glycerol, 1mM DTT, (pH7.5)) and then 20 column volumes of ice cold low 
salt buffer (25mM Tris-HCl, 0.1M NaCl, 10% glycerol, 1mM DTT, (pH7.5)).  Prior to washing, the 
high and low salt buffers were filtered through a 0.22μm filter unit.  All buffers and protein 
solutions were kept on ice.   
 
Bacterial clarified extract containing recombinant human Polβ was prepared as previous 
described (section 2.4.2) and loaded onto the ion exchange columns.    The columns were 
washed with 10 column volumes of low salt buffer and the anion exchange column was 
removed from the circuit.  Polβ was eluted from the cation exchange column with a salt 
gradient from 0.1M NaCl to 1M NaCl over 15 column volumes and 1ml elution fractions were 
collected.  Aliquots of the column load, flow through and elution fractions were analysed by 
10% SDS PAGE and peak fractions were dialysed into storage buffer (25mM Tris-HCl, 150mM 
NaCl, 10% glycerol, 1mM DTT) using a D-Tube™ Dialyzer (Novagen).  The protein concentration 
of the final dialysed fractions was quantified by the Lowry method using the DC Protein Assay 
(BioRad) with BSA used as a protein standard.  The dialysed fractions were aliquoted, snap 
frozen in liquid nitrogen and stored at -80°C.   
 
2.4.5 Purification of His-tagged Chlorella Virus DNA ligase from E.coli by 
immobilised metal affinity chromatography (IMAC) 
 
Recombinant wild-type His-tagged DNA ligase from Chlorella Virus and a C-terminally 
truncated Chlorella Virus DNA ligase mutant (CΔ5) were overexpressed in BL21 (DE3) E.coli 
cells as described (section 2.4.1) using the expression vectors pET16b- PBCV- Ligase and 
pET16b- PBCV- CΔ5 respectively (Table 2.4).  The His-tagged Chlorella Virus DNA ligase proteins 
were purified by immobilised metal affinity chromatography (IMAC) on Ni-NTA agarose beads.  
A Ni-agarose column with a 5.0ml bed volume was prepared by loading 1ml Ni-NTA Agarose 
resin (Qiagen) onto a Bio-Rad PolyPrep column and washing with 10 column volumes of ice 
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cold sonication buffer (25mM Tris-HCl (pH8.0), 0.5M NaCl, 10% glycerol, 1mM DTT, 1mM 
imidazole (pH8.0)).   
 
20ml clarified E.coli extract containing His-tagged recombinant protein was loaded onto the Ni-
NTA agarose column at 4°C.  All subsequent steps were also carried out at 4°C.  The column 
was washed three separate times with 10 column volumes of sonication buffer containing 
20mM, 40mM and 80mM imidazole respectively.  His-tagged protein was then eluted with 5 
column volumes of sonication buffer containing 250mM imidazole and 0.5ml elution fractions 
were collected.  Aliquots of the column load, flow through, washes and elution fractions were 
analysed by SDS-PAGE.  Peak elution fractions were dialysed into storage buffer (25mM Tris-
HCl (pH8.0), 150mM NaCl, 10% glycerol, 1mM DTT) using a D-Tube™ Dialyzer (Novagen).  The 
protein concentration of the final dialysed fractions was quantified by the Lowry method using 
the DC Protein Assay (BioRad) with BSA used as a protein standard.  The dialysed fractions 
were aliquoted, snap frozen in liquid nitrogen and stored at -80°C.   
 
2.5 In Vitro Single-Strand Break Repair Assays 
2.5.1 Urea polyacrylamide gel electrophoresis (Urea PAGE) 
Urea polyacrylamide gels were prepared using the SequaFLOWGel Sequencing Kit (Flowgen 
Bioscience) using a 21cm x 40cm Sequi-Gen GT Sequencing Cell (Bio-Rad).  Radiolabelled DNA 
was denatured by heating to 90°C in formamide loading buffer (1x concentration: 30% 
formamide, 0.04% w/v bromophenol blue) and was separated on 15% urea polyacrylamide 
gels (50ml total volume: 30ml SequaGel Concentrate, 15ml SequaGel Diluent, 5ml SequaGel 
Buffer, 400μl 10% APS, 20μl TEMED).  Prior to loading of the DNA samples, the polyacrylamide 
gel was pre-run by carrying out electrophoresis at 45W for 45 min.  Denatured DNA samples 
were then loaded and electrophoresis was carried out in 1xTBE (90mM tris, 90mM boric acid, 
2mM EDTA) at 45W for 90 – 180 min.  After electrophoresis the polyacrylamide gel was 
incubated in 10% acetic acid 10% methanol for at least 20 min, dried and exposed to a 
Phosphor Screen (GE Healthcare).  Radiolabelled DNA was detected by phosphorimaging using 
a Storm™ phosphoimager (GE Healthcare) and visualised by ImageQuant TL software (GE 
Healthcare).   
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2.5.2 Native polyacrylamide gel electrophoresis (Native PAGE) 
15% native polyacrylamide gels were prepared using 40% acrylamide/bis-acrylamide (19:1) 
solution and 1xTBE.  DNA samples were loaded onto the native acrylamide gel in type II loading 
buffer (1 x concentration:  0.04% w/v bromophenol blue, 0.04% w/v xylene cyanol FF, 2.5% 
w/v ficoll (Type 400 from Pharmacia)) in distilled water.  Electrophoresis was carried out using 
Mini Protean II apparatus (Bio-Rade) in 1xTBE at 80V for 2 hours.  After electrophoresis the 
polyacrylamide gels were incubated in 10% acetic acid 10% methanol, dried and exposed to 
Phosphor Screens (GE Healthcare).  Radiolabelled DNA was detected by phosphorimaging 
using a Storm™ phosphoimager (GE Healthcare) and visualised by ImageQuant TL software (GE 
Healthcare).   
 
2.5.3 Preparation of a model oxidative SSB substrate in vitro 
Double stranded oligonucleotide duplexes harbouring a SSB with a 1 nucleotide gap were 
prepared by annealing 17mer and 25mer oligonucleotides to a complimentary 43mer 
oligonucleotide backbone.  An oligonucleotide duplex containing a nick instead of a gap could 
be prepared by substituting the 17mer oligonucleotide with an 18mer.  Additionally a duplex 
containing a SSB that mimicked an oxidative break with a 3’-phosphate could also be prepared 
by using a 17mer with a 3’ phosphate modification.  Unless otherwise stated all other termini 
contain an OH.  All oligonucleotides used in this thesis are detailed in Table 2.6 and were 
obtained from Eurofins MWG Operon.   
 
To prepare a SSB substrate in which repair of the 5’ termini could be visualised, the 25mer was 
first radiolabelled on the 5’ termini by incubating the oligonucleotide with 32P ATP and T4 PNK 
(Roche) in a total volume of 40μl for 60 min at 37°C.  Unincorporated radionucleotides were 
then removed by applying the reaction to an illustra MicroSpin™ G-25 Columns (GE 
Healthcare) and centrifuging according to manufacturer’s specifications.  To prepare a SSB 
substrate in which repair of the 3’ termini could be visualised, the 17mer was radiolabelled.  To 
radiolabel a 17mer harbouring a 3’ phosphate modification, T4 PNK 3’ phosphatase free 
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mutant (Roche) was used to prevent processing of the 3’ termini.  The success of the 
radiolabelling was determined by analysing the reaction products by 15% urea PAGE.     
 
The radiolabelled oligonucleotides were annealed to a two-fold molar excess of unlabelled 
oligonucleotides in by incubating 95°C for 5 min and then incubating successively at 70°C, 50°C, 
37°C, and room temperature for 10 min each before placing on ice.  A control sample lacking 
either the 17mer or 25mer was annealed in parallel.  The annealed products were fractionated 
by 15% native PAGE.   
 
2.5.4 Preparation of 5’-AMP abortive ligation intermediates in vitro 
To prepare a 5’-AMP abortive ligation intermediates in vitro, an oxidative SSB substrate was 
adenylated using T4 DNA ligase.  The 25mer (25μM) was radiolabelled on the 5’ termini by 
incubating with 1U T4 DNA ligase and γ32P ATP in a volume of 40μl for 1 hour at 37°C.  
Unincorporated radionucleotides were removed using an illustra MicroSpin™ G-25 Columns 
and the 32P radiolabelled 25mer was annealed (11.25μM) to a two-fold excess of unlabelled 
17mer 3’-P (22.5μM) and 43mer (22.5μM) in Buffer EB (Qiagen).  The annealed oxidative SSB 
was then adenylated by incubating 7.5μM of the oligonucleotide duplex with 1U of T4 DNA 
ligase (Roche) for 30°C for 1 hour in 25mM tris-HCL (pH7.5), 130mM KCl, 1mM DTT, 10mM 
MgCl2,  and 1mM ATP.  A mock adenylated control lacking T4 DNA ligase was prepared by 
incubated 7.5μM of the oxidative SSB with ligase storage buffer (20 mM Tris-HCl (pH 7), 60 
mM KCl, 1 mM EDTA, 5 mM DTT, 50% glycerol (v/v)).  The efficiency of the adenylation 
reaction is not 100% and there is always some unadenylated 32P-25mer present necessitating 
purification of the AMP-32P-25mer by denaturing gel extraction using the Crush and Soak 
method.   
 
The reaction products were fractionated by 15% urea PAGE and the position of the adenylated 
and mock adenylated 25mer oligonucleotides was determined by autoradiography using blue 
sensitive film.  The AMP-32P-25mer and 32P-25mer were excised from the gel and the DNA was 
eluted from the acrylamide by crushing the gel slice and incubating overnight at room 
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temperature in 2x volume crush and soak buffer (300mM sodium acetate, 1mM EDTA (pH 
8.0)).  The resulting slurry was centrifuged at high speed and the supernatant retained.  1µl of 
Pellet Paint® NF Co-precipitant (Merck Biosciences) was added to the supernatant followed by 
2 x volume of ice cold absolute ethanol.  The solution was incubated at -80°C overnight and the 
DNA pelleted by centrifugation at 14,000 rpm for 20min at 4°C.  The pellet was washed twice 
with ice cold 70% ethanol, air dried and the purified DNA resuspended in 30μl Buffer EB 
(Qiagen).   
 
The purity of the purified AMP-32P-25mer and 32P-25mer oligonucleotides were determined by 
analysing by 15% denaturing PAGE.  The concentration of the purified oligonucleotides was 
determined by quantifying the intensity of the AMP-32P-25mer and 32P-25mer bands using 
ImageQuant TL software (GE Healthcare) and relating it to the intensity of a known quantity of 
the pre-gel extracted 32P-25mer.  The final adenylated and mock adenylated substrates 
containing a 1 nucleotide gap were prepared by annealing the purified AMP-32P-25mer and 
32P-25mer to a 2x molar excess of unlabelled 43mer and 17mer as previously described and 
analysing by 15% native PAGE.  A substrate containing an adenylated nick was prepared by 
substituting the 17mer for the 18mer oligonucleotide.   
 
2.5.4.1 Preparation of a dual radiolabelled 5’-AMP abortive ligation intermediate in vitro 
An adenylated SSB substrate containing a 32P radiolabel on the radiolabel of both the 17mer 
and 25mer oligonucleotides was prepared.  The 17mer 3’-P and 25mer were 32P radiolabelled 
with T4 PNK 3’ phosphatase free and annealed to a 2x fold molar excess of the unlabelled 
43mer.  The annealed duplex was then adenylated and mock adenylated as previously 
described.  The substrates were separated on 15% native PAGE and the fully annealed 
duplexes were purified from the partially annealed duplexes by gel extraction using the crush 
and soak method as described in section 2.5.4.  The purity of the final purified adenylated and 
mock adenylated duplexes were determined by analysis by 15% native PAGE and 15% urea 
PAGE and the concentration of the substrates were determined as described above.   
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 2.5.5 In vitro repair of adenylated SSB substrates by whole cell extracts 
For reactions involving whole cell extracts, 25nM of adenylated SSB substrate was incubated 
with the indicated concentrations of whole cell extract for 60 min at 30°C in reaction buffer 
containing 25mM HEPES (pH8.0), 130mM KCl, 1mM DTT, 10mM MgCl2, 100μM 
deoxynucleoside triphosphates (dNTPs) and 1mM ATP unless otherwise stated.  1000x fold 
molar excess of competitor oligonucleotide (Table 2.6) was added to the reactions to suppress 
non-specific nuclease activity.  Reactions were stopped by addition of 1/3 volume of 
formamide gel loading buffer (90% formamide, 0.12% w/v bromophenol blue) and denaturing 
by incubation at 90°C for 5 min.  Reaction products were separated by 15% urea PAGE gels and 
visualised by phosphorimaging as described previously.    
 
2.5.6 In vitro repair of SSBs by recombinant proteins 
For reactions involving recombinant proteins, 100nM of adenylated SSB substrate was 
incubated with the indicated concentrations of recombinant proteins for 60 min at 30°C in 
reaction buffer containing 25mM tris-HCL (pH7.5), 130mM KCl, 1mM DTT, 10mM MgCl2, 
100μM dNTPs and 1mM ATP unless otherwise stated.  Reactions were stopped by addition of 
1/3 volume of formamide gel loading buffer (90% formamide, 0.12% w/v bromophenol blue) 
and denaturing by incubation at 90°C for 5 min.  Reaction products were separated by 15% 
urea PAGE gels and visualised by phosphorimaging as described previously.    
 
2.5.7 In vitro ligase adenylation assay 
Ligase adenylation was assayed by incubating 100ng DNA ligase with 5 µM α32P ATP, 10nM 
ATP, 25mM HEPES (pH8.0), 130mM KCl, 1mM DTT and 10mM MgCl2 at 30°C for 5 min.  
Reactions were stopped by addition of SDS loading buffer (1x concentration:  50mM Tris 
pH8.0, 2% w/v SDS, 10% w/v glycerol, 0.1% w/v bromophenol blue 200mM DTT) and reaction 
products were fractionated by SDS PAGE.  Proteins were visualised by coomassie brilliant blue 
staining as described previously followed by destaining in 10% methanol 10% acetic acid.  The 
acrylamide gel was dried and adenylation of the ligase was visualised by phosphorimaging as 
described previously.   
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2.6 Mammalian Cell Culture 
Sources and genotypes of mammalian cell lines employed in experiments within this thesis are 
detailed in Table 2.7.   
 
2.6.1 Maintenance of mammalian cell lines 
All mammalian cell lines were incubated in a humidified atmosphere with 5% carbon dioxide at 
37°C.  The primary fibroblast cell lines FD105 and 1BR were maintained as monolayers in MEM 
supplemented with 15% (v/v) foetal calf serum (FCS), 100units/ml penicillin, 100Μg/ml 
streptomycin and 2mM L-glutamate.  The hTERT immortalised fibroblast cell lines FD105 M20 
hTERT, FD105 M21 hTERT and 1BR M20 hTERT were maintained in the same media containing 
0.3μg/ml puromycin and 300μg/ml G418.  The cultures were passaged every 2-4 days to 
maintain them in logarithmic growth phase.  Cells were washed with PBS and incubated in 1x 
trypsin (250mg/ml trypsin in PBS) for 5min.  Cells were shaken into suspension, washed with 
fresh media and an appropriate volume transferred into a fresh flask with fresh media.   
 
The lymphoblastoid cell lines (LCL) MT1 and MT6 were maintained in suspension in RPMI 
supplemented with 10% (v/v) foetal calf serum (FCS), 100units/ml penicillin, 100mg/ml 
streptomycin and 2mM L-glutamate.  Cells were passaged every 1-3 days by diluting in fresh 
media to maintain them in logarithmic growth phase at no greater than 1x106 cells/ml.   
 
For long term storage cells were pelleted by centrifugation at 1,500rpm for 3min and 
resuspending in fresh media containing 10% DMSO to a density of 5.0- 7.5x106 cells/ml.  1ml 
aliquots were transferred to cryotubes and cooled slowly to -80°C before storage in liquid 
nitrogen.  Cultures were regenerated by quickly thawing a frozen aliquot at 37°C and 
subsequently adding to fresh media in fresh flask (10ml media in a 75cm2 flask for fibroblasts 
or 5ml media in a 25cm2 flask for lymphoblastoid cell lines).  The hTERT immortalised 
82 
 
fibroblasts were incubated in drug free medium for 24 hours before replacing with selection 
media.   
 
2.6.2 Preparation of total cellular protein extracts 
Cell pellets were lysed in 1x SDS loading buffer (50mM Tris pH8.0, 2% w/v SDS, 10% v/v 
glycerol, 0.1% w/v bromophenol blue, 200mM DTT) at 94°C at a cell density of 0.5- 2x106 
cells/μl.  Total protein extracts were separated by SDS-PAGE and transferred onto 
nitrocellulose for immunoblotting.   
 
2.6.3 Preparation of cell free protein extracts 
7.5x106 cells were harvested by centrifugation at 1,500 rpm and washed in 3xPBS.  Cell pellets 
were lysed by incubation with 0.2ml cell lysis buffer (20 mM Tris-HCl (pH 7.5), 10 mM EDTA, 1 
mM EGTA, 100 mM NaCl, 1% Triton X-100 and 1/100 dilution of protease inhibitor cocktail 
(Sigma)) on ice and cell free extracts were prepared by centrifuging at 13,000rpm for 20min at 
4°C.  The supernatant was retained and the protein concentration quantified by the Lowry 
method using the DC Protein Assay (BioRad) with BSA used as a protein standard.  Cell free 
extracts were aliquoted and stored at -80°C.  
 
 2.6.4 Preparation of quiescent fibroblasts 
To render human fibroblasts quiescent, cells were cultured in complete media (MEM 
supplemented with 15% FCS) until confluence.  For hTERT immortalised fibroblasts, cells were 
seeded in a 75cm2 flask and grown until confluent.  Complete media was then replaced with 
serum- free media (MEM supplemented with 0.1% FCS) and cells were incubated for seven 
days.  24 hours prior to experimentation, on day six, media containing antibiotic selection was 
removed and the cells were incubated in drug free media.  For primary fibroblasts 6x105 cells 
were plated in 60mm culture dishes in complete media and grown until confluence.  Complete 
media was then replaced with serum – free media and incubated for 28 days.  Media was 
replaced with fresh media every 7 days.   
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2.7 DNA Replication Assays 
 2.7.1 3H-thymidine incorporation in the presence or absence of aphidicolin 
3H-thymidine incorporation was used as a measure of DNA replication synthesis in cycling and 
quiescent fibroblasts in the presence or absence of aphidicolin.   For quiescent fibroblasts, 
1x105 cells were seeded in duplicate into a 6 well dish and allowed to adhere by incubation at 
37°C for 4hrs.  Cells were then incubated with complete media containing 0.02μCi/ml 14C- 
thymidine for 48hrs, at which point the cells had achieved confluence.  The cells were washed 
in PBS three times and then incubated in serum-free media (MEM supplemented with 0.1% 
FCS) for seven days.  Following this cells were incubated with serum-free media containing 
50μM APH or an equal volume of DMSO for 60 min at 37°C.  3H-thymidine was added to the 
cells to a final concentration of 20μCi/ml in the presence of APH or DMSO and incubated for 3 
hours at 37°C.   
 
For cycling fibroblasts, 0.5x105 cells were seeded in duplicate into a 6 well dish and allowed to 
adhere for 4 hours.  Cells were then incubated with complete media containing 0.02μCi/ml 14C- 
thymidine for 48hrs and subsequently chased for 4 hours in complete media lacking the 
radionucleotide.  Following this cells were incubated with complete media containing 50μM 
APH or an equal volume of DMSO for 60 min at 37°C.  3H-thymidine was added to the cells to a 
final concentration of 20μCi/ml in the presence of APH or DMSO and incubated for 3 hours at 
37°C.   
 
Cells were washed in PBS three times and harvested and lysed by scrapping in 2% SDS.  100μl 
was spotted in duplicate onto filter paper, which was then incubated in 5% trichloroacetic acid 
for 5 min and then in 70% ethanol for 5min.  The filters were dried overnight,  incubated in 1ml 
Ecoscint™ A (National Diagnostics) and the 3H and 14C signal was counted by liquid scintillation 
counting.  3H-thymidine counts were normalised to 14C-thymidine counts and the data was 
plotted graphically.   
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2.8 Cellular DNA Strand-Break Repair Assays 
 2.8.1 Alkaline Single-Cell Agarose Gel Electrophoresis (Alkaline Comet Assay) 
The alkaline comet assay was used to measure the rate of repair of DNA strand breaks in 
mammalian cells after treatment with DNA damaging agents. 
 
2.8.1.1 Preparations 
For cycling primary and hTERT immortalised fibroblasts, cells were seeded into a 75cm2 flask 
and cultured until approximately 50% confluence.  24 hours prior to treatment of the hTERT 
immortalised fibroblasts, media containing antibiotic selection was removed and the hTERT 
fibroblasts were incubated in drug – free media.  Quiescent primary and hTERT immortalised 
fibroblasts were prepared as previously described in section 2.6.4.  On the day of the 
experiment, cells were trypsinised and resuspended in fresh media to a cell density of 2x105 
cells/ml.   
 
Agarose slides were prepared by coating frosted slides (Fisher) with 0.6% (w/v) ultrapure 
electrophoresis grade agarose (Invitrogen) dissolved in PBS.  150μl 0.6% agarose was spread 
under a coverslip in duplicate to prepare two mini agarose gels per slide and stored at 4°C for 
at least 60 min until use.   
 
2.8.1.2 Cell treatments, repair and cell harvesting 
Before treatment a 1ml mock treated sample was removed and kept on ice.  For treatment by 
exposure to γ-rays, cells were irradiated in suspension in complete media on ice.  After 
treatment, cells were incubated at 37°C for a desired repair period and harvested by 
centrifuging at 1,500 rpm at 4°C and resuspending in 1ml ice cold PBS.  Untreated and no 
repair samples were harvested in the same manner as repair samples.  For dose response 
assays, cells were irradiated with increasing doses of γ-rays and samples were immediately 
harvested.  All samples were retained on ice until plating.   
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2.8.1.3 Cell plating, cell lysis and electrophoresis 
200μl of the cell suspensions were mixed with 200μl of 1.2% low melting point agarose (Sigma) 
and 150μl of the mixture was quickly spread over the 0.6% mini agarose gels on frosted slides 
(described in section 2.8.1.1) on ice.  Slides were maintained at 4°C in the dark for the 
remainder of the assay.  Cells were lysed by immersing in ice cold lysis buffer (2.5M sodium 
chloride, 100mM EDTA, 10mM Tris, 1% DMSO, 1% Triton-X-100, pH10) for 60 min.  Slides were 
washed three times with ice cold ddH2O and DNA was denatured by incubating slides in 
alkaline electrophoresis buffer (50mM sodium hydroxide, 1mM EDTA, 1% DMSO) for 45 min.  
The DNA was subjected to electrophoresis for 25 min at 25V and then subsequently 
neutralised by incubating in 0.4M Tris pH7.0 for 30 min.   
 
2.8.1.4 Nucleic acid staining and scoring 
DNA was stained with SYBR green (1:10000 dilution) and visualised by fluorescent microscopy 
(Nikon Eclipse E400) at 20x magnification.  Comet tail moment for 100 cells per sample was 
determined using Comet Assay IV software (Perceptive Instruments).  The average tail moment 
and scatter graphs of tail moments were calculated plotted for each repair time point.   
 
2.8.1.5 Pre-treatment of cells with aphidicolin 
For comet assays in the presence of aphidicolin, the cells were either pre-treated with 50μM 
APH (stock 30mM in DMSO) in complete media or with equal volume of DMSO for 60 min at 
37°C.  The cells were then irradiated and allowed to repair in the presence of APH or DMSO.  
The comet assay was performed as described above.   
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CHAPTER THREE 
A defect in short-patch SSBR in AOA1 cell 
extracts 
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3.1 Introduction 
AOA1 is an autosomal recessive ataxia that clinically presents with early onset ataxia, 
oculomotor apraxia, cerebellar atrophy and axonal motor neuropathy and is caused by 
mutations in the gene APTX (Barbot et al., 2001, Date et al., 2001).  APTX has been shown to 
resolve abortive ligation intermediates in vitro by catalysing the release of adenylate groups 
covalently linked to 5’ phosphate terminus of a DNA SSB or DSB (Ahel et al., 2006, Rass et al., 
2007a, Rass et al., 2008).  Whole cell extracts prepared from APTX-/- DT40 cells or APTX-/- 
mouse primary cortical astrocytes lack AMP-DNA hydrolase activity and are unable to perform 
short-patch SSBR on an in vitro substrate modelling an abortive ligation of an oxidative SSB 
(Ahel et al., 2006).  APTX has been proposed to play a role in SSBR following DNA damage as a 
way of resetting an abortive ligation and allowing repair to continue (Figure 3.1).  
 
3.1.2 Aims of this chapter 
So far all the in vitro data on the role of APTX in repairing aborted ligation intermediates has 
been presented using recombinant proteins and cell free extracts from APTX-/- DT40 cells or 
APTX-/- mouse cortical astrocytes (Ahel et al., 2006, Rass et al., 2007a, Rass et al., 2008).  The 
aim of this chapter is to determine if whole cell extracts prepared from human AOA1 disease 
cell lines are also defective in the short-patch SSBR of abortive ligation intermediates.  To 
achieve this lymphoblastoid cell lines (LCL) derived from an individual with AOA1 were 
cultured and whole cell extracts from these cells were prepared.  A model substrate of an 
abortive ligation of an oxidative SSB was prepared in vitro using 32P radiolabelled 
oligonucleotides and AOA1 and WT whole cell extracts were compared for their ability to 
repair an abortive ligation intermediate in vitro.   
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3.2 Results 
To measure short patch SSBR in vitro a double stranded oligonucleotide duplex harbouring a 
SSB was prepared  by annealing 17mer and 25mer oligonucleotides to a complimentary 43mer 
oligonucleotide backbone resulting in an oligonucleotide duplex that contains a 1 nucleotide 
gap and non-complementary 3’ overhangs (Figure 3.2 A).  The 3’ termini of the 17mer 
oligonucleotide (17mer-P) possess a 3’-phosphate terminus, mimicking the most common type 
of 3’ termini that arises from oxidative DNA damage (Ward, 1998, Ward et al., 1987, Caldecott, 
2001).  To visualise the substrate the 5’ termini of the 25mer was radiolabelled using 32P ATP 
and T4 PNK prior to annealing.  Unless otherwise stated all other termini contain an OH.  
 
3.2.1 Preparation of 5’-AMP abortive ligation intermediates in vitro 
To prepare 5’-AMP abortive ligation intermediates in vitro, an oxidative SSB substrate was 
adenylated using T4 DNA ligase.  A schematic detailing the preparation of the 5’-AMP substrate 
is presented (Figure 3.2 B).  To prepare the model abortive ligation intermediate substrate, the 
5’ termini of the 25mer was first radiolabelled by incubating with 1U of T4 PNK and 32P ATP at 
30°C for 1 hour.  The unincorporated nucleotides were removed using spin-column 
chromatography.  The radiolabelled 32P-25mer was then annealed into a double stranded 
duplex by mixing with a 2x molar excess of unlabelled 43mer and 17mer-P and heating the 
mixture to 94°C for 5 min followed by cooling slowly to room temperature.  The substrate was 
then adenylated by incubation with 1U of T4 DNA ligase at 30°C for 1 hour, or mock 
adenylated in the absence of ligase.  The 5’- adenylated 32P-25mer product of this abortive 
ligation reaction, which arises because the ligation reaction is prevented from going to 
completion due to the presence of the 3’P on the 17-mer and the 1 nucleotide gap, is shown in 
Figure 3.3A.  The adenylated 25mer (AMP-32P-25mer) was then separated from the non-
adenylated 25mer (32P-25mer) by 15% denaturing PAGE, recovered by gel extraction (Figure 
3.3B), and re-annealed with the 17mer and 43mer to create the final adenylated substrate 
(Figure 3.3C).   
 
To confirm the substrate was fully annealed the oligonucleotide duplexes were fractionated by 
15% native PAGE (Figure 3.3 C).  The fully annealed oligonucleotide duplex (lane 1) was readily 
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distinguished from a control partially annealed duplex lacking the 17mer (Figure 3.3 C, lane 2) 
and from the single stranded AMP-32P-25mer (lane 3).  This final substrate contains a SSB with 
a 1 nucleotide gap, a 3’P and a 5’AMP.  It has been estimated that ~70% of SSBs produced by 
ROS have a 3’P so this substrate is a good model of an abortive ligation of an oxidative SSB 
(Caldecott, 2001).  This substrate is also useful for measuring short-patch SSBR as the position 
of the 32P radiolabel on the 5’ of the 25mer means that long-patch SSBR events will not be 
detected.   If gap filling extended past incorporation of a single nucleotide, a 5’ flap containing 
the 32P radiolabel would be generated.  Cleavage of this 5’ flap by FEN1 would result in loss of 
the label.  Thus only repair involving short-patch SSBR would result in the 32P radiolabel being 
incorporated into a ligation product. 
 
3.2.2 Overexpression and purification of His-tagged APTX in E.coli  
To investigate the role of APTX in the repair of abortive ligation intermediates in vitro 
recombinant APTX was purified to homogeneity by two successive rounds of chromatography.  
Human APTX cDNA is present within the expression vector pB352 under the control of the T7 
promoter and carries an N-terminal 6x histidine-tag (Clements et al., 2004).  Expression of 
APTX was induced by addition of 1mM IPTG to a 500ml culture at OD600 0.6 and incubation at 
30°C for 3hrs.  After induction of protein the cells were harvested and lysed by sonication.  
Clarified extract was prepared by pelleting the insoluble material by centrifugation and 
retaining the supernatant.  His-APTX was then purified by immobilised metal affinity 
chromatography (IMAC) on a column prepared using nickel-nitrilotriacetic acid (Ni-NTA) 
agarose beads (first described in (Porath et al., 1975)).  The clarified extract was loaded onto 
the column, washed three times and eluted in sonication buffer containing 250mM imidazole.  
Aliquots of the column load, flow through and elution fractions were analysed by 10% SDS-
PAGE (Figure 3.4 A).  His-APTX bound tightly to the Ni-NTA agarose column and was 
significantly depleted in the flow through.  It eluted over four fractions following addition of 
elution buffer containing 250mM imidazole, peaking in the second fraction (Figure 3.4 A).  A 
number of contaminating proteins co-purified with His-APTX.  These most likely reflected 
contaminating histidine-rich E.coli proteins and were subsequently removed by cation 
exchange chromatography.  
 
90 
 
Cation exchange was chosen because the isolelectric point (PI) of APTX is 9.27, and is therefore 
a basic protein at neutral pH.  Peak His-APTX fractions from IMAC were (1 & 2) were pooled 
and loaded onto a cation exchange column.  His-APTX bound tightly to the column and was 
undetectable in the flow through (Figure 3.4 B).  Following extensive washing His-APTX was 
eluted with a salt gradient (NaCl) from   0.1M to 1M and aliquots of elution fractions analysed 
by 10% SDS PAGE (Figure 3.4 B).  His-APTX eluted in a sharp peak at approximately 300-
400mM NaCl.  Fractions 26 and 27 were pooled, dialysed into storage buffer, quantified by 
Bradford assay and 500ng of this material analysed by SDS-PAGE and coomassie blue staining 
(Figure 3.4 C).   
 
3.2.3   AOA1 whole cell extracts display defective short-patch SSBR of an abortive 
ligation intermediate in vitro 
To determine if human AOA1 cells have the ability to repair an abortive ligation intermediate 
in vitro, the lymphoblastoid cell lines (LCL) cell lines MT6 (AOA1) and MT1 (WT) were 
employed.  MT6 is a cell line derived from an individual that is homozygous for a whole 
genomic deletion of APTX (Reynolds et al., 2009).  7.5x106 cells from each line were harvested 
by centrifugation at 1,500 rpm, washed in 3xPBS and whole cell extracts were prepared.  The 
AOA1 and WT whole cell extracts were then  assayed for their ability to repair an abortive 
ligation intermediate by incubating 6.25g of extract with 25nM of the abortive ligation 
intermediate described in Figure 3.2 & 3.3 and depicted again in Figure 3.5.  Reaction products 
were fractionated by denaturing PAGE and detected by phosphorimaging (Figure 3. 5).   
 
Removal of the AMP from the 5’-terminus of the SSB was indicated by an increase in the 
electrophoretic mobility of the AMP-32P-25mer, due to loss of the AMP moiety.  In the lanes 
containing the products of reactions containing wild-type extract the AMP-32P-25mer was 
rapidly converted to 32P-25mer (Figure 3.5 lanes 4-7).  One limitation of reactions involving 
whole cell extracts is the presence of non-specific nucleases that result in degradation of the 
substrate.  Whilst the impact of such nucleases was suppressed by inclusion of a 1000x fold 
molar excess of a single-stranded competitor oligonucleotide, some non-specific nucleolytic 
products were still evident (Figure 3.5 asterisk).  Notably, however, whilst non-specific 
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nucleolytic products were also produced in reactions containing AOA1 LCL extracts, formation 
of the 32P-25mer product of APTX activity was not evident in such reactions, and there was no 
detectable loss of AMP-32P-25mer, during the 60min incubation (Figure 3.5. lanes 9-12).  
Indeed the difference in size between the non-specific bands present in lanes containing WT 
and AOA1 extracts is due to the persistence of the 5’AMP in the latter.  This suggests that APTX 
is the major, if not only, AMP-DNA hydrolyse activity present in human lymphoblastoid cells.   
 
Direct processing of the 3’ termini of the SSB (i.e. on the 17-mer) could not be visualised due to 
the location of the 32P radiolabel on the 25mer oligonucleotide.  However the presence of a 
fully repaired ligation product of 43bp requires both 3’ phosphatase and gap filling activities 
and is therefore an indirect measure of 3’ processing.  Wild-type whole cell extracts proved 
able to repair the abortive ligation intermediate and ligation was evident from 10min onwards 
(Figure 3.5 lanes 4-7).  There was very little if any ligation product detectable in reactions 
containing AOA1 whole cell extract, at any time point examined (Figure 3.5 lanes 9-12).  Whole 
cell extract prepared from AOA1 cells, lacking 5’AMP-DNA deadenylase activity, were unable 
to support short-patch SSBR of an abortive ligation intermediate in vitro.   
 
3.2.4 AOA1 cell free extracts are proficient in the short-patch SSBR of a non-
adenylated oxidative SSB 
To confirm that the short-patch repair defect in reactions containing AOA1 extracts was caused 
by loss of aprataxin, I first compared the presence of levels of core SSBR proteins involved in 
the repair of oxidative SSBs (Figure 3.6).  The repair of a common oxidative SSB consisting of a 
1 nucleotide gap and 3’-P is thought to require the activities of PNK, Polβ and LigIIIα.  XRCC1 
has also been reported to stimulate the activities of SSBR end-processing enzymes in vitro and 
is required for the stability of LigIIIα and a defect in this protein could result in less efficient 
repair of SSBs in vitro (Caldecott et al., 1995, Whitehouse et al., 2001).  10µg of wild-type and 
AOA1 whole cell extracts were immunoblotted for the SSBR proteins APTX, PNK, Polβ, LigIIIα 
and XRCC1 (Figure 3.6).  The extracts were also probed for -tubulin and actin as loading 
controls.  AOA1 whole cell extracts had levels of protein similar to the wild-type control, with 
the exception of APTX which was undetectable in the AOA1 extracts (Figure 3.6).  This supports 
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the hypothesis that AOA1 extracts are defective in the short-patch repair of abortive ligation 
intermediates due to the loss of APTX and not other core SSBR factors. 
 
To confirm directly that the short-patch repair defect in reactions containing AOA1 extracts 
was caused by loss of aprataxin, I attempted to complement reactions containing AOA1 whole 
cell extracts with recombinant His-APTX and (Figure 3.7).  A titration of wild-type and AOA1 
whole cell extracts (5µg, 1µg, 0.1µg ) was incubated with 25nM of the adenylated SSB in the 
presence or absence of 100nM His-APTX at 30°C for 60min.  In the absence of recombinant 
His-APTX, 5’AMP deadenylase activity was detectable in reactions containing as little as 0.1µg 
of wild-type whole cell extract (Figure 3.7 lane 5).  This activity was greater in reactions 
containing 1µg and 5µg of wild type whole cell extract and ligation product was also detected 
at these concentrations (Figure 3.7 lanes 3&4).  In contrast, as observed in Figure 3.4, AOA1 
whole cell extracts were unable to repair the abortive ligation intermediate and the 5’AMP 
termini persisted at all concentrations of extract employed (Figure 3.7 lanes 6-8).  Notably, 
complementation of AOA1 whole cell extracts was observed by the inclusion of 100nM His-
APTX, which completely rescued repair of the abortive ligation intermediate (Figure 3.7 
compare lanes 12-14 to lanes 3-5).   In contrast, there was no increase in the repair of abortive 
ligation intermediate in wild type extracts supplemented with His-APTX (Figure 3.7 compare 
lanes 3-5 and 9-11) indicating that APTX activity is not rate limiting in the wild-type 
lymphoblastoid extracts.  These data confirm that short-patch SSBR of an abortive ligation 
intermediate fails in reactions containing AOA1 whole cell extract in vitro due to the absence 
of APTX.   
 
It has been reported in one study that APTX possesses 3’ phosphatase activity (Takahashi et al., 
2007a).  The loss of 3’ phosphatase activity in AOA1 whole cell extracts might contribute to 
defective short-patch SSBR because the persistence of an unrepaired 3’-P terminus would 
inhibit gap-filling.  To determine if the APTX dependant SSBR defect was due to loss of 5’AMP 
deadenylase activity and/or 3’ phosphatase activity, the ability of AOA1 whole cell extracts to 
repair a non-adenylated SSB was examined (Figure 3.8).  5µg of AOA1 and WT whole cell 
extract were incubated at 30°C for 60min with 25nM of a mock-adenylated or adenylated SSB, 
containing a 1 nucleotide gap and a 3’-phosphate terminus.  As observed in the previous 
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experiments, AOA1 whole cell extracts could not repair the adenylated oxidative SSB (lane 5).  
Importantly, however, AOA1 cell extracts were proficient in the repair of a non-adenylated SSB 
(compare lanes 3 and 5) and showed levels of repair comparable to wild-type (compare lanes 3 
and 4).  This shows that AOA1 whole cell extracts are proficient in the repair of a non-
adenylated SSB containing a 3’-phosphate terminus and thus that the repair of an abortive 
ligation intermediate stalls in AOA1 whole cell extracts due to the presence of a 5’-AMP 
terminus, and not a 3’-phosphate terminus.   
 
3.2.5 Short Patch SSBR reaction requires 1nt gap filling  
Due to the location of the 32P radiolabel on the 5’ termini of the SSB, repair of the 3’ terminus 
cannot be directly visualised, and so 3’ end processing and gap-filling events are measured 
indirectly by the appearance of DNA ligation product. Whilst the appearance of ligation 
product requires processing of the 3’-terminus I considered the possibility that the repair 
reaction could occur in the absence of 1nt gap filling by ligation across the 1nt gap.  Such 
ligation has been reported by T4 DNA ligase (Nilsson and Magnusson, 1982).  Because I wished 
to ensure the repair reaction faithfully recapitulated short patch SSBR it was important to 
confirm that the repair reaction was dependent upon gap filling. To test this, 5µg of wild type 
and AOA1 whole cell extract was incubated with 25nM of an abortive ligation intermediate in 
the presence or absence of 100µM dNTPs (Figure 3.9).   The absence of dNTPs from the 
reaction mix impaired the full repair of the abortive ligation intermediate in wild-type extracts.  
Repair of the 5’-AMP terminus was still complete upon incubation with 5µg of wild-type 
extract but ligation product was not detectable (compare lanes 1 and 5), suggesting that repair 
of abortive ligation intermediates was dependent on gap-filling.  This experiment confirms that 
short-patch SSBR proceeds through a gap-filling event.  This also suggests that since repair of a 
non-adenylated 3’-phosphate substrate was normal in AOA1 then 1nt gap filling is also most 
likely to be normal. 
 
As controls I also included in the above experiments reactions lacking ATP or MgCl2 (Figure 
3.9).  Since PNK, Polβ and LigIIIα activities all require a metal divalent metal cofactor the repair 
reaction was, as expected, dependent on  Mg2+ (lanes 7 and 8). However, wild type extracts 
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removed AMP from the 5’-termini of the SSB, consistent with the metal independence of APTX 
activity (Parks et al., 2004, Seidle et al., 2005, Ahel et al., 2006) (compare lanes 1 to 7).  It is 
also noteworthy that the non-specific nucleolytic degradation of the substrate is also 
dependent on the presence of MgCl2 (compare lanes 1 and 2 to 7 and 8).  Interestingly, the 
absence of ATP from the reaction mix had no effect on the repair of an abortive ligation 
intermediate and there was only a small reduction in the levels of ligation (compare lanes 1 
and 3).  Although the reaction mechanism of mammalian ligases is ATP-dependent, ligases 
exist in both pre-adenylated form and non-adenylated state, enabling one round of ligation 
even in the absence of exogenous ATP (Figure 1.11) (Little et al., 1967, Weiss et al., 1968a, 
Gumport and Lehman, 1971).  Alternatively, it is possible that there is ATP present in the 
whole cell extracts.   
 
3.3 Discussion 
The data presented in this chapter reveal that whole cell extracts prepared from a human 
AOA1 disease cell line are defective in the short-patch SSBR of an abortive ligation 
intermediate in vitro.  This defect is caused by the loss of APTX 5’-AMP DNA deadenylase 
activity because AOA1 cell extracts are proficient in the repair of a non-adenylated SSB.  This 
suggests that it is the persistence of the unrepaired 5’AMP that blocks subsequent repair 
events in the AOA1 whole cell extracts, rather than processing of 3’-phosphate termini, gap 
filling, or DNA ligation.  This is consistent with data previously seen in APTX-/- DT40 cells and 
APTX-/- primary mouse cortical astrocytes (Ahel et al., 2006).  Having established an assay to 
measure the short-patch repair of a SSB in vitro, I employed the assay in the following chapters 
to further investigate the nature for the repair defect in AOA1. 
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CHAPTER FOUR 
Defective DNA ligation of Adenylated 
Nicks in AOA1 cell extracts 
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4.1 Introduction 
The data presented in the previous chapter showed that whole cell extracts prepared from an 
AOA1 lymphoblastoid cell line are unable to support short-patch SSBR of an abortive ligation 
intermediate in vitro.  This repair defect is a consequence of APTX loss as repair of an abortive 
ligation intermediate was rescued to WT levels when AOA1 extracts were supplemented with 
recombinant His-APTX.   Importantly AOA1 extracts were also proficient in the repair of a non-
adenylated  SSB indicating that the repair defect resulted from  the loss of 5-’AMP DNA 
deadenylase activity. 
 
The SSB substrate employed in the in vitro repair assays in the previous chapter was an 
oligonucleotide duplex containing a SSB designed to model an abortive ligation of a common 
oxidative DNA lesion.  The substrate harboured a 1 nucleotide gap with 3’-P and 5’-AMP 
termini and in WT extracts the repair of this substrate would be expected to involve processing 
of the 5’-terminus by APTX, processing of the 3’-terminus by PNK, gap-filling by Polβ, and 
finally ligation for complete repair (Figure 4.1A).    Whilst the previous chapter demonstrated 
that persistence of 5’-AMP blocked repair, this observation is puzzling because should 
processing of the 3’-terminus proceed normally via end processing by PNK and gap filling by 
Polβ, then the resulting adenylated nick should simply be ligated by non-adenylated DNA ligase 
IIIα (Figure 4.1B).   Since this didn’t occur, it was hypothesised that either end processing by 
PNK or gap filling by Polβ could be blocked by the presence of the 5’-AMP (Figure 4.1B).  This 
possibility was tested in this chapter.   
 
4.1.2 Aims of this chapter 
The aim of this chapter was to determine at which stage the repair of an SSB with a 5’-AMP 
terminus fails in AOA1 whole cell extracts.  The effect of the presence of the 5’AMP on 3’ end-
processing by PNK, gap-filling by the short-patch polymerase Polβ, and finally ligation by DNA 
ligase III was thus measured using a combination of recombinant SSBR proteins and AOA1 and 
wild-type whole cell extracts.   
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4.2 Results 
To directly measure repair of the 3’-phosphate by PNK and gap-filling by Polβ, an abortive 
ligation intermediate was prepared containing a 5’ 32P radiolabelled 17mer oligonucleotide 
with either a 3’-P or 3’-OH terminus annealed to a 32P-25mer and an unlabelled 43mer.  This 
substrate was then adenylated or mock-adenylated with T4 DNA ligase as previously 
described.  The fully annealed dual 32P radiolabelled substrate was purified from partially 
annealed species by native PAGE gel extraction.  The final purified substrates consisted of an 
oligonucleotide duplex with a SSB consisting of a 1 nucleotide gap, a 3’-phosphate or 3’-
hydroxyl terminus and a 5’-AMP terminus (Figure 4.2).   
 
4.2.1 Overexpression and purification of recombinant His-tagged PNK from E.coli 
To obtain recombinant His-PNK for these experiments I first optimised the expression 
conditions of the recombinant human protein in E.coli.  Optimal expression conditions for His-
PNK in E.coli were determined by setting up six small scale cultures with different induction 
conditions (Figure 4.3).  Three growth temperatures of 15°C, 20°C and 25°C and two induction 
times of 90min and 180min were tested and aliquots of the soluble and insoluble fractions 
were analysed by 10% SDS-PAGE.  As both incubation time and temperature increased, the 
total level of His-PNK expressed in bacterial cells increased (Figure 4.3 A), but the amount of 
soluble protein compared to insoluble protein decreased (Figure 4.3 B).  An incubation 
temperature of 20°C for 90min was considered optimal because this produced a high ratio of 
soluble to insoluble His-PNK without sacrificing high levels of total protein expression.    
 
Clarified extract containing soluble His-PNK was prepared as previously described for His-APTX 
in chapter 3 and purified by immobilised metal affinity chromatography (IMAC) on a Ni-NTA 
agarose column (Figure 4.4 A).  His-PNK eluted from the column over six fractions, with a large 
peak occurring in the second fraction (Figure 4.4 A).  His-PNK co-eluted with a large number of 
contaminating bands necessitating a further purification step.  PNK has a predicted PI of 8.73 
and is a basic protein at neutral pH.  Peak elution fractions (2 & 3) were pooled and His-PNK 
was further purified by cation exchange chromatography (Figure 4.4 B).  The peak elution 
fractions from cation exchange (16 & 17) contained a single major band that corresponded to 
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His-PNK, as measured by coomassie blue staining, with some evidence of a smaller 
contaminating species in fraction 16.  Elution fraction 17 was chosen for use in experiments 
and was dialysed into appropriate buffer.   
 
4.2.2 The presence of a 5’-AMP does not block the 3’ phosphatase activity of PNK 
The ability of His- PNK to convert a 3’-P to a 3-OH in the presence and absence of a 5’-AMP 
terminus was compared in vitro. Reactions containing various amounts of recombinant His-
PNK (250nM, 100nM, 50nM and 25nM) and 25nM of either an adenylated or mock-adenylated 
SSB substrate containing a 3’-P terminus were incubated for 1hr at 30°C (Figure 4.5).  The 
reaction products were then fractionated by 15% denaturing PAGE and visualised by 
phosphorimaging.  PNK-dependent conversion of the 3’-P terminus to a 3-OH terminus was 
indicated by decreased mobility of oligonucleotide containing the latter, due to the loss of 
negative charge. Comparable levels of conversion of 3’-P termini to 3’-OH termini by His-PNK 
were observed with the adenylated and mock-adenylated substrates.  These data reveal that 
the presence of a 5’-AMP terminus does not prevent processing of a 3-’P terminus by His-PNK 
suggesting that the short-patch SSBR repair defect observed in reactions driven by  AOA1 
whole cell extracts in the last chapter was not due to  reduced 3’-end processing by PNK.    
 
4.2.3 Overexpression and purification of recombinant Polβ from E.coli 
As the presence of a 5’-AMP terminus at a SSB does not inhibit the 3’ phosphatase of 
recombinant PNK the next stage of repair that could fail in the presence of a 5’-AMP is gap-
filling by Polβ.  To test this, recombinant human Polβ was purified to by ion exchange 
chromatography employing anion and cation exchange as described previously (Sobol et al 
1996).  Aliquots of the column load, flow through and representative elution fractions were 
analysed by 10% SDS PAGE (Figure 4.6).  The peak elution fraction (14) of Polβ contained very 
little contaminating protein as measured by coomassie blue staining and following dialysis into 
an appropriate buffer was employed for the experiments described below.  
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4.2.4 The presence of a 5’-AMP terminus does not block gap-filling by Polβ 
The ability of recombinant human to insert a single nucleotide into a SSB containing a 5’-AMP 
was tested.  To test this, a titration of Polβ (100nM, 30nM, 15nM and 5nM) was incubated 
with 25nM of an adenylated or mock-adenylated SSB substrate with a 1 nucleotide gap, a 3’OH 
terminus, and either a 5’-AMP or a 5’-P terminus for 1hr at 30°C (Figure 4.7).  The reaction 
products were fractionated by 15% denaturing PAGE and visualised by phosphorimaging.  Gap-
filling was indicated by conversion of the 32P-17mer-OH to a 32P-18mer-OH, which 
consequently exhibited reduced electrophoretic mobility indicating that a single nucleotide 
had been inserted into the gap.  Similar levels of single nucleotide incorporation was visualised 
on both adenylated and mock-adenylated substrates revealing that the presence of a 5’-AMP 
terminus did not prevent recombinant Polβ.  This suggests that that the short-patch SSBR 
defect observed in reactions containing AOA1 extract in the last chapter was not due to 
reduced Polβ activity.   
 
4.2.5 Short-patch SSBR stalls at the final stage of DNA ligation in AOA1 whole cell 
extracts 
The previous data suggests that short-patch SSBR repair of an abortive ligation intermediate by 
AOA1 extract does not stall during PNK dependent end-processing or Polβ mediated gap-filling.  
This suggests that short patch SSBR in such extracts stalls at the stage of DNA ligation, thereby 
accumulating adenylated nicks.  This is surprising because adenylated nicks arise as a normal 
intermediate of DNA ligation as very transient repair intermediate that are rapidly converted 
into an intact phosphodiester bond by non-adenylated ligase, which catalyses nucleophilic 
attack of the 5’-AMP terminus by the 3’-OH terminus releasing the AMP and reforming the 
phosphpodiester bond (Olivera et al., 1968, Harvey et al., 1971, Weiss et al., 1968b, Gumport 
and Lehman, 1971, Lehmann, 1978) (a more detailed description of the ligase mechanism is 
found in section 1.3.4.1 and in Figure 1.11).  
 
To confirm that short patch SSBR reactions fail in AOA1 extracts due to failed DNA ligation, the 
ability of AOA1 and WT whole cell extracts to ligate an adenylated nick was compared directly 
in vitro.  6.25μg of whole cell extracts prepared from WT and AOA1 LCLs were incubated at 
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30°C for the indicated times with 25nM of an adenylated nick (Figure 4.8).  In contrast to the 
substrates used in the previous experiments in this chapter, the substrate used for this 
experiment contained a single 32P radiolabel on the 5’ terminus of the 25mer oligonucleotide 
(32P-25mer).  The reaction products were fractionated by 15% denaturing PAGE and detected 
by phosphorimaging.  As seen previously the 5’-AMP was rapidly removed in WT extracts and 
the resulting non-adenylated nick was ligated (lanes 4-7).  However in contrast, not only did 
the AOA1 extract fail to remove the 5’-AMP, as expected, but also failed to reseal the 
adenylated nick (lanes 9-12).  This experiment confirmed that short-patch repair of SSBs 
containing 5’-AMP termini fail in the absence of aprataxin at the very step of DNA ligation.  
 
4.3 Discussion 
The data presented in this chapter reveal that the presence of a 5’-AMP at a SSB does not 
inhibit the activities of either recombinant PNK or Polβ in vitro.  Rather AOA1 extracts fail to 
repair such SSBs due to an inability to conduct the final step of ligating the adenylated nick.  
This in turn suggested that adenylated nicks could potentially accumulate in the absence of 
APTX.  This was surprising because adenylated nicks arise as normal intermediates of DNA 
ligation reactions and are normally rapidly resealed by non-adenylated DNA ligase.  Why then 
does non-adenylated DNA ligase not reseal these nicks in AOA1 extracts?  One possibility is 
that lower levels of active DNA ligase are present in AOA1 extracts compared to wild-type 
extracts.  This can be discounted, however, as AOA1 extracts were normal for the repair of a 
non-adenylated SSB (Figure 3.8).   
 
Another possibility is that there are very low levels of non-adenylated ligase in AOA1 extracts.  
This could be a specific deficit in AOA1 extracts, if APTX can also deadenylate DNA ligases.   
APTX is a member of the Hint branch of the HIT superfamily of nucleotide hydrolases and 
transferases which exhibit AMP-lysine hydrolase activity (Brenner, 2002, Brenner et al., 1999, 
Bieganowski et al., 2002b, Krakowiak et al., 2004b).  Indeed it has been shown that APTX 
possesses weak AMP-lysine hydrolase activity (Seidle et al., 2005).  Alternatively, however, it is 
not necessary to invoke a specific reduction in levels of non adenylated ligase in AOA1, since 
the presence of relatively high levels of ATP in cells and in the reactions described here ensure 
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that most DNA ligases are present predominantly in their adenylated form.  The addition of an 
excess of pyrophosphate to the reaction could be used to investigate this.  Pyrophosphate is 
generated when the ATP molecule is cleaved and the AMP moiety is transferred to the active 
site lysine during ligase adenylation (Olivera et al., 1968, Harvey et al., 1971, Weiss et al., 
1968b, Gumport and Lehman, 1971, Lehmann, 1978).  The presence of excess pyrophosphate 
should alter the equilibrium of this reaction in favour of the deadenylated ligase which could 
be used to rescue the defec t in the AOA1 extracts. 
 
The hypothesis that limiting levels of non-adenylated ligase is cause for the failure of AOA1 
whole cells extracts to ligate a pre-adenylated nick raises specific predictions that can be 
tested.  In particular, if the lack of APTX-independent short patch repair results from 
insufficient non adenylated DNA ligase then the repair of an abortive ligation intermediate 
should be rescued in AOA1 extracts by addition of excess recombinant DNA ligase in the 
absence of ATP (to minimise adenylation of the recombinant ligase).  This possibility was 
tested in the next chapter. 
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CHAPTER FIVE 
Short-patch SSBR of an abortive ligation 
intermediate fails in AOA1 cells in vitro 
due to insufficient levels of non-
adenylated ligase 
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5.1 Introduction 
The data presented in previous chapters demonstrated that short-patch repair of a single-
stranded gap with 5’-AMP termini failed in AOA1 whole cell extracts in vitro.  The persistence 
of the 5’-AMP at the SSB in the absence of APTX did not block either PNK-mediated end-
processing or Polβ-mediated gap-filling.  Rather, it was observed that repair failed at the final 
stage of ligating the residual adenylated nick.  This was surprising because adenylated nicks 
arise as a normal intermediate of every DNA ligation reaction, and require only non-
adenylated DNA ligase for ligation to be completed.  The inability of AOA1 extracts to ligate 
adenylated nicks was not due to a general defect in DNA ligation because AOA1 whole cell 
extracts were proficient in the short-patch repair of a non-adenylated break.   
 
DNA ligases are nucleotidyltransferases (NTases) that utilise a high energy cofactor to catalyse 
phosphodiseter bond formation in a universal three-step reaction mechanism and all 
eukaryotic ligases use ATP as a cofactor (Figure 5.1).  In the first step of DNA ligation, the ligase 
reacts with ATP to form a ligase-adenylate intermediate in which AMP is covalently linked to 
the active-site lysine via a phosphoamide bond (Olivera et al., 1968, Harvey et al., 1971, Weiss 
et al., 1968b, Gumport and Lehman, 1971, Lehmann, 1978).  The formation of this ligase-
adenylate intermediate is energetically favourable at cellular concentrations of ATP and the 
adenylated form of the ligase is stable in the absence of DNA breaks.  Consequently, although 
DNA ligases exist in two forms it is likely that the adenylated form is the predominant one 
present in cells.   
 
Once adenylated DNA ligase encounters a DNA break the second step of ligation is the 
activation of the 5’P by adenylation of the DNA (Sekiguchi and Shuman, 1997, Sriskanda and 
Shuman, 1998a, Odell et al., 2000, Odell et al., 2003, Tomkinson et al., 2006, Nair et al., 
2007b).  During this step the oxygen of the 5’P attacks the phosphorus of the AMP, dispelling 
the lysine and transferring the adenylate group onto the 5’P, forming an AMP-DNA 
intermediate (Odell et al., 2003, Nair et al., 2007a).  The final step of ligation is the reformation 
of the phosphodiester backbone (Lehmann, 1978).  During this step the non-adenylated ligase 
catalyses the nucleophilic attack of the 5’AMP by the 3’OH, displacing the AMP and joining the 
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two polynucleotides by formation of a phosphodiester bond (Odell et al., 2000, Sriskanda and 
Shuman, 2002b, Sriskanda and Shuman, 2002a, Nair et al., 2007a, Crut et al., 2008).  This step 
is very rapid, and the rate of phosphodiester resynthesis is much faster than the adenylation of 
the DNA (Crut et al., 2008).  Normally these two steps are coupled such that the adenylated 
nick is rapidly sealed by the deadenylated ligase (Figure 5.1).   
 
However, if step 2 and 3 are ‘uncoupled’, due to abortive ligation events at breaks with 
blocked 3’-termini, the non-adenylated ligase will be rapidly readenylated. Consequently, it is 
possibile that the cellular level of non-adenylated DNA ligase is insufficient to complete ligation 
of pre-adenylated nicks. This may not be a problem in WT extracts because the presence of 
APTX restores the nick to a non-adenylated state (Figure 5.2A.)  However, in AOA1 extracts, 
repair is now dependent on the pre-existing level of non-adenylated ligase, which we 
hypothesize, may be too low to facilitate step 3 of the ligase reaction (Figure 5.2B).  
 
5.1.2 Aims of this chapter 
The hypothesis that limiting levels of non-adenylated ligase account for the failure of AOA1 
whole cells extracts to ligate adenylated nicks invokes the testable predictions that the repair 
of an adenylated gap or nick can be restored in AOA1 extracts by supplementing repair 
reactions with recombinant de-adenylated DNA ligase, in an ATP-sensitive manner.  This is 
because omitting ATP will increase the relative level of recombinant DNA ligase that is non-
adenylated, which the above hypothesis predicts will promote complementation, whereas 
including ATP will reduce the presence of adenylated DNA ligase, which the above hypothesis 
predicts will inhibit complementation.  Also, as this model requires the addition of 
deadenylated ligase, T4 DNA ligase was initially used instead of human ligase, as commercial 
preparations of T4 DNA ligase are largely deadenylated.  Additionally the hypothesis also 
predicts that repair of an adenylated gap or nick can be reconstituted with purified 
recombinant proteins in vitro in the absence of aprataxin, if the reactions are conducted in the 
absence of ATP.  These predictions were tested in the current chapter.  
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5.2 Results 
5.2.1 Short-patch repair of SSBs with 5’-AMP termini is rescued in AOA1 cell 
extracts by addition of recombinant DNA ligase 
To test whether the failure of AOA1 whole cell extracts to repair a pre-adenylated nick was due 
to limiting levels of non-adenylated DNA ligase, AOA1 whole cell extracts were complemented 
with  T4 DNA ligase (Roche) in the presence or absence of ATP (Figure 5.3).  T4 DNA ligase was 
used as commercial preparations are not pre-adenylated.  5μg of WT and AOA1 whole cell 
extracts were incubated at 30°C for 1 hour with an a 1nt gap  harbouring 3’-P and a 5’-AMP 
termini in the presence or absence of 1mM ATP and 1U T4 DNA ligase (Roche).  The reaction 
products were fractionated by 15% denaturing PAGE and detected by phosphorimaging.  
1000x fold molar excess of a single-stranded competitor oligonucleotide was added to the 
reactions to reduce the impact of the non-specific nucleolytic degradation of the substrate 
(Figure 5.3 asterisk). 
 
As observed previously, AOA1 whole cell extracts were unable to repair the adenylated 1nt gap 
(lanes 4 and 6).  Strikingly, addition of T4 DNA ligase in the absence of ATP rescued short-patch 
SSBR in AOA1 whole cell extracts to levels similar to WT (compare lanes 5 and 6 to lanes 9 and 
10).  Importantly, this APTX-independent repair was strongly inhibited by the presence of 1mM 
ATP (compare lanes 8 and 10), consistent with the non-adenylated sub-fraction of T4 ligase 
being responsible for restoration of repair in AOA1 whole cell extracts.  It is also important to 
note that the addition of T4 DNA ligase did not significantly increase levels of repair in WT 
extracts either in the presence or absence of ATP (compare lanes 3 and 4 to lanes 7 and 8).   
 
5.2.2 APTX-independent repair of an adenylated 1nt gap occurs by short patch SSBR 
It has been previously been shown that T4 DNA ligase can ligate single-strand gaps where 
several nucleotides are missing, by ligation across the gap (Nilsson and Magnusson, 1982).  It 
was considered possible that the complementation by T4 ligase observed above was not 
occurring by bona fide short patch repair but rather by this route.  To test this, 
dideoxythymidine triphosphate (ddTTP) was added to the reactions.  Dideoxynucleotides lack a 
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3’OH and so are unable to form a phosphodiester bond with another nucleotide, thereby 
terminating further DNA ligation following their insertion in a 1nt gap (Figure 5.3).  Since the 
nucleotide putatively inserted in the 1nt gap was thymidine, the dNTP reaction mix was 
prepared with ddTTP instead of dTTP.  If the repair of the abortive ligation intermediate was 
proceeding through a gap-filling event then the ddTTP would be inserted into the gap, and due 
to the absence of the 3’OH on the ddTTP, the resulting nick would be un-ligatable.  Thus repair 
would be inhibited by the presence of ddTTP in the reaction.  However if the addition of T4 
DNA ligase to the reaction was biasing repair towards an ‘across-the-gap‘ ligation event then 
the full repair product would be resistant to addition of the ddTTP.     
 
The adenylated 1nt gap (see cartoon in Figure 5.4) was incubated at 30°C for 1 hour with 5µg 
of WT or AOA1 whole cell extract in the presence or absence of 1mM ATP, 1U of T4 DNA ligase 
and 100μM dNTPs containing either dTTP or ddTTP (Figure 5.4).  The reaction products were 
then fractionated by 15% denaturing PAGE and detected by phosphorimaging.  As observed 
previously, complementation of the AOA1 whole cell extracts with T4 DNA ligase completely 
rescued the repair of an abortive ligation intermediate in vitro, in the absence of ATP (compare 
lanes 6 and 8).  Importantly the presence of ddTTP in the reaction mix completely inhibited the 
short-patch repair conducted by either WT or AOA1 extracts, both in the presence and 
absence of T4 DNA ligase (lanes 9 – 16).  This result demonstrates that the SSBR reactions in 
my experiments required DNA gap-filling, as expected for bona fide short patch SSBR 
reactions. 
 
5.2.3 Short-patch repair of SSBs with 5’-AMP termini is rescued in extracts prepared 
from quiescent APTX-/- mouse neural extracts by addition of recombinant DNA 
ligase 
Since it was confirmed that the ligase complementation was occurring via a bona fide short-
patch repair mechanism, I next wished to repeat these experiments using a neuronal cell type 
as neurodegeneration is the primary presentation of AOA1.   I thus employed cell extracts 
prepared from quiescent neural astrocytes recovered from APTX+/+ and APTX-/- mice (Figure 
5.5) (Reynolds et al., 2009).  As seen with the AOA1 cell extracts, the addition of 1 U T4 DNA 
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ligase to APTX-/- neural cell extracts restored the repair of adenylated 1nt gaps to WT levels in 
the absence of ATP (compare lanes 5 and 6 to lanes 9 and 10).  Once again, the addition of ATP 
to the reaction strongly inhibited the ability of T4 DNA ligase to complement the repair defect 
in APTX-/- extracts (compare lanes 8 and 10).   
 
5.2.4 Restoration of short-patch repair of an adenylated 1nt gap in AOA1 whole cell 
extracts by recombinant human LigIIIα 
The ability of human LigIIIα to complement the AOA1 short-patch repair defect of an abortive 
ligation intermediate was tested.  Numerous studies have suggested that LigIIIα is responsible 
for the majority of short-patch repair events and it was therefore important to determine if 
the ability of T4 DNA ligase to complement AOA1 extracts was unique or also applicable to 
human ligases.  Recombinant His-LigIIIα was expressed and purified essentially as described 
previously (Caldecott et al., 1995) and in materials and methods.  Aliquots of the recombinant 
protein prior to and following purification by IMAC and cation exchange chromatography are 
shown in Figure 5.6.  
 
The adenylated 1nt gapped substrate (see cartoon in Figure 5.7) was incubated with 5µg of WT 
or AOA1 whole cell extract as indicated and 8nM-72nM His-LigIIIα in the presence or absence 
of 1mM ATP at 30°C for 1 hour (Figure 5.7).  As observed with recombinant T4 DNA ligase, the 
addition of His-LigIIIα to AOA1 whole cell extracts in the absence of ATP increased repair of the 
adenylated 1nt gap (compare lanes 15-17 to lane 2).  However, in contrast to T4 DNA ligase, 
which restored repair to WT levels, His-LigIIIα only partially rescued the repair defect in AOA1 
cell extracts (Figure 5.3).  Once again, the addition of ATP to the reaction inhibited the ability 
of the DNA ligase to restore repair of the gapped substrate in AOA1 extracts (compare lanes 6-
8 to lanes 15-17).  Additionally no repair was evident when His-LigIIIα was incubated alone 
with the substrate showing that repair of the abortive ligation intermediate required 
processing of the 3’ terminus.  A possible explanation for this difference between T4 DNA 
ligase and His-LigIIIα could be that while commercial T4 DNA ligase is largely non-adenylated, 
His-LigIIIα purified from E.coli is likely to be predominantly pre-adenylated as the ligase 
adenylation reaction is very rapid in cellular concentrations of ATP.   
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5.2.5 Reconstitution of APTX-independent SSBR of adenylated SSBs by purified 
recombinant human proteins 
So far the data presented here has shown that short-patch SSBR of an adenylated 1nt gap can 
be rescued in AOA1 whole cell extracts by increasing the level of DNA ligase, in the absence of 
ATP, indicating that APTX-independent repair of adenylated SSBs is possible.  I next examined 
whether APTX-independent SSBR could be reconstituted in vitro using purified recombinant 
human short-patch repair proteins.  60nM of adenylated 1 nt gapped substrate was incubated 
at 30°C for 1 hour with 250nM His-PNK, 100nM Polβ and 80nM His-LigIIIα in the presence or 
absence of 100nM His-APTX and 1mM ATP (Figure 5.8).  As expected, in the presence of ATP, 
repair of the adenylated 1nt gap was dependent on His-APTX (compare lanes 1 and 2).  
However, in the absence of ATP, short-patch SSBR of the abortive ligation intermediate was 
independent of His-APTX (compare lanes 3 and 4).  I noted that the absence of ATP only mildly 
reduced repair of the adenylated nick in the presence of APTX (compare lanes 1 and 3), 
suggesting that the preparation of His-LigIIIα contained significant levels of pre-adenylated 
DNA ligase.  This also supports the explanation that the partial complementation of AOA1 
extracts with His-LigIIIα compared to T4 DNA ligase was indeed due to high levels of pre-
adenylated His-LigIIIα (Figure 5.7).  I also noted that, as expected, and in contrast to APTX-
dependent SSBR, APTX-independent SSBR proceeded without removal of AMP from the 5’-
terminus (compare the amount of AMP-32P-25mer present in lanes 3 & 4). 
 
5.2.6 Complementation of the AOA1 repair defect independently of ATP with a non-
adenylatable ligase mutant 
The data described above confirmed the prediction that repair of adenylated SSBs can be 
repaired in an APTX-independent manner, by supplementing reactions with recombinant DNA 
ligase in an ATP sensitive fashion. This in turn supports the hypothesis that short patch SSBR 
reactions fail in the absence of APTX due to insufficient levels of non-adenylated DNA ligase.  
To test this hypothesis directly, I next employed recombinant preparations of a mutant DNA 
ligase.  The three catalytic steps of DNA ligation are relatively separate reactions and mutant 
derivatives of DNA ligases have been created that disrupt each of the individual steps.  A direct 
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prediction of the above hypothesis is that a mutation that prevents or reduces the adenylation 
of a DNA ligase (step 1 in Figure 5.1), but which still allows catalysis of ligation in the presence 
of adenylated nicked substrate (i.e. still allows step 3; Figure 5.1) should support APTX-
independent short patch SSBR, even in the presence of ATP.  The most well characterised DNA 
ligase is the Chlorella Virus PBCV-1 (CV DNA Ligase) (Ho et al., 1997).  CV DNA ligase is the 
simplest known eukaryotic ATP-dependent DNA ligase and although it consists of only the 
catalytic core it can almost fully compensate the loss of both S.cerevisiae DNA ligases, Cdc9p 
and Lig4p, in vivo making it ideal to use in biochemical assays requiring a functional ligase 
(Sriskanda et al., 1999).   
 
A mutant CV DNA ligase has been characterised that lacks the five most C-terminal amino acids 
of the enzyme and which prevents formation of the ligase-AMP complex and, strikingly, a 
exhibits a 16x increased rate of ligation of pre-adenylated nick (Sriskanda and Shuman, 1998b).  
All ATP dependent ligases contain 6 short highly conserved NTase motifs (I, III, IIIa, IV, V and VI) 
each arranged in the same order and with similar spacing (Shuman and Schwer, 1995).  
Different motifs have been shown to have critical roles in each of the three stages of DNA 
ligation.  In chlorella virus DNA ligase, Motif VI consists of the six most C-terminal amino acids 
and is critical for the first step of ligase adenylation.  It has been postulated that a closed 
conformation in the ligase brings motif VI into contact with the β- and γ- phosphates of ATP, 
allowing it to reorientate the α- phosphate for nucleophilic attack from the active site lysine in 
motif I (Sriskanda and Shuman, 1998b).  Once this happens the ligase-AMP adopts a more 
open conformation facilitates nick-sensing.  Therefore a non-adenylated wild-type ligase would 
naturally be in the closed conformation which is thought to be rate-limiting in the ligation of a 
pre-adenylated nick.  Loss of the five most C-terminal amino acids of the enzyme is thought to 
open up the ligase, preventing it from interacting with ATP, but adopting a conformation that 
is more amenable to the ligation of a pre-adenylated nick (Sriskanda and Shuman, 1998b).  
Thus, due to the simplicity of the CV DNA ligase, along with the well characterised nature of 
both the WT protein and the C-terminal deletion mutation, this mutant would be an ideal 
ligase to complement the AOA1 short-patch SSBR defect.   
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Wild-type and mutant chlorella virus (CV) DNA ligase were expressed in E.coli and purified as 
described previously (Sriskanda and Shuman, 1998b) and in materials and methods. Aliquots of 
the two CV ligases before and after purification by IMAC are shown in Figure 5.9.   The ability 
of the two chlorella virus  DNA ligases to auto-adenylate was tested by incubating 100ng of 
each DNA ligase with α-32P ATP at 30°C for 5min and analyzing the reaction products by SDS-
PAGE and autoradiography (Figure 5.10 A).  During ligase adenylation, the α-phosphate of ATP 
is transferred to the active site lysine of the protein and in the process the ligase will become 
32P-radiolabelled.  There was a very strong 32P signal in the lane containing reaction products 
from the WT CV ligase adenylation reaction which ran at the expected size for WT CV ligase.  
However in the lane containing reaction products from the CΔ5 CV ligase adenylation there 
was no detectable signal confirming, as reported (Sriskanda and Shuman, 1998b) that the 
ligase mutant was unable to efficiently adenylate itself. 
 
The ability of WT and mutant CΔ5 chlorella virus DNA ligase to complement the short-patch 
SSBR defect in AOA1 cell extracts was next tested (Figure 5.9 B).  As observed for T4 and 
human LigIIIα DNA ligases, WT chlorella virus DNA ligase supported the repair of adenylated 
1nt gapped substrates by AOA1 extracts, and the presence of ATP inhibited this rescue 
(compare lanes 6 and 8).  Importantly, CΔ5 chlorella virus DNA ligase also supported repair in 
AOA1 whole cell extracts, and this rescue was not inhibited by ATP (compare lanes 2 and 4).   
 
APTX-independent SSBR was next reconstituted in vitro using the two chlorella DNA ligases 
and recombinant SSBR proteins (Figure 5.11).  In agreement with previous data WT CV ligase 
rescued APTX-independent short-patch repair in the absence of ATP and this rescue was 
inhibited by the addition of ATP (compare lanes 2 & 4).  TheCΔ5 mutant CV ligase also 
supported APTX-independent repair and, importantly, this rescue was not inhibited by the 
presence of ATP in (compare lanes 6 and 8).   
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5.3 Discussion 
The previous chapters have demonstrated that short-patch SSBR of an abortive ligation 
intermediate fails in AOA1 whole cell extracts in vitro.  This does not reflect a general defect in 
SSBR as short-patch repair is rescued to WT levels in AOA1 extracts when complemented with 
recombinant his-APTX (Figure 3.7) and importantly AOA1 extracts are proficient in the repair of 
a non-adenylated oxidative SSB (Figure 3.8).  Additionally, levels of core SSBR proteins in AOA1 
LCLs are largely comparable to WT when analysed by western blot (Figure 3.6).  In this study I 
have also presented data showing that the repair defect lies within the ligation step.  PNK-
mediated end-processing (Figure 4.4) or Polβ-mediated gap-filling (Figure 4.6) were both 
unaffected by the presence of a 5’AMP and finally it was shown that AOA1 extracts were 
unable to ligate an adenylated nick in vitro (Figure 4.7).  As adenylated nicks arise as normal 
intermediates of DNA ligation this was unexpected. The first step of ligation, the formation of 
the ligase-adenylate intermediate is very energetically favourable at cellular concentrations of 
ATP and this adenylated form of the ligase is stable in the absence of DNA.  Consequently, 
although ligases can exist in two forms in the cell it is likely that the adenylated ligase is the 
predominant form in the cell.  Therefore in the unique situation where APTX is not present in 
the cell and unrepaired adenylated nicks persist, it is likely that the level of non-adenylated 
ligase present in the cell is too low to support ligation of adenlyated nicks.  
 
Although adenylated nicks do arise as normal intermediates during the second step of DNA 
ligation, this is usually tightly coupled with the third step of phosphodiester bond formation.  
In fact, this final step is very rapid, and the rate of phosphodiester synthesis is much faster 
than adenylation of the DNA and probably the only time the second and third steps of ligation 
would become uncoupled is in the event of a ligase attempting to prematurely ligate a nick 
with an incompatible 3’ terminus (Crut et al., 2008).  If this occurs in a WT cell then APTX 
would be present to remove the 5’-AMP and the abortive ligation would be effectively reset.  
Therefore in a WT situation it is unlikely that a DNA ligase would ever encounter a persisting 
adenylated nick and the need to directly ligate an adenylated nick would only arise in the 
absence of APTX.   
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The hypothesis that insufficient levels of non-adenylated ligase are the cause of the AOA1 
short-patch repair defect was tested by making two predictions; firstly that the 
complementation of AOA1 extracts with non-adenylated DNA ligase would rescue the short-
patch repair defect of an adenylated 1nt gapped substrate, typical of those likely arising during 
‘abortive’ ligation by adenylation of 1nt gaps with ‘blocked’ 3’-termini, and secondly that this 
repair would be strongly inhibited by the presence of ATP.  In the case of the first prediction it 
was shown that the AOA1 short-patch repair defect could be rescued by the addition of 
recombinant human LigIIIα, T4 DNA ligase or CV Ligase in the absence of ATP (Figure 5.3, 5.7 
and 5.10).  The second prediction was also proved correct and the presence of ATP in the 
reaction buffers prevented the recombinant ligases from rescuing repair in an AOA1 extract.  
Finally complementation of AOA1 extracts with a ligase mutant defective in the first step of 
enzyme adenylation restored repair in an AOA1 extract both in the presence and absence of 
ATP to equal levels, further supporting the hypothesis that the AOA1 repair defect is the result 
of limiting levels of non-adenylated ligase (Figure 5.10 and 5.11).     
 
It was noted when comparing the ligase complementation with the human LigIIIα to T4 DNA 
ligase or CV Ligase that His-LigIIIα only partially rescued the repair defect in AOA1 cell extracts 
(Figure 5.7) compared to complementation with T4 DNA ligase or CV Ligase (Figure 5.3 and 
5.10).  This could be explained by either by differences in the relative level of pre-adenylated 
DNA ligase in the recombinant preparations and/or the possibility that the amount of LigIIIα 
used in the experiments was less active than the amount of T4 DNA ligase used.  As 
commercial T4 DNA ligase is largely non-adenylated, while His-LigIIIα purified from E.coli is 
likely to be predominantly pre-adenylated, as the ligase adenylation reaction is very rapid in 
cellular concentrations of ATP, differences in the adenylation states of the ligases is the most 
probable explanation.  This could be addressed using an adenylation assay in which His-LigIIIα 
is adenylated with [α32P] ATP.  A comparison of samples which have been deadenylated with 
pyrophosphate or mock deadenylation could be used to evaluate the levels of preadenylation 
in the Hi-LigIIIα preparation.  However the partial rescue nonetheless still supports to the 
hypothesis that the failure of AOA1 whole cell extracts to repair an abortive ligation 
intermediate is due to limiting levels of non-adenylated ligase in the extracts.    
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Importantly, APTX-independent short-patch repair of an abortive ligation intermediate could 
also be reconstituted in vitro in the absence of ATP using recombinant SSBR proteins (Figure 
5.8 and 5.11).  As expected, in the presence of ATP, repair of the abortive ligation intermediate 
was dependent on APTX (Figure 5.8 compare lanes 1 and 2) and, in the absence of ATP, short-
patch SSBR of the abortive ligation intermediate was independent of APTX (Figure 5.8 compare 
lanes 3 and 4). I noted that the absence of ATP only mildly reduced repair of the adenylated 
nick in the presence of APTX (Figure 5.8 compare lanes 1 and 3), suggesting that the 
preparation of LigIIIα contained sufficient levels of pre-adenylated DNA ligase to drive ligation 
of non-adenylated nicks.   
 
The data presented here provides evidence that adenylated nicks persist during short-patch 
repair in AOA1 extracts in vitro, due to insufficient levels of non-adenylated ligase.  Although it 
has yet to be determined that these lesions actually arise in cells, this is still an intriguing 
observation as it could provide an explanation for why AOA1 cell lines do not exhibit a 
consistent cellular repair defect.  As end-processing and gap-filling can proceed as normal in 
AOA1 extracts and the adenylated nicks that could potentially accumulate during short-patch 
repair should possess a conventional 3’-OH, these lesions could act as potential substrates for 
long-patch repair.  Therefore, in living cells, the existence of a short-patch repair defect in 
AOA1 cells could be masked by the action of long-patch repair.  This hypothesis could be 
tested by blocking long-patch SSBR in AOA1 cells.  If long-patch repair was compensating for a 
short-patch repair defect in AOA1 cells then blocking long-patch repair would uncover an 
APTX-dependent cellular SSBR defect.   
 
This could also have important implications in understanding the pathology of the disease and 
provide a potential explanation for why the brain is so sensitive to loss of APTX.  Many long-
patch repair factors are also replicative factors, and are known to be down regulated in post-
mitotic neurones (Cam et al., 2004).  Additionally post-mitotic neurones in G0 would lack 
alternate repair pathways associated with S-phase or G2 phase, such as homologous 
recombination or replication coupled SSBR and would therefore be more dependent on short-
patch repair.  In the case of defective short-patch repair, unrepaired SSBs could accumulate 
leading to blocked transcription forks and eventual cell death.  The observation that a ligase 
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mutant that is defective in the adenylation of a DNA ligase, but which can still catalyse the 
ligation of an adenylated nicked substrate supported APTX-independent short patch SSBR even 
in the presence of ATP could have implications in the treatment of the disease.  As the catalytic 
steps of DNA ligation are relatively separate reactions, it is possible that a compound could be 
developed that mimics the CV CΔ5 DNA ligase mutant by inhibiting ligase adenylation but 
leaving the third step intact.  Indeed a number of ligase inhibitors which have different 
specificities for DNA LigI, LigIIIα and LigIV have been discovered (Zhong et al., 2008, Chen et al., 
2008).  Interestingly these inhibitors prevented DNA-adenylation and ligation, but have no 
detectable effect on ligase-adenylation, showing that the individual stages of DNA ligation can 
be individually targeted for inhibition, raising the intriguing possibility that other inhibitors 
could potentially be found to target ligase-adenylation while leaving nick ligation unaffected.  
If administered to patients it may be possible to temporarily reset the ligase present in the cell 
and allow it to repair any persisting adenylated breaks.    
 
This is entirely speculative, however, and there are numerous obstacles to overcome.  The first 
is how to administer any inhibitors to the target tissue.  The brain is surrounded by a barrier, 
called the blood-brain barrier, which is composed of high density cells that restrict the passage 
of substances between the bloodstream and the brain (Alavijeh et al., 2005).  This is a 
limitation common to many agents designed to target the brain.  Another more important 
issue is that the affected tissue in AOA1 is post-mitotic and non-regenerative.  Thus any 
treatment of the disorder could only hope to prevent the progression of the disease at the 
onset rather than cure it.   
 
A question that still needs to be address is whether this is specific to AOA1 extracts or whether 
it is true for wild-type extracts as well.  It is possible that APTX plays a role in deadenylating 
DNA ligases.  APTX is a member of the Hint branch of the HIT superfamily of nucleotide 
hydrolases and transferases which exhibit AMP-lysine hydrolase activity (Brenner, 2002, 
Bieganowski et al., 2002a, Krakowiak et al., 2004a, Seidle et al., 2005, Kijas et al., 2006).  
Indeed it has been shown that mutations in APTX that are associated with AOA1 inactivate 
AMP-lysine hydrolase activity (Seidle et al., 2005).  In AOA1 extracts this would lead to a 
decrease in the levels of non-adenylated ligase.  To answer this, one strategy would be to 
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determine levels of LigIIIα adenylation in AOA1 and wild-type cells by immunoprecipitating the 
XRCC1-LigIIIα complex from cells and incubating with [α32P] ATP.  Co-immunoprecipitating 
LigIIIα via its interaction with XRCC1 would avoid the potential issue that the α-LigIIIα antibody 
could inactivate the ligase by blocking the active site (Caldecott et al., 1994, Caldecott et al., 
1995).   
 
There is precedence for the regulation of ligase adenylation levels being regulated by a 
component of a DNA repair pathway in the proposed role of LigIV readenylation by XLF 
following DNA ligation (Riballo et al., 2009).  Unlike other DNA ligases, the adenylation reaction 
of DNA LigIV proceeds very slowly and is the rate limiting step in vitro (Wang et al., 2007).  XLF 
can enhance this reaction in vitro and it has been proposed that XLF stimulates NHEJ by 
readenylating LigIV (Riballo et al., 2009).  Thus it is possible that APTX fulfils an opposing role 
to XLF by deadenylating DNA ligases following premature adenylation of a non-ligatable nick.  
This would effectively reset the ligase and allow it to repair any persisting adenylating nicks.   
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CHAPTER SIX 
Investigating the role of APTX in DNA 
repair in living cells 
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6.1 Introduction 
The data presented in the previous three chapters have demonstrated that short-patch SSBR 
of an abortive ligation intermediate fails in AOA1 whole cell extracts in vitro at the final stage 
of ligating an adenylated nick.  This defect was due to loss of APTX because short-patch SSBR 
was rescued to levels comparable to WT in AOA1 whole cell extracts when complemented with 
recombinant His-APTX (Figure 3.7).  It was also specific for adenylated nicks, because AOA1 
extracts were proficient in the repair of a non-adenylated SSB (Figure 3.8).  
 
While the evidence for the existence of defective short-patch SSBR in AOA1 extracts in vitro is 
compelling, the evidence for the existence of a cellular repair defect in living cells is conflicting.  
While some studies report that APTX defective cells exhibit defective DNA repair (Hirano et al., 
2007, Mosesso et al., 2005), this is contradicted by other studies (Reynolds et al., 2009, El-
Khamisy et al., 2009).  It has also been reported that APTX defective cells are mildly sensitive to 
DNA damaging agents (Gueven et al., 2004, Clements et al., 2004).  However, the finding that 
short–patch repair of abortive ligation intermediates stall at the stage of ligating an adenylated 
nick offers a potential explanation for the discrepancy between the in vitro and cellular data.  
Since neither PNK mediated end-processing or Polβ mediated gap-filling are disrupted the 
unrepaired adenylated nicks that accumulate in AOA1 cells would potentially possess a 3’-
hydroxyl terminus, and might thus be channelled into long-patch SSBR.   
 
The hypothesis that long-patch repair can compensate for the loss of APTX in a cellular context 
has been tested using quiescent neural astrocytes from WT and APTX-/- littermate mice 
(Reynolds et al., 2009).  As the pathology of the disease is restricted to the brain, mouse 
astrocytes are more likely to mimic the affected cell types in AOA1 individuals than fibroblast 
or lymphoblastoid cell lines.  Aphidicolin (APH) is a selective inhibitor of the B family 
polymerases α, δ and ε and is traditionally used to block DNA replication (Oguro et al., 1979, 
Ikegami et al., 1979, Wist and Prydz, 1979, Byrnes, 1984, Wright et al., 1994).  As Pol δ/ε are 
also involved with PCNA dependent long-patch SSBR, APH can be employed to inhibit this 
process, rendering SSBR dependent on short-patch DNA polymerases.  
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In the absence of APH, quiescent WT and APTX-/- mouse astrocytes exhibit similar rates of SSBR 
after induction of oxidative DNA damage (Reynolds et al., 2009) (Figure 6.1; reproduced with 
permission from Sherif El-Khamisy).  The rate of repair in the WT astrocytes was also 
unaffected by the presence of APH, demonstrating that APH – resistant polymerases can 
support the repair of oxidative damage in quiescent mouse astrocytes.  In contrast, quiescent 
APTX-/- mouse astrocytes showed reduced rates of repair in the presence of APH, suggesting 
that in the absence of APTX an alternate repair pathway involving APH-sensitive polymerases 
(most likely Pol δ/ε) can repair oxidative DNA strand breaks.  In the presence of APH this repair 
pathway is significantly delayed.  It is also noteworthy that SSBR was delayed rather than 
prevented, implying the presence of an additional, albeit slower, APTX – independent repair 
process involving one or more APH-resistant DNA polymerases (Figure.6.1).   
 
Quiescent APTX-/- mouse astrocytes were also found to be defective in the repair of MMS 
induced alkylation DNA damage in the presence of APH (Reynolds et al., 2009).  The data from 
these experiments are presented in Figure 6.2 with permission of Sherif El-Khamisy.  Quiescent 
WT and APTX-/- mouse astrocytes were incubated with a titration of MMS in the presence or 
absence of APH and rates of repair measured by alkaline comet assay.  Repair of MMS induced 
alkylation DNA damage is measured in a different way to ROS induced oxidative damage.  
MMS introduces base damage which has to be recognised and cleaved before it can be seen as 
a DNA break in the alkaline comet assay.  The rate of repair of these damaged bases is 
measured indirectly by quantifying the total level of DNA breaks present in a cell after 
incubation with an alkylating agent at 37°C for a specified time period.  The total level of DNA 
breaks measured in this way will represent the net difference between damage induction and 
damage removal, and is an efficient way to measure defects in SSBR.  Consistent with these 
data, deletion of HNT3 (the APTX homologue) in budding yeast in a rad27Δ (FEN1 homolog) 
background resulted in synergistic sensitivity to H2O2 and MMS (Daley et al., 2010).  
 
6.1.2 Aims of this chapter 
The aim of this chapter is to investigate the role of alternate APTX independent mechanisms in 
the repair of abortive ligation intermediates in AOA1 cells.  The existence of redundancy in the 
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repair of an adenylated SSB would explain why AOA1 cells do not exhibit a consistent cellular 
SSBR defect.  One hypothesis is that unrepaired adenylated nicks can be channelled into long-
patch SSBR in the absence of APTX-dependent short-patch repair in AOA1 cells.  This 
hypothesis is supported by the existence of an APH – dependent repair defect in quiescent 
APTX-/- mouse astrocytes and observation that hnt3Δ/rad27Δ double mutant is more sensitive 
to DNA damage than the single mutants.  However confirmation is required that long–patch 
repair can compensate for defective short–patch repair in human AOA1 cells.   
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6.2 Results 
6.2.1 Repair of γ-irradiation induced SSBs in human fibroblasts utilises B family 
polymerases 
It has been shown that APTX has a role in the repair of oxidative and alkylating DNA damage in 
mouse astrocytes.  A SSBR defect was uncovered in quiescent APTX-/- mouse astrocytes upon 
incubation with APH, suggesting that long–patch SSBR can compensate for the loss of APTX 
(Reynolds et al., 2009).  However whether or not long-patch repair can substitute for APTX-
dependent repair in human AOA1 cell lines remained to be determined.  To test this, hTERT 
immortalised AOA1 fibroblasts (FD105 hTERT) that were either mock-complemented (FD105 
M20 hTERT cells (AOA1)) or complemented by stable retroviral expression of human APTX 
(FD105 M21 hTERT (Corrected)) were employed.  A western blot comparing the total level of 
APTX protein expressed in these cell lines and also in a WT hTERT fibroblast cell harbouring the 
empty expression vector (1BR M20 hTERT) is shown (Figure 6.3A).  
 
It was decided in these experiments to employ -irradiation to induce oxidative DNA strand 
breaks in AOA1 fibroblasts, rather than hydrogen peroxide for technical reasons.  Whilst both 
agents are sources of ROS and generate DNA breaks with termini of similar chemistry, the level 
of DNA breaks induced by -irradiation is more uniform between individual cells than hydrogen 
peroxide which displays large variations in DNA break induction between cells.  The dose of -
irradiation chosen for my experiments (30 Gy) was established using a dose response curve 
generated with the hTERT cell lines FD105 M20 and FD105 M21, with DNA strand breaks 
quantified by alkaline comet assays (Figure 6.3B).  This dose was chosen because it induced a 
high level of DNA strand breaks (~30,000 SSBs & ~1,000 DSBs) and was still in the linear region 
of the dose response curve.  
 
To render human hTERT fibroblasts quiescent I employed by contact inhibition followed by 
serum starvation for 7 days (Coller et al., 2006).  In initial experiments I employed pulse-
labeling with [3H] thymidine, as described in materials and methods, to verify that this 
approach resulted in non-replicating populations fibroblasts (Figure 6.4). Cycling and quiescent 
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cells were also mock-treated (using DMSO) or treated with 50μM APH for 1hr prior to pulse 
labelling with [3H] thymidine, to confirm that replication was also inhibited by  this inhibitor 
under the conditions employed (Figure 6.4B).  [3H] incorporation was evident in both APTX 
complemented and AOA1 cycling hTERT fibroblasts, albeit to a lesser extent in the latter.  
While maintaining the cell line it was noticed that the AOA1 cycling hTERT fibroblasts grew at a 
slower rate than the corrected line, which was consistent with the observed rates of [3H] 
incorporation.  Incubation with 50μM APH decreased the level of [3H] signal to low levels in 
cycling populations of both APTX complemented and AOA1 fibroblasts, suggesting that that 
the concentration of APH employed was sufficient to block DNA synthesis (Figure 6.4B).  
Notably, [3H] incorporation was greatly reduced in populations of both APTX complemented 
and AOA1 fibroblasts following confluence and serum starvation and this level was not 
reduced further by incubation with APH, confirming that these cells were not replicating.  
 
Surprisingly, I failed to detect a significant difference between the rate of repair of -ray 
induced DNA strand breaks in APTX-corrected FD105 M21 hTERT cells, compared to  FD105 
M20 hTERT cells (harbouring empty vector), irrespective of whether or not cells were 
incubated with APH (compare grey and green bars in Figure 6.5).  Moreover, APH largely or 
completely blocked SSBR in both APTX complemented and AOA1 cell lines, with little 
detectable reduction in the quantity of DNA breaks present after a 60 min repair period (Figure 
6.5).  This result contrasts with data from experiments employing quiescent mouse astrocytes, 
in which APH-sensitive repair was evident only if APTX-dependent repair was absent. This 
result was unexpected because APH-sensitive DNA polymerases such as Polδ/ε are believed to 
operate during long–patch SSBR, which is normally suppressed in non- cycling cells due to 
down-regulation of the essential long–patch DNA repair factors PCNA and FEN1 (Takasaki et 
al., 1981, Otterlei et al., 1999, Warbrick et al., 1998, Iatropoulos and Williams, 1996).  Indeed, 
immunoblotting confirmed that both PCNA and FEN-1 levels were greatly reduced in quiescent 
cell population employed for my experiments (Figure 6.6).  Together these data suggest that, 
in contrast to quiescent mouse neural astrocytes, most if not all SSBR in quiescent 
immortalised human fibroblasts following -irradiation is dependent on aphidicolin-sensitive 
DNA polymerases typically associated with long-patch repair. 
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Because the hTERT fibroblasts employed above were immortilised by hTERT expression I 
repeated the experiments using primary WT (1BR) and AOA1 (FD105) human fibroblasts 
(Figure 6.7).  However, the observed results were similar to those described above, with SSBR 
rates largely or entirely determined by APH-sensitive repair and unaffected by loss of APTX.  
 
To examine whether the results described above reflected the quiescent status of the cell 
lines, I repeated the experiments using cycling fibroblasts (Figure 6.8 and 6.9).  However, once 
again, repair was largely APH sensitive, and was unaffected by loss of APTX, irrespective of 
whether or not the cells were primary (Figure 6.9) or were immortalised with hTERT (Figure 
6.8). It was noticeable however, that repair did occur in the presence of APH, albeit very slowly 
and independently of APTX, suggesting that whilst  cycling human fibroblasts are also highly 
dependent on the APH – sensitive repair some APH–resistant repair does occur.  
 
6.2.2 Short-patch repair in WT whole cell extracts is APH resistant in vitro 
The experiments described above strongly suggest that SSBR in human fibroblasts is conducted 
largely if not entirely by the aphidicolin-sensitive polymerases Polδ and/or Polε. This contrasts 
with the widely held view that most SSBR following oxidative stress is conducted by the short 
patch DNA polymerase Polβ, in non-cycling cells at least.  I was thus concerned that the 
concentration of APH employed here, whilst within the range used in previous literature 
(Reynolds et al 2009) might inhibit Polβ.  To address this possibility I examined the impact of 
50μM APH on the polymerisation activity of purified recombinant human Polβ (Figure 6.10).  
Notably, this concentration of APH failed to inhibit Polβ, suggesting that the aphidicolin 
sensitivity of SSBR in human fibroblasts γ-irradiation was not due to an ‘off-target’ impact of 
this inhibitor on Polβ (Wist and Prydz, 1979).  
 
6.3 Discussion 
The data presented in Chapter 3 showed that short-patch SSBR of an abortive ligation 
intermediate fails in AOA1 whole cell extracts in vitro.  This short-patch repair defect reflects a 
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failure to ligate an adenylated nick in the absence of APTX, due to insufficient levels of non-
adenylated ligase, resulting in an inability to ligate a pre-adenylated nick (see chapters 4 & 5). 
These observations can provide a possible explanation for the lack of a detectable 
chromosomal SSBR defect in APTX defective cell lines.  Because end-processing and gap-filling 
occurs normally in AOA1 extracts, the adenylated nicks that accumulate during short-patch 
repair could be channelled into long-patch repair.  Consistent with this idea, quiescent APTXx-/- 
mouse astrocytes that were pre-treated with APH to inhibit the long-patch repair polymerases 
Polδ/ε exhibited significantly reduced rates of chromosomal SSBR, compared to similarly 
treated WT cells (Reynolds et al., 2009).  Similar results were observed with mouse granule 
cells, a bona fide type of post-mitotic cortical neuron (Caldecott and S.F. El-Khamisy et al, 
unpublished observations). 
 
To investigate the presence of redundant APTX-independent repair pathways in human cells, I 
employed human fibroblasts that were mock-complemented or complemented by stable 
expression of human APTX. Interestingly, [3H] thymidine incorporation in aprataxin-defective 
AOA1 fibroblasts was significantly less than in complemented AOA1 cells (Figure 6.4).  This may 
reflect a requirement for APTX during S phase, or an impact of loss of APTX on cell cycle 
progression. However if this was a consistent phenotype of APTX-defective cells then it might 
be expected that AOA1 individuals would exhibit pronounced developmental defects, which 
they not appear to do. Moreover, differences in growth rate have not been reported for other 
cell types in response to loss of APTX, including chicken DT40 cells (Caldecott, unpublished 
observations). Alternatively, although the two cell lines were created from the same parental 
cell line it is possible that there has been significant genetic drift.  To resolve this question will 
require the creation and analysis of additional matching WT and APTX-defective cell lines.  
 
In contrast to mouse neural cells, both AOA1 and WT human fibroblasts exhibited a striking 
SSBR defect upon incubation with APH, irrespective of whether such cells were primary or 
immortalised, and to a large extent independent of proliferation status.  These data suggest 
that all repair events occurring in the quiescent human fibroblasts following induction of 
oxidative damage by γ-irradiation are aphidicolin-sensitive, and can be conducted 
independently of APTX.  
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There are number of possible explanations for the different results observed with mouse 
neural cells versus human fibroblasts.  First, astrocytes and fibroblasts are different cell types 
and it is possible that they employ different DNA polymerases during SSBR.  Second, it is 
possible that there are major differences between mouse and man in terms of DNA 
polymerase selection during DNA repair.  Differences between human and mouse in terms of 
the response to DNA damage is most evident from the fact that APTX-/- mice do not 
recapitulate the neurodegenerative pathology evident in AOA1 individuals (unpublished 
observations).  This means that the APTX-/- mice are perhaps not the ideal model system to 
study APTX dependent repair in the context of the AOA1 disorder.  Perhaps a better model cell 
system for future studies of this type would be to differentiate human stem cells or SH-SY5Y 
neuroblastoma cells before or after depletion of APTX by siRNA.   
 
Third, whereas the experiments employing mouse neural cells used hydrogen peroxide to 
induce oxidative DNA breaks, my experiments employed -irradiation.  -irradiation was 
chosen for technical reasons as, whilst both agents induce oxidative damage via attack of 
deoxyribose and DNA bases by reactive oxygen species, resulting in DNA strand breaks with 
termini of similar chemistry, the level of DNA breaks induced by -irradiation is more uniform 
between individual cells than hydrogen peroxide.  Individual cells treated with hydrogen 
peroxide display large variations in the levels of damage induction.  However H2O2 induces 
~2000 SSBs for every DSB, whereas IR induces ~20-40 SSBs for every DSB (Ward, 1998, Ward et 
al., 1987).   Therefore it is possible that different cellular responses/SSBR repair pathways are 
elicited in response to the two agents, with different DNA polymerase requirements.  Finally 
another possibility is that Polδ/ε, and/or some other APH sensitive DNA polymerase, are 
essential for SSBR in response to very high levels of oxidative damage while Polβ and other 
APH – resistant polymerases are involved in the repair of lower, more physiological, doses of 
DNA damage.  It has been suggested that the fraction of repair carried out by either APH-
sensitive or APH-resistant polymerases can change according to the dose of damaging agent 
used (Dresler and Lieberman, 1983a, Dresler and Lieberman, 1983b).  It would be prudent to 
repeat the experiments with dose response of γ-irradiation to determine if APH-resistant SSBR 
operates at lower doses of DNA damage.   
125 
 
 
 
6.3.1  The roles of the different families of polymerases in SSBR in human fibroblasts 
The unexpected observation that emerged from the experiments utilising human fibroblasts 
was that APH sensitive polymerases were essential for repair of γIR induced DNA damage in 
human fibroblasts, irrespective of proliferative status.  It would be important in future studies 
to determine if this was common to other human cell lines, or whether this is a characteristic 
of the specific fibroblast cell lines employed here.  
 
Numerous biochemical studies with recombinant protein and whole cell extracts have 
implicated the APH-resistant DNA polymerase, Polβ, as fulfilling the primary role in gap filling 
during short-patch SSBR, as well as participating during long-patch repair.  Quiescent Polβ-/- 
MEFs exhibit sensitivity to γ-irradiation, although this sensitivity is not evident in cycling Polβ-/- 
MEFs, and whole cell extracts prepared from Polβ defective mouse cell lines show a reduced 
capacity for BER in vitro (Vermeulen et al., 2007b, Vermeulen et al., 2008, Parlanti et al., 2004).  
This is reduced further, but not absent, when the extracts are treated with APH.  Polλ a DNA 
polymerases from the same family as Polβ, and Polι, have also been implicated in APH-
resistant repair in vitro (Braithwaite et al., 2005a, Braithwaite et al., 2010, Braithwaite et al., 
2005b, Petta et al., 2008, Shimazaki et al., 2002b, Vens et al., 2007).   
 
Given the evidence for a role for Polβ and other APH – resistant polymerases in SSBR, it was 
surprising that the human fibroblasts employed in my experiments were largely unable to 
repair γ-irradiation induced DNA damage in the presence of APH.   These data suggest that 
Polδ and/or Polε, and/or some other APH sensitive DNA polymerase, are essential for SSBR in 
response to oxidative stress in human fibroblasts. Whilst these data could represent the 
activity of an APH-sensitive polymerase during short patch repair, it seems more likely that the 
APH-sensitive SSBR detected in these experiments reflects a long patch process. Indeed, the 
latter would be compatible with the apparent absence of requirement for APTX during SSBR in 
human fibroblasts, since the latter is likely of utility only during short patch repair.  
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Notably, however, total levels of PCNA and FEN1 protein were greatly reduced in the quiescent 
fibroblasts compared to the cycling fibroblasts.  Such a reduction has been observed previously 
and is consistent with the primary role of PCNA and FEN1 being during S phase (Li et al., 1995b, 
Takasaki et al., 1981, Levin et al., 1997, Levin et al., 2000, Iatropoulos and Williams, 1996).   
This would imply that long patch repair is attenuated in quiescent human fibroblasts, rather 
than being the dominant source of SSBR. However, it is still possible that the residual level of 
PCNA and FEN1 present in the quiescent human fibroblasts employed here is sufficient for 
SSBR.  Alternatively, the APH sensitive repair detected in these experiments may reflect a long 
patch repair pathway that employs PCNA and FEN-1 independent mechanism for gap filling 
and removal of the 5’ DNA flap.  In terms of the endonuclease involved, Mre11/Rad50/Nbs1 
complex (MRN) is a candidate, since it can process 5’-termini during DNA resection and during 
the removal of 5’-termini harbouring covalently linked protein (Nicolette et al., 2010b, Paull, 
2010a, You et al., 2009a, Mimitou and Symington, 2009, Moreau et al., 1999, Milman et al., 
2009, Hartsuiker et al., 2009, Rass et al., 2009, Xie et al., 2009).   
 
Additionally, mutation of the MRX complex in S.cerevisiae results in hypersensitivity to 
alkylating agent MMS and significantly reduced ability to repair base damage in vitro 
(Steininger et al., 2010).  Intriguingly there was no further decrease in efficient of repair of the 
uracil containing substrate when the xrs2 mutant extracts were incubated with APH, placing 
the MRX complex in the same pathway as the APH – sensitive polymerases.  When 
investigated further it was revealed that the MRX complex was required for efficient strand 
elongation during gap filling in vitro.  As the MRX complex is required for the processing of the 
5’ termini of DSBs, it can be imagined that it may also function to remove a 5’ DNA flap created 
during long-patch repair.  This hypothesis could be tested using human fibroblast cell lines 
derived from patients with Ataxia Telangtiectasia - Like Disorder (ATLD), a disorder in which 
Mre11 is mutated (Stewart et al., 1999).  
 
The aim of this chapter was to investigate the role of alternate APTX independent mechanisms 
in the repair of abortive ligation intermediates in AOA1 cells.  The presence of redundant 
repair mechanisms can explain why AOA1 cells do not exhibit a cellular SSBR defect.  In 
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contrast to mouse neural cells however, which can employ an APH-resistant repair process if 
APTX is missing, quiescent and proliferating human fibroblasts are largely or entirely 
dependent on APH-dependent repair, such that APTX is completely dispensable. It will now be 
important to examine if this is also the case in other cell types, including human neural cell 
types obtained by differentiation of human stem cells or neuroblastoma cell lines. 
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CHAPTER SEVEN 
Discussion 
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7.1 Discussion 
AOA1 is an autosomal recessive ataxia that clinically presents with early onset ataxia, 
oculomotor apraxia, cerebellar atrophy, and axonal motor neuropathy caused by mutations in 
the gene APTX a member of the Hint-like histidine triad (HIT) superfamily, which consist of 
adenosine 5’-monophosphoramide hydrolyases (Date et al., 2001, Barbot et al., 2001, Brenner, 
2002, Bieganowski et al., 2002a, Krakowiak et al., 2004a, Seidle et al., 2005, Kijas et al., 2006).  
APTX is a nuclear protein (Sano et al., 2004) that possess a divergent zinc finger motif (ZnF) and 
an amino-terminal fork-head associated (FHA) domain that has homology with the amino-
terminus of PNK (Barbot et al., 2001).  APTX interacts with CK2 phosphorylated XRCC1 and 
XRCC4 via the N-terminal FHA domain and co-immunoprecipitates in complexes containing 
SSBR and DSBR machinery(Luo et al., 2004, Sano et al., 2004, Clements et al., 2004, Date et al., 
2004, Gueven et al., 2004). 
 
APTX catalyses the release of adenylate groups covalently linked to 5’ phosphate termini of a 
DNA SSB or DSB (Ahel et al., 2006, Rass et al., 2007b, Rass et al., 2008) and cell-free extracts 
prepared from APTX-/- mouse cortical astrocytes are defective in assays that measure short 
patch SSBR of an adenylated SSB in vitro (Ahel et al., 2006).  Adenylated nicks are produced as 
a normal intermediate during ligation by an ATP-dependant DNA ligase, and a stable abortive 
ligation intermediate can arise if a ligase has prematurely adenylated a SSB with a 3’ terminus 
other than a 3’OH (Figure 1.11).  Thus, APTX has been proposed to play a role in SSBR in the 
rapid resetting of abortive ligations as they arise.   
 
7.1.1 Short-patch repair of abortive ligation intermediates fails in the absence of 
Aprataxin due to insufficient levels of non-adenylated DNA ligase  
To date, data on the role of APTX in repairing abortive ligation intermediates has emerged 
from in vitro repair assays employing recombinant proteins and cell free extracts from APTX-/- 
avian  DT40 cells or mouse APTX-/- cortical astrocytes (Ahel et al., 2006, Rass et al., 2007b, Rass 
et al., 2008).  It was therefore important to determine if whole cell extracts prepared from 
human AOA1 disease cells lines are similarly defective in the short-patch SSBR of abortive 
ligation intermediates and indeed lymphoblastoid cell lines (LCL) derived from an AOA1 
130 
 
individual homozygous for a whole genome deletion of APTX were found to be defective in the 
short-patch SSBR of an abortive ligation intermediate in vitro (Figure 3.5).   
 
This defect was caused by the loss of APTX 5’-AMP DNA deadenylase activity because 
complementation of AOA1 extracts with recombinant human His-APTX completely rescued this 
defect (Figure 3.7) and AOA1 cell extracts were proficient in the repair of a non-adenylated SSB 
substrate (Figure 3.8).  This suggested that it is the persistence of the unrepaired 5’AMP that 
blocks one or more subsequent repair events in AOA1 extracts in vitro, rather than defective 
processing of 3’-phosphate termini, gap filling, or DNA ligation per se and consistent with this, 
it was found that an inability to ligate an adenylated nick was responsible for the short-patch 
repair defect in AOA1 extracts (Figure 4.8).  This was not due to lower levels of active DNA 
ligase per se in AOA1 extracts compared to wild-type extracts, as AOA1 extracts were 
competent for repair of a non-adenylated SSB.  Notably, the presence of a 5’-AMP at a SSB did 
not inhibit the activities of either recombinant PNK or Polβ in vitro.   
 
Alternatively, it was considered possible that WT and/or AOA1 cells possess levels of non-
adenylated ligase that are insufficient to catalyse efficient ligation of non adenylated nicks. 
Such a defect might be specific to AOA1, if APTX has a role in deadenylating DNA ligases in 
addition to deadenyating DNA.  Consistent with this idea, APTX is a member of the Hint branch 
of the HIT superfamily of nucleotide hydrolases/transferases that possess AMP-lysine 
hydrolase activity (Brenner, 2002, Bieganowski et al., 2002a, Krakowiak et al., 2004a, Seidle et 
al., 2005, Kijas et al., 2006).  Although preliminary experiments failed to reveal any activity of 
APTX on adenylated LigIIIa, the activity of APTX on LigI was not tested (Caldecott, unpublished 
observations).  As DNA LigI was recently implicated in two studies to be the main DNA ligase 
involved in XRCC1 dependent SSBR, it cannot yet be discounted that APTX has a role in 
deadenylating DNA LigI instead of LigIIIα  (Simsek et al., 2011, Katyal and McKinnon, 2011, Gao 
et al., 2011).  
 
There is precedence for the role of a DNA repair factor in the regulation of adenylation levels 
of a DNA ligase.  Unlike other DNA ligases, DNA ligation events catalysed by DNA LigIV proceed 
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slowly in vitro due to a rate limiting enzyme-adenylation reaction (Wang et al., 2007).  
Consistent with this, LigIV ligation events are not stimulated by the presence of ATP (Riballo et 
al., 2001).  Recently it has been shown that XLF promotes LigIV-dependent ligation events by 
stimulating adenylation of the ligase (Riballo et al., 2009).  Thus XLF has been proposed to 
perform an important, though non-essential, role as a NHEJ stimulatory factor by promoting 
the readenylation of LigIV following ligation events.  Although it is possible that there are also 
active mechanisms to stimulate the adenylation of DNA LigIIIα or DNA LigI, both ligases are 
stimulated by the addition of ATP and show no evidence of a slow ligase-adenylation reaction, 
so it is unlikely that they would require a recharging step in the same manner as LigIV 
(Ellenberger and Tomkinson, 2008b).   
 
Alternatively, another explanation is that both WT and AOA1 extracts possess levels of non-
adenylated DNA ligase too low to support the ligation of non-adenylated nicks that accumulate 
in the absence of APTX.  The majority of DNA ligases, including DNA LigI and LigIIIα, are rapidly 
adenylated in the presence of ATP, forming a ligase-adenylate intermediate in which AMP is 
covalently linked to the active-site lysine via a phosphoamide bond and consequently, 
although DNA ligases exist in equilibrium between adenylated and non adenylated state, the 
adenylated form predominates in cells.  (Olivera et al., 1968, Harvey et al., 1971, Weiss et al., 
1968b, Gumport and Lehman, 1971, Lehmann, 1978).  Once an adenylated DNA ligase 
encounters a DNA break the second step of ligation results in formation of an AMP-DNA 
intermediate (Olivera et al., 1968, Harvey et al., 1971, Odell et al., 2003, Nair et al., 2007a).  In 
the final step of ligation the DNA phosphodiester bond is reformed (Lehmann, 1978) when the 
newly de-adenylated ligase catalyses nucleophilic attack of the 5’AMP by the free 3’OH 
terminus, (Odell et al., 2000, Sriskanda and Shuman, 2002b, Sriskanda and Shuman, 2002a, 
Nair et al., 2007a, Crut et al., 2008).  Normally the formation of deadenylated ligase during 
step 2 and the completion of step 3 are coupled, such that the adenylated nick is rapidly sealed 
by the deadenylated ligase.  However, if step 2 and 3 become ‘uncoupled’ (e.g. due to the 
presence of blocked 3’-termini) the non-adenylated ligase will likely be rapidly readenylated by 
cellular ATP (Olivera et al., 1968, Harvey et al., 1971, Weiss et al., 1968b, Gumport and 
Lehman, 1971, Lehmann, 1978). This will not be a problem in WT extracts because the 
presence of APTX restores the nick to a non-adenylated state.  However, in AOA1 extracts, 
132 
 
repair is now dependent on the pre-existing level of non-adenylated ligase, which we 
hypothesized, may be too low to facilitate step 3 of the ligase reaction.  
 
The hypothesis that insufficient levels of non-adenylated ligase are the cause of the AOA1 
short-patch repair defect was tested by making two predictions; firstly that the 
complementation of AOA1 extracts with non-adenylated DNA ligase would rescue the short-
patch repair defect of an adenylated 1nt gapped substrate, typical of those likely arising during 
‘abortive’ ligation by adenylation of 1nt gaps with ‘blocked’ 3’-termini, and secondly that this 
repair would be strongly inhibited by the presence of ATP.  Indeed both of these predictions 
proved to be true using not only human LigIIIα but also with two unrelated DNA ligases, T4 
DNA ligase and Chlorella ligase, suggesting that this is an inherent limitation of ATP-dependent 
DNA ligases rather than a feature of a specific ligase.  In addition, complementation of AOA1 
extracts with a mutant Chlorella ligase defective in the first step of enzyme adenylation 
restored repair in an AOA1 extract both in the presence and absence of ATP, further 
supporting the hypothesis that the AOA1 repair defect is the result of limiting levels of non-
adenylated ligase (Figure 5.10 and 5.11).  Importantly, APTX-independent short-patch repair of 
an abortive ligation intermediate was reconstituted in vitro in the absence of ATP using 
recombinant human SSBR proteins, and was also reconstituted in the presence of ATP by 
employing the Chlorella mutant DNA ligase.   
 
These data support a hypothesis that adenylated nicks accumulate during short-patch repair in 
AOA1 extracts in vitro due to insufficient levels of non-adenylated ligase.  However one critical 
piece of the puzzle is still missing as it has yet to be shown that adenylated SSBs are a 
physiologically relevant lesion in living cells.  Until 5’AMP-DNA lesions are observed to be 
present in living cells, the role for APTX in the repair of abortive ligation intermediates can only 
be hypothesised.  However, detecting the presence of 5’AMP lesions in living cells has proved 
to be difficult.  Attempts to show that genomic DNA extracted from AOA1 cells possessed 
higher levels of AMP than wild-type cells by mass-spec analysis has proved largely unsuccessful 
due to a high level of background and the high sensitivity of the assay (Caldecott and El-
Khamisy, unpublished observations).  An alternative strategy would be to generate a lesion 
specific antibody that recognised the adenylate groups in the context of DNA, such as the well 
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characterised antibody that recognises the oxidative base lesion, 8-oxo-G (Bespalov et al., 
1999).   
 
Another strategy would be to attempt to increase the amount of abortive ligations in AOA1 
cells to detectable levels.  The depletion or inhibition of PNK in AOA1 cells could serve to 
increase the amount of abortive ligations due to the increased levels of un-ligatable SSBs 
possessing 3’-P termini (Bernstein et al., 2008, Freschauf et al., 2010, Freschauf et al., 2009).  
There is precedence for this in the synergistic decrease in SSBR rates observed in a APTX-/-
TDP1-/- double knockout mice compared to either single mutant (El-Khamisy et al., 2009).  
Alternatively, abortive ligations could be directly increased through the use of a ‘toxic’ ligase 
that harbours a mutation that allows adenylation of the ligase and DNA but blocks the final 
step of ligating an adenylated nick.  One such mutation has been found in chlorella virus DNA 
ligase within NTase motif V (K188A) (Sriskanda and Shuman, 2002a).  Overexpression of this 
‘toxic’ ligase in AOA1 cells might be sufficient to overload the capacity of any redundant APTX-
independent repair pathways, and unrepaired SSBs may be visualised in AOA1 cell lines.  
Indeed this strategy has already proved useful in investigating the role of TDP1 in S.cerevisiae 
by showing that induction of a ‘toxic’ topoisomerase 1 mutant in a tdp1Δ background 
sensitises the cells (Pouliot et al., 2001).    
 
7.1.3 Pathway redundancy during the repair of adenylated SSBs in human cells 
While the evidence for a SSBR defect in AOA1 extracts in vitro is convincing, the existence of a 
cellular repair defect is less so.  Several studies have shown that APTX defective cell lines 
exhibit normal rates of SSBR upon treatment with H2O2 or MMS when measured by comet 
assay or NAD(P)H depletion assay (Gueven et al., 2004, Reynolds et al., 2009, El-Khamisy et al., 
2009) while other studies have reported that APTX defective cells possess a SSBR defect upon 
treatment with CPT as measured by alkaline comet assay, or following UV irradiation in cells in 
which these lesions are channelled into SSBR (Mosesso et al., 2005, Hirano et al., 2007).    
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The hypothesis that adenylated nicks accumulate during short-patch repair in AOA1 provides a 
possible explanation for the absence of a major or consistent cellular repair defect in these 
cells.  This is because adenylated nicks are potential substrates for long-patch repair, which in 
a cellular context might compensate for the absence of APTX-dependent short patch repair. 
This could also have important implications in understanding the pathology of the disease and 
provide a potential explanation for why the brain is sensitive to loss of APTX.  Many long-patch 
repair factors are also replicative factors, and are known to be down regulated in post-mitotic 
neurones (Cam et al., 2004).  Additionally post-mitotic neurones in G0 would lack alternate 
repair pathways associated with S-phase or G2 phase, such as replication coupled SSBR, is 
hypothesis to predominantly involve long-patch repair factors, and would therefore be more 
dependent on short-patch repair (Caldecott, 2008, Caldecott, 2001, Caldecott, 2003b).  
Unrepaired SSBs might thus lead to blocked transcription in post-mitotic neurones, and 
eventual cell death.  The hypothesis that long-patch repair might compensate for the loss of 
APTX in some cellular contexts was addressed using quiescent neural astrocytes from WT and 
APTX-/- littermate mice, and using Aphidicolin (APH)  to inhibit ‘classical’ long  patch repair 
polymerases Polδ and Polε (Reynolds et al., 2009).  
 
Notably, WT and APTX-/- mouse astrocytes exhibit similar rates of SSBR following either 
oxidative DNA damage or treatment with the base damaging agent, MMS (Reynolds et al., 
2009), and the rate of repair in WT astrocytes was unaffected by the presence of APH. 
However, quiescent APTX-/- mouse astrocytes showed reduced rates of repair in the presence 
of APH, suggesting that in the absence of APTX an alternate repair pathway involving APH-
sensitive polymerases (most likely Pol δ/ε) can indeed repair SSBs.  Similar results were 
observed with mouse granule cells, a bona fide type of post-mitotic cortical neurone 
(Caldecott and S.F. El-Khamisy et al, unpublished observations).  It is also noteworthy that SSBR 
was delayed rather than prevented, implying the presence of an additional, albeit slower, APTX 
– independent repair process involving one or more APH-resistant DNA polymerases (Figure 
6.1).  Together, the results obtained with mouse neural cells support the hypothesis that, in 
the absence of APTX, adenylated SSBs can be channelled into long-patch repair. However, 
different results were observed if human fibroblasts were employed. In contrast to mouse 
neural cells, both AOA1 and WT human fibroblasts exhibited a striking SSBR defect upon 
incubation with APH, irrespective of whether such cells were primary or immortalised, and to a 
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large extent independent of proliferation status.  These data suggest that all repair events 
occurring in the quiescent human fibroblasts following induction of oxidative damage by γ-
irradiation are aphidicolin-sensitive, and can be conducted independently of APTX.  
 
There are several possible explanations for the different results observed with mouse neural 
cells versus human fibroblasts.  First, astrocytes and fibroblasts are different cell types and 
may employ different DNA polymerases during SSBR. Differences between human and mouse 
in terms of the response to DNA damage is most evident from the fact that APTX-/- mice do not 
recapitulate the neurodegenerative pathology evident in AOA1 individuals (unpublished 
observations).  Perhaps a better model cell system for future studies of this type would be to 
differentiate human stem cells or SH-SY5Y neuroblastoma cells before or after depletion of 
APTX by siRNA.  The SH-SY5Y cell line possesses many biochemical and functional properties of 
neurons and can be differentiated into a functionally mature neuronal cell type in the 
presence of various agents, making it a popular model system for the study of neurotoxicity 
and neurodegeneration and has been used to model the neuropathology seen in Parkinson’s 
disease (Xie et al., 2010).  Thus SH-SY5Ys could also prove to be a useful tool for investigating 
the impact of DNA repair defects on the survival of functionally mature neurons.   
 
Second, whereas the experiments employing mouse neural cells used hydrogen peroxide to 
induce oxidative DNA breaks my experiments employed -irradiation.  Both agents induce 
oxidative damage via attack of deoxyribose and DNA bases by reactive oxygen species, 
resulting in DNA strand breaks with termini of similar chemistry.  -irradiation was originally 
chosen as a source of oxidative DNA damage as, unlike hydrogen peroxide which exhibits large 
variations in damage induction between individual cells, -IR induces a more uniform level of 
DNA breaks between samples.  However H2O2 induces ~2000 SSBs for every DSB, whereas IR 
induces ~20-40 SSBs for every DSB (Ward, 1998, Ward et al., 1987).  Therefore it is possible 
that different cellular responses/SSBR repair pathways are elicited in response to the two 
agents, with different DNA polymerase requirements.    
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A final possibility is that Polδ/ε, and/or some other APH sensitive DNA polymerase, are 
involved in the response to very high levels of oxidative DNA damage while Polβ and other APH 
– resistant polymerases are involved in the repair of lower, more physiological, doses of DNA 
damage.  Previous studies have shown that the fraction of repair carried out by either APH-
sensitive or APH-resistant polymerases can change according to the dose of DNA damaging 
agent used, and indeed the higher the level of DNA damage, the higher the dependence on 
APH-sensitive polymerases (Dresler and Lieberman, 1983a, Dresler and Lieberman, 1983b).  To 
test this hypothesis, the experiments could be repeated with lower doses of γ-irradiation to 
determine if APH-resistant SSBR operates at lower doses of DNA damage.   
 
As these experiments were unable to demonstrate the existence of APTX-dependent repair 
following oxidative DNA damage in living cells, it is necessary to attempt different approaches 
to investigate the role of APTX in DNA repair in living cells.  To investigate whether long-patch 
SSBR could function to repair adenylated SSBs in the absence of APTX, the APTX-/- mouse could 
be crossed with a mouse strain possessing deletions in one or more long-patch repair factors.  
FEN1 is a core component of long-patch repair and an APTX-/-FEN1-/- double knockout mouse 
would be an ideal tool to test the redundancy between APTX and long-patch SSBR.  Although 
germline deletion of  FEN1 is embryonically lethal due to the essential role of FEN1 in the 
maturation of Okazaki fragments during DNA replication, FEN1 could be conditionally 
disrupted in the central nervous system, a strategy previously used to overcome the lethality 
of a whole body knockout of XRCC1 in mice (Larsen et al., 2003, Zheng et al., 2007, Lee et al., 
2009).  Rates of chromosomal SSBR could then be compared using astrocytes obtained from 
APTX-/-FEN1-/-, APTX-/-, and FEN1-/- mice to determine if there was a synergistic reduction in 
repair rates in the double mutant compared to either single mutant, which would be predicted 
if there was redundancy between APTX and long-patch dependent repair of abortive ligation 
intermediates.  
 
Another advantage of an APTX-/-FEN1-/- double knockout mouse is that this could potentially 
lead to an increase in the levels of unrepaired adenylated SSBs in the nervous system.  A 
potential explanation for the lack of neurodegenerative pathology in APTX-/- mice is that 
adenylated SSBs do not accumulate in sufficient numbers in the adult mice due to their 
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comparatively short life spans.  The age of onset of AOA1 is between early childhood and 
adolescence and which is considerably longer than the lifespan of a mouse and the co-
disruption of long-patch repair and APTX in mouse could increase levels of adenylated SSBs to 
a level sufficient to impact on the survival of post-mitotic neurons. 
 
This strategy of crossing APTX-/- mice with DNA repair defective strains of mice strains could 
also be used to investigate the role of other DNA repair pathways in the APTX-independent 
repair of adenylated SSBs.  It has been considered possible that components of HDR and SSBR 
function together as a back-up mechanism to ensure that SSBs do not become permanent 
blocks to replication in RC-SSBR, which raises the possibility that nucleases involved in the 
processing of DSBs, such as MRN, could also function to process adenlyated SSBs in the 
absence of APTX (Nicolette et al., 2010b, Paull, 2010a, You et al., 2009a, Mimitou and 
Symington, 2009, Moreau et al., 1999, Milman et al., 2009, Hartsuiker et al., 2009, Rass et al., 
2009, Xie et al., 2009).  Such a hypothesis could also be tested by crossing APTX-/- with a mouse 
strain possessing a neural specific disruption of Mre11 (Stracker and Petrini, 2011).  Depletion 
APTX in ATLD cell lines or Mre11 in AOA1 cell lines by siRNA could also be performed in parallel 
to lend support to this hypothesis.   
 
7.1.4  The roles of different DNA polymerases during SSBR  
As discussed in the previous chapter, the surprising observation that arose from the 
experiments employing human fibroblasts was that SSBR following oxidative damage was 
driven almost exclusively by one or more APH sensitive DNA polymerases.  This contradicts 
numerous biochemical and cellular studies have implicated the APH resistant polymerases β, λ 
and ι as having a significant role in both short-patch and long-patch SSBR (Braithwaite et al., 
2005a, Braithwaite et al., 2010, Braithwaite et al., 2005b, Petta et al., 2008, Vermeulen et al., 
2007a, Vermeulen et al., 2008, Vens et al., 2007, Parlanti et al., 2004).  However, as most of 
the cellular studies have employed MEFs, whereas my experiments have employed human 
fibroblasts.  It is possible that this reflects differences in the contributions of polymerases in 
SSBR between human and mouse, with the APH-sensitive polymerases perform a much larger 
role in human fibroblasts than MEFS.   
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It would be interesting to extend my experiments to other human cell lines, and particularly 
other primary cells, to determine if the dependence of APH-sensitive polymerases for the 
repair of oxidative DNA damage is a feature of fibroblast cell lines or whether it is common to 
other human cell lines.  Lymphoblastoid cell lines, MRC5, which is an embryonic lung fibroblast 
cell line and 293T, which is a cell line derived from embryonic kidney cells, are three commonly 
used non-malignant human cell lines which could be used to test the roles of APH-sensitive 
polymerases in SSBR in different cell types.  Alternatively, another strategy would be to use 
siRNA mediated depletion of different combinations of polymerases in human cells to test 
their contributions to SSBR.   
 
However, what is not clear from my experiments is whether the APH-sensitive repair seen in 
human fibroblasts is a long patch repair mechanism.  Total levels of the classical long patch 
repair factors PCNA and FEN1 protein were reduced in the quiescent fibroblasts, yet SSBR 
following oxidative stress was still largely APH-dependent.  It is possible that the level of PCNA 
and FEN1 was sufficient for Pol δ/ε mediated long patch repair, or that another APH-sensitive 
polymerase and/or nuclease mediates this process in these cells.  Finally, the repair event 
could reflect a short patch mechanism, mediated either by an as yet unidentified APH-sensitive 
polymerase or by Polδ/ε.   Another possibility is that the APH sensitive repair could reflect 
Polδ/ε–dependent short – patch repair.   Polδ/ε have been shown to be capable of inserting a 
single nucleotide into a SSB, albeit less efficiently than Polβ is more efficient at this.  
 
7.1.5 Conclusions and future perspectives 
The major finding of this study is that short-patch repair of an abortive ligation intermediate 
fails in AOA1 due to limiting levels of non-adenylated ligase, supporting the hypothesis that 
adenylated nicks accumulate in the absence of APTX.  This finding has implications for the 
pathology of AOA1 as the accumulation of unrepaired SSBs could result in an increase in the 
levels of collapsed transcription forks in post-mitotic neurons, ultimately leading to a higher 
occurrence of neuronal cell death in AOA1 individuals.  This has also been proposed to be the 
underlying cause of the neurodegeneration seen in SCAN1individuals.   Indeed it has been 
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demonstrated that a significant portion of the abortive Top1-SSBs seen in SCAN1 cells 
following CPT treatment by alkaline comet assay are dependent on the presence of active 
transcription and it has been known for a while that collision with transcription machinery 
converts Top1 cleave complexes into abortive Top1-SSB (Kroeger and Rowe, 1989, Bendixen et 
al., 1990, Wu and Liu, 1997, Miao et al., 2006, El-Khamisy et al., 2005).   
 
Another factor which could be significant in the pathology of AOA1 is that post-mitotic 
neurons are highly active cells and exhibit high levels of mitochondrial respiration but have a 
reduced capacity to neutralise reactive oxygen species, which would lead to a higher level of 
oxidative stress in the central nervous system compared to other tissue types (Weissman et al., 
2007, Barzilai, 2007).  This high level of oxidative damage would result in higher levels of SSBs 
with blocked 3’ termini which could lead to an increase in the levels of abortive ligations.  
Thus, in combination with absence of redundant DNA repair pathways that operate in S-phase 
and G2 and the proposed attenuation of long-patch repair, post-mitotic neurons could be 
more heavily reliant on APTX-dependent repair pathways that other tissue types.   
 
 The findings in this study could also have implications for possible future clinical interventions.  
For example, the observation that the short-patch repair in AOA1 extracts is rescued in vitro 
with the addition of non-adenylated DNA ligase, may provide a possible route for clinical 
intervention.  The three steps of DNA ligation are relatively separate reactions that can be 
independently disrupted with individual point mutations and a recent study presented data on 
three compounds, with different specificities for the three human DNA ligases, that selectively 
inhibited the last two steps of DNA ligation while leaving the ligase-adenylation reaction 
unaffected (Chen et al., 2008, Zhong et al., 2008).  This raises the possibility that an inhibitor 
could be designed that selectively inhibits ligase re-adenylation but allows the ligation of an 
adenylated nick.  It can be speculated that the use of such an inhibitor in AOA1 cells might 
increase the level of non-adenylated DNA ligase, transiently at least, and thereby cleanse the 
genome of accumulated adenylated nicks. 
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This is, however, at present entirely speculative and there are a number of issues to be 
addressed.  The first is that, as mentioned previously, it has yet to be proved that that 
adenylated SSBs are a physiologically relevant lesion in living cells, and it cannot be ruled out 
that APTX can act on other DNA substrates (Takahashi et al., 2007a).  Such an inhibitor would 
only work if the disease pathology in AOA1 was due to the accumulation of unrepaired 
adenylated SSBs, and not another type of lesion.  Secondly, a limitation of any compound that 
is targeted to the brain is the existence of the blood-brain barrier that completely separates 
the brain from the bloodstream and prevents the transmission of most small molecules 
between the two (Alavijeh et al., 2005).  Indeed, due to this and other complications inherent 
with targeting drugs to the brain, it takes significantly longer for a therapeutic drug targeted to 
the central nervous system to get to market compared to other drugs (Alavijeh et al., 2005).  
Another issue with this approach, and possibly the most significant issue for the patients 
suffering from this disorder, is that due to the low regenerative capacity of the brain, it would 
not be possible to reverse the neurodegeneration seen in AOA1.  The most that can be hoped 
for is that regular treatments with a drug could halt the progression of the disease once it has 
been diagnosed.   
 
While it is very unlikely that any pharmaceutical companies would invest the huge amount of 
time and money required for drug development in a drug specifically designed to treat AOA1, a 
very rare disorder when compared to the incidence of major diseases such as cancer, the 
potential use of DNA ligase inhibitors as novel chemotherapeutic agents has already been 
proposed.  The success of PARP inhibitors in the treatment of BRCA1 and BRCA2 defective 
tumours has demonstrated the potency of inhibiting SSBR in homologous recombination 
defective cells and fuelled the search for novel chemotherapeutic drug targets (Farmer et al., 
2005, Bryant et al., 2005, Guo et al., 2011).  Indeed, along with DNA ligase inhibitors, PNK 
inhibitors have also been proposed as a strategy to increase the cytotoxicity of either 
radiotherapy or CPT treatment (Bernstein et al., 2008, Freschauf et al., 2010, Freschauf et al., 
2009).   
 
There are some important questions about APTX and the disease that need to be addressed.  It 
is currently not clear whether the neuropathology of the disease is due to unrepaired SSBs or 
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DSBs.  Although a role for APTX in DSBR has not been discussed in this study, APTX is found in a 
constitutive interaction with CK2 phosphorylated XRCC4 and thus could have a role in the 
processing of DNA ends during NHEJ (Clements et al., 2004).  Although it has been proposed 
that an accumulation of unrepaired adenylated nicks in AOA1 neurones could lead to blocked 
transcription and eventual cell death, resulting in the pathology of the disease, it could also be 
the result of accumulating DSBs.  However as was the case with the previously conflicting 
evidence for the existence of a chromosomal SSBR defect in AOA1 cells, a convincing DSBR 
defect has not been found in APTX-defective cells.  
 
Another critical question is what are the affected cerebellar cell types in AOA1? Because the 
Aptx-/- mice do not exhibit neurodegeneration it has not been possible to pinpoint which 
neural populations are the affected.  It has been shown that severe purkinje cell loss is 
associated with AOA1 (Sugawara et al., 2008).  This could reflect a direct impact of unrepaired 
breaks on purkinje cell viability an indirect result of cell death in cells that maintain neuronal 
homeostasis, such as neuroglia cells.  
 
Additionally AOA1 lacks any extra-neurological symptoms that are commonly associated with 
DNA repair defective disorders, in particular cancer predisposition.  This is a feature with is 
shared by AOA1, SCAN1 (caused by mutations in TDP1) and MCSZ (caused by mutations in 
PNK) despite the different neuropathologies of AOA1 and SCAN1 compared to MCSZ.  As 
mentioned earlier, one explanation for this is that cycling cells possess redundant DNA repair 
pathways that operate solely during S-phase or G2 that can deal with any unrepaired SSBs, 
such as the replication-coupled SSBR or HR (Caldecott, 2008, Caldecott, 2001, Caldecott, 
2003b).  It is likely that RC-SSBR would predominantly involve long-patch repair due to its 
association with the replication machinery, which as discussed earlier is a potential mechanism 
for repairing adenylated nicks in the absence of APTX.  The nucleases involved in resection of 
DNA ends during HR, such as MRN, could also function as redundant mechanisms for the 
processing of SSBs with blocked 3’ or 5’ DNA ends in the absence of APTX, PNK or TDP1.  
Additionally, as HR is an error-free repair pathway, this would prevent the mis-repair of any 
persisting SSBs and DSBs by more error prone pathways, such as NHEJ, which has been 
implicated in carcinogenesis (Schlissel et al., 2006).   
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Finally, although the clinical presentations of AOA1 and SCAN1 are similar and probably have 
similar underlying causes, the neuropathology of MCSZ is very different.  While both AOA1 and 
SCAN1 are neurodegenerative disorders that are associated with progressive degeneration and 
atrophy of the cerebellum after birth, MCSZ presents with severe microcephaly from birth, but 
exhibits no evidence of subsequent degeneration (Shen et al., 2010, Date et al., 2001, Moreira 
et al., 2001, Takashima et al., 2002).  The underlying cause of microcephaly is a reduction in 
total brain volume caused by defects occurring during brain development (O'Driscoll and 
Jeggo, 2008).  Therefore the different presentations potentially reflects that the loss of APTX 
and TDP1 primarily effect post-mitotic neurones while mutations in PNKP have a greater 
impact upon the developing brain.   
 
The absence of microcephaly in AOA1 and SCAN1 could reflect the potential rarity of the DNA 
lesions that APTX and TDP1 repair.  It is possible that these rare lesions would not accumulate 
in enough numbers to impact upon the neuronal progenitors in the VZ and SVZ of the 
developing brain, whereas PNKP substrates would be amongst the most commonly arising 
DNA lesions due to the highly metabolic status of the developing brain (Bayer et al., 1991, 
Barnes et al., 1998, Gao et al., 1998, Hoshino and Kameyama, 1988, Hoshino et al., 1991, 
Narasimhaiah et al., 2005). 
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Figure 1.1  -  The mutagenic potential of the common oxidative lesion 8-oxo-
guanine 
 
Oxidative base adducts are an abundant type of DNA damage that can be caused by 
reactive oxygen species generated as by-products of cellular metabolism.  Oxidation of 
guanine can lead to the formation of 8-oxo-guanine (8-oxo-G) (A).  8-oxo-G is the 
probably one of the most abundant oxidative DNA lesions.  8-oxo-G is has the 
potential to be mutagenic as it can form base pairs with both cytosine and adenine (B).  
The mis-incorporation of adenine opposite the oxidative lesion can lead to a G→T 
conversion following two rounds of DNA replication (C). 
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Figure 1.2 -  Alkylation base damage in DNA 
 
Alkylating agents from exogenous and endogenous sources can cause a variety of 
alkylation base adducts in DNA.   
A  S-adenosylmethionine (SAM) is an intermediate in the synthesis of the amino acid 
methionine and functions as a methyl donor in enzyme-catalysed reactions during a 
number of cellular metabolic processes.  It has been shown in vitro that SAM can also 
catalyse the non-enzymatic transfer of its methyl group (high-lighted in red) to DNA and 
has been implicated as an endogenous source of alkylation damage in cells.  
B  Some common alkylation base adducts that can arise in DNA. 
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Figure 1.3  -  Spontaneous deamination of bases in DNA 
 
DNA base residues are susceptible to spontaneous hydrolytic deamination.  A  
Cytosine and it’s methylated form, 5-methlycytosine, are the most susceptible bases to 
spontaneous deamination and can be converted to uracil and thymine respectively.   
B  Although the rate of hydrolytic deamination of purine bases is much slower than that 
of pyramidine bases, guanine can also be converted to xanthine and oxanine and 
adenine can be converted to hypoxathine,.  C  Deamination of cytosine to uracil results 
in mutagenic U:G mis-pairs and can lead to a C→T conversion following two rounds of 
DNA replication.  C→T conversions can also result from the deamination of 5-
methylcytosine and are the most common single site mutation found in mammalian 
cells.   
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Figure 1.4 -  Model of direct single strand break repair 
Direct DNA single-strand breaks (SSB) induced by reactive oxygen species (ROS) are 
typically associated with a 1 nucleotide gap and “damaged” termini (represented by red 
circles) and are repaired in rapid repair pathways collectively termed single-strand break 
repair (SSBR).   
 
Detection:  Direct SSBs are detected by poly(ADP-ribose) polymerase 1 (PARP1), which 
binds to the break and auto-ribosylates itself, promoting the rapid accumulation of the 
scaffold protein XRCC1 and other downstream SSBR factors.  Once auto-modified, 
PARP1 disassociates from the SSB and Poly(ADP-ribose) glycohydrolase (PARG) rapidly 
degrades the PAR chains, recycling the PARP1 molecule for another round of SSB 
detection.   
 
End processing:  During end processing the damaged termini (red circles) are restored 
to the conventional 3’-OH and 5’-P chemistries.  Direct SSBs are processed by 
polynucleotide kinase 3′-phosphatase (PNK), AP endonuclease I (APE1) and aprataxin 
(APTX) (Table 1.).   
 
Gap-filling:  Two sub-pathways operate during SSBR; short-patch repair, during which 
polymerase β (Polβ) inserts a single nucleotide to fill the gap, and long-patch repair, which 
involves extension of 2-12 nucleotides by either Pol β or the processive polymerases Pol 
δ or Pol ε (Pol δ/ε).  During this step, a 5’ DNA flap is produced which is cleaved by the 
enzyme, Flap endonuclease 1 (FEN1). 
 
DNA ligation:  Two DNA ligases are thought to operate in SSBR.  DNA ligase IIIα 
(LigIIIα) is traditionally associated with short-patch repair events while DNA ligase I (LigI) 
is associated with long-patch repair.  (Adapted from Caldecott 2009) 
 
Ade, aldehyde; AMP, 5′-AMP; OH, 5′-hydroxyl; P, 3′-phosphate; PG, 3′-phosphoglycolate 
Figure 1.5 -  Model of mammalian base excision repair 
Base excision repair (BER) is a repair pathway that is responsible for the repair of 
damaged bases (red star) and is a major source of indirect SSBs.  Base damage can arise 
from either oxidative or alkylating DNA damage.   
 
Recognition and excision of base damagde is carried out by DNA glycosylases.  There are 
two types of DNA glycosylase.  Mono-functional DNA glycosylases excise only the 
damaged base, leaving an intact apurinic/apyramidinic (AP), site which is processed by 
APE1.  Bi-functional DNA glycosylases contain an additional AP lyase activity after 
excision of the damaged base, it cleaves the AP site, via either a β or βδ elimination 
reaction mechanism.  The indirect SSBs produced during these steps are then repaired in 
the single-strand break repair pathway (SSBR).   
 
Indirect SSBs produced during BER have “damaged” termini (red circles) and require end 
processing by Pol β, APTX and/or PNK to restore the conventional 3’-OH and 5’-P 
chemistries.  Following end-processing, the gap is filled by the action of either short-patch 
or long-patch SSBR.  During short-patch repair, Polβ inserts a single nucleotide to fill the 
gap.  In contrast, long-patch repair involves extension of 2-12 nucleotides by either Pol β 
or the processive polymerases Pol δ or Pol ε (Pol δ/ε), during which a 5’ DNA flap is 
displaced and removed by the enzyme Flap endonuclease 1 (FEN1).  The final stage in 
the repair of indirect SSBs is DNA ligation.  Like the repair of direct SSBs, two DNA 
ligases are thought to operate in SSBR.  LigIIIα is mainly associated with short-patch 
repair events while LigI is associated with long-patch repair (Adapted from Caldecott 
2009) 
 
(α,β, 3′-α,β unsaturated aldehyde; P, 3′-phosphate; PG, 3′-phosphoglycolate; AMP, 5′-
AMP; OH, 5′-hydroxyl; dRP, 5′-deoxyribose phosphate.) 
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Figure 1.6  -  Model of the repair of topoisomerase 1 induced SSBs 
 
Another source of SSBs is the abortive activity of DNA topoisomerase 1 (Top1). Top1 
relaxes supercoiled duplex DNA during transcription and DNA replication by nicking 
one strand of the DNA double helix and allowing the DNA to unwind. These cleavage 
complexes can become trapped, however, upon collision with either a transcription or 
replication fork or if the cleavage complex occurs in close proximity to other DNA 
lesions.   
 
These Top1-linked SSBs are repaired by the end-processing enzyme Tyrosyl-DNA 
phosphodiesterase 1 (Tdp1), which leaves a 3’-P and 5’-OH, and PNK, which restores 
the conventional DNA termini.  Processing of the Top1-SSB leaves a conventional nick 
which can then be re-ligated.  As Tdp1 interacts with LigIIIα it is likely that Top1-SSBs 
will be quickly ligated following end-processing.  However it is possible that under 
some circumstances, a gap-filling step could be involved.   
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Figure 1.8  -  Structures of the types of damaged 3’ termini that can arise at DNA 
single-strand breaks 
 
Types of damaged termini that arise at the 3’ of a DNA single strand break include a 3’ 
phosphate (3’P), 3’ phosphoglycolate (3’PG), 3’ αβ unsaturated aldehyde (3’PUA) and 
a 3’ Top1-linked SSB (3’ Top1).  The  altered chemistries of the DNA termini are 
highlighted in red. 
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Figure 1.9 -  Structures of the types of damaged 5’ termini that can arise at DNA 
single-strand breaks 
 
Types of damaged termini that can arise at the 5’ of a DNA single strand break include 
a 5’ hydroxyl (5’OH), 5’ deoxyribose phosphate (5’dRP), 5’ aldehyde (3’PG), and a 5’ 
adenosine monophosphate (5’AMP). The  altered chemistries of the DNA termini are 
highlighted in red. 
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Figure 1.10 – Domain structure of mammalian ligases 
 
There are 3 DNA ligases that are present in mammalian cells.  All mammalian ligases 
contain a DNA binding domain (DBD) and a catalytic core which contains the active 
site lysine that becomes adenylated during the ligation mechanism.   
 
A  The mammalian LIG3 gene encodes three distinct  DNA Ligase III polypeptides.  
LigIIIα is ubiquitously expressed in all tissue types and an alternate translation initiation 
mechanism allows for the encoding of nuclear and mitochondrial versions.  Additionally 
a germ-line specific alternative splicing mechanism, in which the terminal 3’-coding 
exon of LigIIIα is replaced by a different exon, generates LigIIIβ, which also includes a 
nuclear and mitochondrial version.  All three polypeptides contain an N-terminal zinc-
finger domain (ZnF) which gives LigIIIα and LigIIIβ a nick sensing ability.  LigIIIα also 
interacts with XRCC1 through its C-terminal BRCT domain.   
 
B  Mammalian cells only contain one LigI polypeptide which contains only the core 
DNA binding and catalytic domains.  The N-terminal region of LigI contains a PIP box 
through which it interacts with PCNA.   
 
C  In addition to the core catalytic domains LigIV contains two tandem C-terminal 
BRCT domains which mediate its interaction with XRCC4.   
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Figure 1.11  –  Reaction mechanism of mammalian ligases 
 
DNA ligases are nucleotidyltransferases (NTases) that utilise a high energy cofactor to 
catalyse phosphodiseter bond formation in a universal three-step reaction mechanism. 
 
Step 1:   In the first step of DNA ligation reacts with ATP to form a ligase-adenylate 
intermediate in which AMP is covalently linked to the active-site lysine. This reaction is 
very energetically favourable and the ligase-adenylate intermediate is stable in the 
absence of a DNA substrate.  Therefore this reaction can be seen as essentially 
irreversible, meaning that the majority of ligase in the cell is likely to be in the 
adenylated form.  
 
Step 2:  The second step of ligation is the activation of the 5’P by adenylation of the 
DNA. During this step the oxygen of the 5’P attacks the phosphorus of the AMP, 
dispelling the lysine and transferring the adenylate group onto the 5’P, forming an 
AMP-DNA intermediate.   
 
Step 3: The final step of ligation is the reformation of the phosphodiester backbone. 
During this step the non-adenylated ligase catalyses the nucleophilic attack of the 
5’AMP by the 3’OH, displacing the AMP and joining the two polynucleotides by 
formation of a phosphodiester bond  
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Figure 1.12  -  Model of replication-coupled single strand break repair 
The collision of a replication fork with a SSB creates a one-ended DSB and a residual 
SSB.  Red circles denoted damaged termini.   
 
End processing:  The 5’-terminus of the DSB is processed and resected by CtIP and 
the MRN complex in anticipation of strand invasion and replication fork restart.  End 
processing of the SSB is carried out by either global SSBR factors or alternatively by 
structure specific nucleases such as ERCC1-XPF, MRN or FEN1.   
 
Gap-filling and DNA ligation: Gap-filling and DNA ligation is carried out by Polδ/ε 
and LigI respectively.   
 
Homologous recombination:  The replication fork is reformed by formation of a 
Rad51 nucleofilament and template switching.   
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Figure 1.13  Mechanism of non-homologous end-joining in mammalian cells 
Non-homologous end-joining (NHEJ) is a double-strand break repair (DSBR) pathway 
that is in operation throughout the cell cycle and is the predominant pathway of choice 
during G1.   
 
Detection:  DNA double-strand breaks (DSB) are rapidly bound by the Ku70/80 
heterodimer which forms a ring-like structure around the DNA.  This leads to the 
activation of the catalytic subunit of the DNA-PK protein complex, DNA-PKcs, which 
catalyses the inward translocation of Ku70/80.  This reveals the ends of the break 
allowing two DNA PKcs molecules to load onto the DNA.  Another aspect of DSB 
signalling is the activation of PARP3 at the site of the break.   
 
Synapsis:  DNA-PKcs plays a critical role in non-homologous end-joining (NHEJ), 
preventing end resection through a series of phosphorylation events and also stabilising 
the break by interacting with each other to form a synapse, tethering the ends of the 
break together.  The loading of DNA-PKcs onto the DNA ends also leads to the 
recruitment of XRCC4/LigIV.   
 
End-processing:  As many DNA DSBs contain ‘damaged’ unligatable DNA termini, a 
variety of end-processing factors, including Artemis, Tdp2, PNKP and APTX, are required 
to restore the ends of the DNA to the conventional 3’OH and 5’P before DNA ligation is 
possible.   
 
DNA ligation:  Once the DNA ends are processed the break is ligated by XRCC4/LigIV 
with the aid of the stimulatory factor XLF and the poly (ADP-ribose) binding protein APLF.   
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Figure 1.14  Model of homology directed DSBR in mammalian cells 
Homologous recombination (HR) is a double-strand break repair pathway (DSBR) that 
operates preferentially in late S and G2 phases of the cell cycle.  HR uses  an undamaged 
homologous sequence as a repair template.  During HR, a DSB is recognised by the MRN 
complex, which tethers the DNA ends and in cooperation with the CtIP/BRCA1/BARD1 
complex initiates 5’ → 3’ end resection to generate 3’ single-stranded DNA (ssDNA) 
overhangs.  RPA coats the ssDNA to prevent the formation of DNA secondary structures, 
allowing the loading of Rad51 by BRCA1 onto the DNA.  Strand invasion and homology 
searching of the intact DNA strand is catalysed by the Rad51 filament.   
 
Synthesis dependent strand annealing:  During SDSA, a single DNA end is captured by 
a migrating D-Loop and DNA synthesis occurs from the captured strand.  Following DNA 
extension, the invading strand is displaced, anneals to the resected second end and is 
ligated.   
 
Homologous recombination:  In the HR model, the second DNA end is captured by 
annealing to the extended D-Loop, forming two Holiday Junctions (HJ).  The double HJ 
structure is then resolved to form either crossover or non-crossover products depending on 
the orientation of resolution.   
 
Single-strand annealing:  During SSA, resection reveals two homologous sequences 
within complementary strands on either side of the break which anneal to each other. 
 
Break induced recombination:  BIR occurs when a one-ended DSB invades the intact 
template, resulting in the formation of a replication fork. (Adapted from Hartlerode and 
Scully, 2009). 
Figure 1.15  -  Model for the ATM signalling cascade in the DNA damage response 
ATM is a member of phosphatidylinositol 3-kinase-related kinases (PIKK) family of 
serine/threonine protein kinase and has a critical role in the DNA damage response (DDR).  
Upon induction of a DSB, MRN rapidly binds to the break and recruits and activates ATM 
which undergoes auto-phosphorylation at S1981.  Upon activation ATM immediately 
phosphorylates the histone variant H2AX on S139, producing γH2AX, and the checkpoint 
protein, CHK2, leading to the phosphorylation of p53.  The mediator protein, MDC1, is 
recruited by γH2AX and becomes phosphorylated by ATM, which then aids in the 
propagation of the γH2AX signal by recruiting more ATM to the break.  MDC1 also recruits 
the ubiquitin ligase RNF8, which ubiquitinates H2A and γH2AX and begins a ubiquitin 
signalling cascade.  Two more ubiquitin ligases, RNF168 which binds to the ubiquinated 
histones, and HERC2, which interacts with RNF8, stimulate spreading of the ubiquitin 
signal.  The BRCA1 complex, itself an E3 ubiquitin ligase, is then recruited to the 
polyubiquitin chains.  The mediator protein 53BP1 is also recruited to the site of the break 
in a manner that is dependent on the presence of γH2AX, MDC1 and RNF8.  This intricate 
ATM dependent signalling cascade serves to stimulate DNA repair as well as to initiate 
check point arrest, preventing cell cycle progression if unrepaired DNA DSBs persist.   
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Figure 1.16 -  Model for nucleotide excision repair 
Nucleotide excision repair (NER) is a DNA repair pathway that detects and repairs 
bulky, helix-distorting DNA lesions.  Two sub-pathways exist within NER that differ in 
the initial stages of detecting the lesion.  During global-genome NER helix-distorting 
DNA damage that arises anywhere in the genome, such as 6-4 photoproducts, is 
recognised and stabilised by XPC and XPE which recruits the large protein complex 
THIIF.  Transcription-coupled NER (TCR) operates on lesions in the transcribed 
strands of expressed genes, such as cyclobutane pyrimidine dimers (CPD).  The CSA 
and CSB proteins are involved in this process in recruiting TFIIH to the sites of blocked 
RNA polymerases.   
 
XPD and XPB are subunits of the THIIH complex that contain ATP dependent 5’ → 3’ 
and 3’ →  5’ DNA helicase activities that unction to open up an bubble surrounding the 
lesion.  RPA is loaded onto the undamaged strand as soon as the ssDNA is revealed.  
Excision of the damaged strand is then achieved by dual incision of the bubble at the 5’ 
and 3’ by the structure specific nucleases ERCC1-XPF and XPG. In the final stages of 
NER, Polδ/ε and PCNA catalyse gap-filling and XRCC1/LigIII ligates the resulting nick.   
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Figure 1.17  -  Structures of the most common types of UV induced 
photodamage 
 
Cyclobutane pyrimidines (CPD) and (6-4) photoproducts are the two most common 
types of UVB induced photodamage.  These bulky DNA adducts cause distortions in 
the DNA double helix which are recognised and repaired by the nucleotide excision 
repair pathway.   
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Figure 1.18  Mechanism of DNA mismatch repair in mammalian cells 
 
DNA mismatches are recognised by the heterodimers MSH2/MSH6 or MSH2/MSH3 (not 
shown) which recruits the MLH1/PMS2 heterodimer.  The protein complex then 
undergoes a conformational shift allowing it to slide away from the mismatch.    The 
PMS2 subunit then introduces nicks in the discontinuous strand (red) in a process that 
requires PCNA and ATP.  The nicked strand is then degraded by EXO1, generating a 
single-stranded gap which is immediately coated by RPA.  Gap-filling is carried out by 
Polδ/ε in with PCNA and DNA ligase I ligates the remaining nick.   
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Figure  1.19 -  APTX mutations found in individuals with ataxia oculomotor 
apraxia 1 
Ataxia oculomotor apraxia 1 is an autosomal recessive ataxia caused by mutations in 
the gene APTX (Date et al 2001; Moreira et al 2001).  APTX is a member of the Hint-
like histidine triad (HIT) superfamily and is involved in the repair of abortive ligation 
intermediates by removing the AMP moiety from the 5’ of SSBs and DSBs (Ahel et al 
2006).  APTX also contains a HIT domain (blue), a divergent zinc finger motif (ZnF) 
(yellow), an amino-terminal fork-head associated (FHA) domain (light green) and an 
NLS (dark green).  APTX interacts with CK2 phosphorylated XRCC1 and XRCC4 via 
the FHA domain (Clements et al 2004).  The red box denotes the location of the H-φ-
H-φ-H-φ-φ HIT motif.  “fs” denotes a frameshift mutation and “Δ” denotes a deletion. 
(Adapted from Caldecott 2009)  
ZnF 
Phoshodiesterase domain NTD 
1 150 160 263 
H493R 
590 
Figure  1.20  -  Mutation in Tdp1 found in individuals with spinocerebellar ataxia 
with axonal neuropathy 1  
Spinocerebellar ataxia with axonal neuropathy 1 is an autosomal recessive ataxia that 
is caused by mutations in TDP1 (Takashima et al 2002).  Tdp1 contains a 
phoshodiesterase domain (blue) and is involved in the repair of abortive 
topoisomerase 1 (Top1) cleavage complexes by removing a 3’-Top1 peptide (Interthal 
et al 2001).  The red boxes indicate the locations of critical HKD active sites (Interthal 
et al 2001).  Tdp1 has been shown to interact with LigIIIα via the N-terminal domain 
(NTD) (green) (Chiang et al 2010).  So far only one mutation (H493R) has been found 
in individuals suffering from SCAN1.  (Adapted from Caldecott 2009).   
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Figure 1.21  -  PNK mutations found in individuals with microcephaly, early-
onset, intractable seizures and developmental delay 
Microcephaly, early-onset, intractable seizures and developmental delay is an 
autosomal recessive disorder caused by mutations in the gene PNK (Shen et al 2010).  
PNK has an amino-terminal fork-head associated domain (FHA) (green) and 
phosphatase (blue) and kinase (yellow) active site domains.  PNK interacts with CK2 
phosphorylated XRCC1 and XRCC4 via the FHA domain.  Two point mutations have 
been discovered in the phosphatase domain (L176F and E326K).  A frameshift 
mutation associated with a premature stop codon (T424GfsX48) and a splice mutation 
resulting in deletion of exon 15 (exon 15 Δ) have been discovered in the kinase 
domain.   
Figure 3.1  –  Model for the role of APTX in resetting abortive ligation 
intermediates during short-patch SSBR 
 
Direct SSBs, primarily arising as the result of exposure to ionising radiation or reactive 
oxygen species, occur thousands of times in each cell per day and are typically 
associated with base and it has been estimated that ~70% of these breaks possess a 
3’- phosphate (Caldecott 2001).  During short-patch SSBR of these oxidative breaks, 3’ 
end processing by PNK and gap-filling by Polβ would be required to restore a ligatable 
nick.   
 
However if a ligase attempts to prematurely ligate the oxidative SSB before the action 
of PNK or Polβ then the ligation reaction will stall and a stable abortive ligation 
intermediate will be produced (*).  APTX is a nuclear DNA repair protein that catalyses 
the release of adenylate groups covalently linked to 5’ phosphate termini of a DNA 
SSBs and it has been proposed that APTX acts to rapidly reset abortive ligations that 
arise during SSBR (**) (Ahel et al 2006; Rass et al 2007; Rass et al 2008).   
 
It has been shown that APTX defective cell extracts lack AMP-DNA hydrolase activity 
and are unable to perform short-patch SSBR on an in vitro substrate modelling an 
abortive ligation of an oxidative SSB (Ahel et al, 2006).  In AOA1 cells, abortive ligation 
intermediates that arise would not be resolved by APTX and could accumulate in the 
absence of redundant repair mechanisms 
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Figure 3.2  –  A schematic detailing the preparation of an aborted ligation 
intermediate in vitro 
 
Schematic detailing the preparation of the aborted ligation intermediate.  The final 
annealed oligonucleotide substrate has a 1 nucleotide gap and 1bp non-
complementary 3’ overhangs. A SSB with a nick can be made by replacing the 17mer 
with an 18mer.   The sequences of the oligonucleotides used to prepare the substrate 
are shown in A.   
B  The 5’-AMP substrate is prepared as follows.   
 
Step 1:  The 25mer is 32P radiolabelled on the 5’ termini by incubation with T4 PNK 
and g32P ATP at 30°C for 1hr.  The 32P-25mer is annealed to a 2x fold excess of 
unlabelled 17mer possessing a 3’P (17mer-P) and unlabelled 43mer backbone 
oligonucleotide.   
 
Step 2:  The 5’ termini of the 32P-25mer is then adenylated or mock adenylated by 
incubation with T4 ligase (Roche) or T4 storage buffer for 1 hour at 30°C.   
 
Step 3:  The reaction is stopped by addition of 3x formamide loading buffer and then 
fractionated by denaturing PAGE.  The adenylated 32P-25mer is gel extracted and 
ethanol precipitated.  The mock adenylated 32P-25mer is purified in parallel.  
 
Step 4:  The purified AMP-32P-25mer and mock adenylated 32P-25mer are reannealed 
to a 2x fold excess of unlabelled 17mer-P and 43mer.  The final substrate contains a 1 
nucleotide gap possessing a 3’P and a 5’AMP.   
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Figure 3.3  –  Preparation of an aborted ligation intermediate in vitro 
 
A  Adenylated AMP-32P-25mer and mock-adenylated 32P-25 oligonucleotide separated 
by 15% denaturing PAGE.  Note that the adenylation reaction was not 100% efficient 
and non-adenylated 32P-25mer was still present.   
 
B  Gel extracted AMP-32 P-25mer and 32P-25mer separated by 15% denaturing PAGE. 
 
C  The annealed adenylated duplex (1) can be separated on a 15% native PAGE from 
a partially annealed duplex lacking the 17mer oligonucleotide (2) and the purified AMP-
32P-25 oligonucleotide (3) by 15% native PAGE.   
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Figure 3.4  –  Overexpression and purification of recombinant His-tagged human 
APTX 
 
A  20ml clarified E.coli extract containing His-APTX was loaded onto a 0.5ml Ni-NTA 
agarose column.  His-APTX was eluted with sonication buffer containing 250mM 
imidazole and aliquots of the column load, flow through and elution fractions 
(numbered) of the purification were analysed by 10% SDS PAGE.  His-APTX runs 
above the 37kDa marker at approximately 40kDa (red arrow).  His-APTX protein 
eluted in the first 4 fractions.   
 
B  Peak His-APTX fractions from IMAC were (1 & 2) were pooled and were purified to 
homogeneity by cation exchange chromatography. His-APTX was eluted from the 
column by increasing the salt concentration from 0.1M to 1M and the elution fractions 
(numbered) were analysed by 10% SDS PAGE. His-APTX eluted in a sharp peak at 
approximately 300-400mM NaCl.   
 
C  The purity of the final dialysed preparation of His-APTX was determined by 
analysing 500ng of protein by 15% SDS-PAGE. 
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Figure 3.5  -  AOA1 cell-free extracts are defective in the short-patch SSBR of an 
abortive ligation intermediate in vitro 
 
6.25μg of whole cell extracts prepared from WT and AOA1 LCLs were incubated at 
30°C for the indicated times with 25nM of an abortive ligation intermediate containing a 
1 nucleotide gap and a 3’P and a 5’AMP.  The substrate was 32P radiolabelled on the 
5’ of the 25mer oligonucleotide (32P-25mer).  A cartoon of the substrate is displayed 
(top).  The reaction products were fractionated by 15% denaturing PAGE and detected 
by phosphorimaging.  Gel extracted AMP-32P-25mer and 32P-25mer were included as 
markers (Lanes 1 and 2).   
 
Repair of the 5’AMP and restoration of a 5’P in the SSB is measured by a decrease in 
size of the AMP-32P-25mer to the 32P-25mer.  Full repair of the SSB is indicated by the 
appearance of a ligation product and requires processing of the 3’-P and filling of the 1 
nucleotide gap.  Cell-extracts from lymphoblastoid cell lines have high levels of non-
specific nuclease activity (*) which was supressed by addition of an 1000x fold molar 
excess of competitor oligonucleotide.   
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Figure 3.6  –  Levels of short patch SSBR proteins are normal in AOA1 whole cell 
extracts 
 
10mg of AOA1 and WT whole cell extract were immunoblotted for the core SSBR 
proteins APTX, PNK, Polb, LigIIIa and XRCC1.  b-tubulin and actin were used as 
loading controls. AOA1 whole cell extracts had undetectable levels of APTX but levels 
of PNK, Polb, LigIIIa and XRCC1 were largely comparable to WT. 
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Figure 3.7 –  Defective short-patch SSBR of abortive ligation intermediates by 
AOA1 whole cell extracts  in vitro is rescued by complementation with 
recombinant His-APTX 
 
An adenylated oxidative SSB containing a 1 nucleotide gap with a 3’-P terminus and a 
5’-AMP terminus was incubated with a titration of WT and AOA1 whole cell extracts 
(5mg, 1mg, 0.1mg) in the presence or absence of 100nM His-APTX at 30°C for 60min. A 
cartoon of the substrate is displayed (top). The reaction products were fractionated by 
denaturing PAGE and detected by phosphorimaging.  Gel extracted AMP-32P-25mer 
and 32P-25mer were included as markers (Lanes 1 and 2).  As seen before cell-
extracts from lymphoblastoid cell lines had high levels of non-specific nuclease activity 
(*) which was supressed by addition of an 1000x fold molar excess of competitor 
oligonucleotide.  Note that this experiment was performed four independent times with 
a representative experiment presented here. 
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Figure 3.8  –  AOA1 extracts are proficient in the repair of a non-adenylated 
oxidative SSB 
 
5mg of WT and AOA1 whole cell extract were incubated with 25nM of an mock-
adenylated or adenylated oxidative SSB, containing a 1 nucleotide gap, a 3’P and a 
5’P or a 5’AMP, at 30°C for 60min. The reaction products were fractionated by 
denaturing PAGE and detected by phosphorimaging. Cartoons of the substrates are 
displayed. Gel extracted AMP-32P-25mer and 32P-25mer were included as markers 
(Lanes 1 and 2).  As seen previously reactions containing cell-extracts from 
lymphoblastoid cell lines exhibited high levels of non-specific nuclease activity (*) 
which was supressed by addition of an 1000x fold molar excess of competitor 
oligonucleotide. Note that this experiment was performed two independent times with a 
representative experiment presented here. 
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Figure 3.9  –  Short-patch SSBR of an abortive ligation intermediate in vitro by 
whole cell extracts is dNTP dependant 
 
An abortive ligation intermediate (25nM) consisting of a 1 nucleotide gap, a 3’P and a 
5’AMP was incubated with 5µg of WT and AOA1 whole cell extract and ATP, dNTPs 
and MgCl2 were separately dropped out of the reaction mix. Gel extracted AMP-
32P-
25mer and 32P-25mer were included as markers (Lanes 9 and 10). As seen reactions 
containing cell-extracts from lymphoblastoid cell lines exhibited non-specific nuclease 
activity (*) which was supressed by addition of an 1000x fold molar excess of 
competitor oligonucleotide. Note that this experiment was performed three 
independent times with a representative experiment presented here. 
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Figure 4.1  –  Model of short-patch SSBR of an abortive ligation intermediate 
occurring in WT and AOA1 whole cell extracts 
 
A  Model for APTX-dependent short-patch SSBR of an abortive ligation intermediate in 
WT whole cell extracts.  During end-processing, APTX cleaves the 5’-AMP, restoring a 
5’-P and PNK converts the 3’P to a 3’OH.  Polβ inserts a single nucleotide to fill the 
gap and the resulting nick is ligated by an adenylated LigIIIα molecule 
 
B  Model for APTX-independent short-patch SSBR of an abortive ligation intermediate 
in AOA1 whole cell extracts.  Note that there are three potential points in which the 
short-patch SSBR of an abortive ligation intermediate can stall in the absence of APTX 
(asterisk).  The presence of the 5’-AMP could prevent access of either PNK or Polβ to 
the 3’ termini, blocking repair at the early steps, or the ligation of the adenylated nick 
could fail.   
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Figure 4.2  -  Details of the SSB substrates employed in this chapter 
 
A  Adenylated and mock adenylated SSB substrates used to directly measure PNK 
dependent repair of 3’- phosphate termini.  The substrates contain a 1 nucleotide gap 
possessing a 3’-phosphate and either a 5’-AMP or 5’-P.  Note the position of 32P 
radiolabels on the 5’ termini of both the 17mer and the 25mer oligonucleotides.   
 
B  Adenylated and mock adenylated SSB substrates used to directly measure gap-
filling by Polβ.  The substrates contain a 1 nucleotide gap possessing a 3’-hydroxyl and 
either a 5’-AMP or 5’-P. Note position of 32P radiolabels on the 5’ termini of both the 
17mer and the 25mer oligonucleotides.   
 
 
C  An adenylated SSB substrate used to measure the direct ligation of an adenylated 
nick.  The substrate contains a nick with a 3’-hydroxyl and a 5’-AMP.  Note that unlike 
the substrates in A and B, this substrate possesses a 32P radiolabel on the 5’ termini of 
the 25mer oligonucleotide only. 
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Figure 4.3  –  Optimising overexpression conditions for recombinant human His-
PNK 
 
A  To determine optimal expression conditions for His-PNK, six small scale cultures 
with three different growth temperatures (15°C, 20°C and 25°C) and two incubation 
times (90min and 180min) were set up. 1ml pre-induction and post-induction samples 
were taken, normalised for cell density of the culture and aliquots were analysed by 
10% SDS-PAGE.  His-PNK migrates at approximately 57kDa by SDS PAGE (red 
arrow).  Total levels of recombinant His-PNK increased as the growth temperature and 
incubation time increased 
 
B  The cultures described above were harvested and sonicated and the soluble and 
insoluble fractions were separated by centrifugation.  10μl aliquots of the soluble and 
insoluble fractions were compared by 10% SDS-PAGE.  The ratio of soluble His-PNK 
to insoluble His-PNK decreased as incubation time and growth temperature increased.  
Optimal conditions for the production of high levels of soluble His-PNK were 
considered to be incubation at 20°C for 90min.   
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Figure 4.4  –  Overexpression and purification of recombinant His-tagged PNK in 
E.coli 
 
A  His-PNK protein expression was induced in a 500ml bacterial culture by addition of 
1mM IPTG and incubation at 20°C for 90min.  1ml pre-induction and post-induction 
samples were taken and normalised for the cell density.  The bacterial cells were 
harvested, resuspended in 20ml buffer and lysed by sonication.  The soluble fraction 
was separated from the insoluble material by centrifugation, and the insoluble material 
was resuspended in 20ml buffer.  The clarified extract was loaded onto a 0.5ml Ni-NTA 
IMAC column, washed three times with 10 column volumes of buffer containing 10mM, 
20mM and 40mM imidazole respectively and eluted in buffer containing 250mM 
imidazole.  10μl aliquots of each of the different fractions were analysed by 10% SDS 
PAGE and staining with coomassie blue.  His-PNK runs at approximately 57kDa (red 
arrow).  His-PNK co-eluted with a significant amount of contaminating proteins 
necessitating a second purification step;  delete this sentence.   
 
B  Elution fractions 2 and 3 from Ni-NTA IMAC were pooled and loaded onto a cation 
exchange column at pH7.5.  His-PNK was eluted from the column with a salt gradient 
from 0.1M to 1M NaCl.  10μl aliquots of the column load, flow through samples and 
selected elution fractions were analysed by 10% SDS-PAGE.  Elution fraction 17 was 
chosen for use in experiments.   
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Figure 4.5  -  A 5’-AMP terminus  does not block PNK mediated 3’ end 
processing 
 
A titration of His-PNK (250nM, 100nM, 50nM and 25nM) was incubated with an 
adenylated or mock-adenylated SSB substrate (25nM) containing a 1 nucleotide gap, a 
3’-P terminus, and a 5’-AMP terminus for 1 hr at 30°C. The products were fractionated 
by 15% denaturing PAGE and detected by phosphoimaging.  The substrate was 32P-
radiolabelled on the 5’ termini of the 17mer oligonucleotide to directly visualise 
processing of the 3’ termini.  Cartoons of the substrates are shown above.  
 
Repair of the 3’-phosphate terminus is indicated by reduced mobility of the 
radiolabelled 17mer. 32P-17mer-P and 32P-17mer-OH oligonucleotides were included 
as markers. Note that this experiment was performed three independent times with a 
representative experiment presented here. 
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Figure 4.6  -  Overexpression and purification of recombinant human Polβ from 
E.coli by cation exchange chromatography 
  
A  Expression of recombinant human Polb was induced by incubation at 42C for 4 
hours.  1ml pre-induction and post-induction samples were taken and aliquots were 
analysed by 10% SDS PAGE. 
 
B  After induction of Polβ, the cells from 500ml of culture were harvested, resuspended 
in 20ml buffer and lysed by sonication.  The soluble material was separated from the 
insoluble fraction by centrifugation.  Clarified extract was then loaded onto a 
consequtive anion and cation exchange columns in series.  Following extensive 
washing the anion exchange column was removed and Polb was eluted from the 
cation exchange column with a salt gradient of 0.1M to 1M NaCl. 10μl aliquots of the 
column load, flow through and selected elution fractions from 6 to 31 were analysed by 
10% SDS PAGE.  Polβ eluted in a sharp peak between elution fractions 13 and 15.  
Elution fraction 14 was chosen for use in experiments.   
 
C  500ng of the final dialysed preparation of Polβ was analysed by 10% SDS-PAGE.   
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Figure 4.7  - A 5’-AMP terminus does not block Polβ mediated 3’ gap-filling 
 
A titration of Polβ (5nM, 15nM, 30nM, or 100nM) was incubated with an adenylated or 
mock-adenylated SSB substrate (25nM) containing a 1 nucleotide gap, a 3’-OH 
terminus  and a 5’-AMP terminus  for 1hr at 30°C.  The products were fractionated by 
15% denaturing PAGE and detected by phosphoimaging.  The substrate was 32P-
radiolabelled on the 5’ termini of the 17mer oligonucleotide to directly measure gap-
filling.  Cartoons of the substrates are shown above.   
 
Incorporation of a single nucleotide into the SSB resulted in an increase conversion of 
the 32P-17mer-OH to an 32P-18mer-OH. 32P-17mer-P and 32P-17mer-OH 
oligonucleotides  were included as markers. Note that this experiment was performed 
four independent times with a representative experiment presented here. 
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Figure 4.8  -  AOA1 whole cell extracts are unable to repair an adenylated nick 
 
6.25μg of whole cell extracts prepared from WT and AOA1 LCLs was incubated at 
30°C for the indicated times with 25nM of an adenylated nick.  The substrate was 32P 
radiolabelled on the 5’ termini of the 25mer oligonucleotide.  A cartoon of the substrate 
is displayed above.  The reaction products were fractionated by 15% denaturing PAGE 
and detected by phosphorimaging.  The AMP-32P-25mer and 32P-25mer were included 
as markers (lanes 1 and 2).  Repair of the pre-adenylated is visualised by the 
appearance of a ligation product.  Cell-extracts from lymphoblastoid cell lines have 
high levels of non-specific nuclease activity (asterisk) which was suppressed by the 
addition of 1000x fold molar excess of a competitor oligonucleotide of unrelated 
sequence.   
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Figure 5.1  –  Reaction mechanism of mammalian ligases 
 
DNA ligases are nucleotidyltransferases (NTases) that utilise a high energy cofactor to 
catalyse phosphodiseter bond formation in a universal three-step reaction mechanism. 
 
Step 1:   In the first step of DNA ligation reacts with ATP to form a ligase-adenylate 
intermediate in which AMP is covalently linked to the active-site lysine. This reaction is 
very energetically favourable and the ligase-adenylate intermediate is stable in the 
absence of a DNA substrate.  Therefore this reaction can be seen as essentially 
irreversible, meaning that the majority of ligase in the cell is likely to be in the 
adenylated form.  
 
Step 2:  The second step of ligation is the activation of the 5’P by adenylation of the 
DNA. During this step the oxygen of the 5’P attacks the phosphorus of the AMP, 
dispelling the lysine and transferring the adenylate group onto the 5’P, forming an 
AMP-DNA intermediate.   
 
Step 3: The final step of ligation is the reformation of the phosphodiester backbone. 
During this step the non-adenylated ligase catalyses the nucleophilic attack of the 
5’AMP by the 3’OH, displacing the AMP and joining the two polynucleotides by 
formation of a phosphodiester bond  
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Figure 5.2  –  Model for the failure of APTX-independent repair of an adenylated 
nick due to limiting levels of non-adenylated DNA ligase 
 
DNA ligases exist within two forms in the cell.  The first form is a non-adenylated 
ligase.  This non-adenylated ligase can repair an pre-adenylated nick in vitro (A).  The 
second form is an adenylated ligase which can repair a conventional nick in vitro, 
during which the ligase will become de-adenylated (B).   
 
The predominant form of ligase in the cell is likely to be the adenylated ligase and it is 
therefore possible that there are insufficient levels of non-adenlyated available to ligate 
a pre-adenylated nick in the absence of APTX (B).   
Figure 5.3  –  Short-patch repair of an adenylated 1nt gap is rescued in AOA1 
independently of APTX by addition of recombinant DNA ligase in the absence of 
ATP 
 
An abortive ligation intermediate (25nM) consisting of a 1 nucleotide gap, a 3’-P 
terminus, and a 5’-AMP terminus, was incubated for 1hr at 30°with 5µg of WT or 
AOA1 whole cell extract in the presence or absence of 1mM ATP and/or absence T4 
DNA ligase. The substrate was 32P-radiolabelled on the 25mer oligonucleotide.  A 
cartoon of the substrate is displayed above.  The reaction products were fractionated 
by 15% denaturing PAGE and detected by phosphorimaging.  AMP-32P-25mer and 
32P-25mer were included as markers (Lanes 1 and 2). Cell-extracts from 
lymphoblastoid cell lines have high levels of non-specific nuclease activity (asterisk) 
which was suppressed by the addition of 1000x fold excess of a competitor 
oligonucleotide of unrelated sequence. Note that this experiment was performed eight 
independent times with a single representative experiment presented here. 
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Figure 5.4  –  Short-patch SSBR of an abortive ligation intermediate in whole cell 
extracts in vitro is ‘poisoned’ by the addition of dideoxythymidine triphosphate 
 
An adenylated 1nt gap (25nM) consisting of a 1 nucleotide gap, a 3’-P and a 5’-AMP 
was incubated at 30°C for 1 hour with 5µg of WT and AOA1 whole cell extract in the 
presence or absence of 1mM ATP, 1U of T4 DNA ligase and 100μM dNTPs containing 
either dTTP or ddTTP.  The substrate was 32P radiolabelled on the 5’ terminus of the 
25mer oligonucleotide (32P-25mer).  A cartoon of the substrate is displayed above.  
The reaction products were fractionated by 15% denaturing PAGE and detected by 
phosphorimaging.   
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Figure 5.5  –  Short-patch SSBR of an adenylated 1nt gap by whole cell extracts 
prepared from quiescent Aptx-/- mouse neural astrocytes is rescued by addition 
of recombinant T4 DNA ligase in the absence of ATP 
 
An abortive ligation intermediate (25nM) consisting of a 1 nucleotide gap, a 3’P and a 
5’AMP was incubated with 5µg of whole cell extracts from WT and Aptx-/- quiescent 
mouse astrocytes in the presence orabsence of 1mM ATP and/or 1U of T4 DNA ligase 
at 30°C for 1 hour. The substrate was 32P radiolabelled on the 5’ of the 25mer 
oligonucleotide.  A cartoon of the substrate is displayed above.  The reaction products 
were fractionated by 15% denaturing PAGE and detected by phosphorimaging.  AMP-
32P-25mer and 32P-25mer were included as markers (Lanes 1 and 2).   
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Figure 5.6  –  Overexpression and purification of recombinant human His-tagged 
LigIIIα 
 
A  His-LigIIIα protein expression was induced in a 500ml bacterial culture by addition 
of 1ml IPTG and incubation at 20°C for 90min.  1ml pre-induction and post-induction 
samples were taken and normalised for the cell density.  The bacterial cells were 
harvested, resuspended in 20ml buffer and lysed by sonication.  The soluble fraction 
was separated from the insoluble material by centrifugation, and the insoluble material 
was resuspended in 20ml buffer.  The clarified extract was loaded onto a 0.5ml Ni-NTA 
IMAC column, washed three times with buffer containing 10mM, 20mM and 40mM 
imidazole respectively and eluted in buffer containing 250mM imidazole.  10μl aliquots 
of each of the different purification stages were analysed by 10% SDS PAGE.   
 
B  Elution fractions 2 and 3 from Ni-NTA IMAC were pooled and the LigIIIα in these 
fractions further purified by cation exchange chromatography at pH7.  His-LigIIIα was 
eluted from the column with a salt gradient from 0.1M to 1M NaCl.  10μl aliquots of the 
column load, flow through samples, and indicated elution fractions were analysed by 
10% SDS-PAGE and staining with coomassie blue.   
 
C  Elution fraction 18 was dialysed into storage buffer and 500ng of LigIIIα was 
analysed by 10% SDS-PAGE.   
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Figure 5.7  –  Complementation of the short-patch SSBR defect in AOA1 whole 
cell extracts with recombinant human LigIIIα in the absence of ATP 
 
An adenylated 1nt gap (100nM) harbouring 3’-P and  5’-AMP termini (top cartoon) was 
incubated 5µg of WT or AOA1 whole cell extract and  8nM, 24nM, or 72nM of His-
LigIIIα in the presence or absence of 1mM ATP at 30°C for 1 hour, as indicated.  His-
LigIIIα was also incubated with the substrate in the absence of whole cell extract as a 
control (lanes 9-11 and 18-20).  The substrate was 32P radiolabelled on the 5’ of the 
25mer oligonucleotide (32P-25mer).  A cartoon of the substrate is displayed (top).  The 
reaction products were fractionated by 15% denaturing PAGE and detected by 
phosphorimaging. Note that this experiment was performed two independent times 
with a single representative experiment presented here. 
 
Lanes              1     2     3     4     5     6    7    8     9   10   11  12   13   14   15   16   17   18   19   20 
17 25 
AMP 
43 
32P P 
25 
AMP 
32P 
25 
32P 
+     +     +     + 
+     +     +     + 
+     +     +     + 
+      -     +      - 
PNK 
LigIIIα 
Polβ 
APTX 
+
A
T
P
 
-A
T
P
 
Figure 5.8  –  Reconstitution of APTX-independent SSBR by purified 
recombinant human proteins  
 
An adenylated 1nt gap (60nM) harbouring 3’-P and  5’-AMP termini was incubated at 
30°C for 1 hour  with 250nM His-PNK, 100nM Polβ and 80nM LigIIIα in the presence 
or absence of 100nM His-APTX and 1mM ATP.  The substrate was 32P radiolabelled 
on the 5’ of the 25mer oligonucleotide (32P-25mer).  A cartoon of the substrate is 
displayed (top).  The reaction products were fractionated by 15% denaturing PAGE 
and detected by phosphorimaging. Note that this experiment was performed two 
independent times with a single representative experiment presented here. 
 
APTX-
dependent 
SSBR 
APTX- 
independent 
SSBR 
Ligation product 
Lanes              1        2       3        4 
17 25 
AMP 
43 
32P P 
25 
AMP 
32P 
25 
32P 
A B 
CΔ5 
1    2    3    4    5    6  
WT  
1    2    3    4    5    6  
C 
Figure 5.9  –  Overexpression and purification of recombinant His-tagged 
Chlorella Virus DNA Ligases by Ni-NTA IMAC 
 
Expression  of wild type  CV DNA ligase (A) and mutant CΔ5 CV DNA ligase (B) was 
induced in a 500ml bacterial culture by addition of IPTG and incubation at 20°C for 
90min.  1ml pre-induction and post-induction samples were taken and normalised for 
the cell density.  The bacterial cells were harvested, resuspended in 20ml buffer and 
lysed by sonication.  The soluble fraction was separated from the insoluble material by 
centrifugation, and the insoluble material was resuspended in 20ml buffer.  The 
clarified extracts were loaded onto two Ni-NTA IMAC columns, washed three times 
with buffer containing 10mM, 20mM and 40mM imidazole respectively and eluted in 
buffer containing 250mM imidazole.  10μl aliquots of different purification stages were 
analysed by 10% SDS PAGE.  WT CV DNA ligase migrates during SDS-PAGE at 
approximately 28kDa while CΔ5 CV DNA ligase migrates slightly faster (red arrow).   
 
C  Elution fraction 2 from each purification was dialysed and 500ng of protein analysed 
by 10% SDS-PAGE and coomassie blue staining.   
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Figure 5.10  –  Short-patch SSBR of an abortive ligation intermediate can be 
restored in AOA1 extracts independently of ATP by addition of a non-
adenylatable DNA ligase mutant 
 
A  100ng (280nM) of WT chlorella virus DNA ligase or CΔ5 chlorella virus DNA ligase 
was incubated with α32P ATP and 10nM cold ATP at 30°C for 5min.  Reactions were 
stopped by addition of formamide loading buffer, fractionationated by 10% SDS PAGE 
and detected by phosphorimaging.  There was a very strong 32P signal in the lane 
containing reaction products from the WT CV ligase adenylation reaction which ran at 
the expected size for WT CV ligase 
 
B  An adenylated 1nt gapped substrate (25nM) harbouring a 3’-P terminus was 
incubated at 30°C for 1 hour with 5µg of WT or AOA1 whole cell extract in the 
presence or absence of 1mM ATP and either 500nM WT chlorella virus DNA ligase or 
CΔ5 chlorella virus DNA ligase .  The substrate was 32P radiolabelled on the 5’ of the 
25mer oligonucleotide.  A cartoon of the substrate is displayed above.  The reaction 
products were fractionated by 15% denaturing PAGE and detected by 
phosphorimaging. Note that this experiment was performed two independent times 
with a single representative experiment presented here. 
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Figure 5.11  –  Reconstitution of APTX-independent SSBR using recombinant 
SSBR proteins and chlorella virus DNA ligases 
 
An adenylated 1nt gapped substrate (25nM) harbouring a 3’-OH terminus was 
incubated at 30°C for 1 hour  with 100nM Polβ and either 500nM WT CV DNA ligase, 
500nM CΔ5 CV DNA ligase or 1U T4 DNA ligase in the presence or absence of 
100nM His-APTX and 1mM ATP.  The substrate was 32P radiolabelled on the 5’ of the 
25mer oligonucleotide (32P-25mer).  A cartoon of the substrate is displayed (top).  The 
reaction products were fractionated by 15% denaturing PAGE and detected by 
phosphorimaging. Note that this experiment was performed two independent times 
with a single representative experiment presented here. 
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Figure 6.1  –  A SSBR defect is uncovered in quiescent mouse APTX-/- astrocytes 
treated with aphidicolin 
 
Astrocytes obtained from APTX-/- and WT littermate mice were cultured and made 
quiescent by contact inhibition and subsequent serum starvation.  After a week in 
serum starvation media, the cells were harvested and pre-treated with 50μM APH or 
DMSO in suspension at 37°C for 30min.  The cells were then washed with DPBS to 
remove any trace of media, and then incubated with 75μM H2O2 for 10min on ice.  
After damage induction, the cells were washed with ice cold DPBS three times and 
then allowed to repair at 37°C in media containing either APH or DMSO.  Samples 
were taken at the indicated time points and comet tail moments were determined for 
100 cells per sample using the Comet Assay IV software.  The data from three 
independent experiments was averaged (+/- SEM).  Asterisks indicate statistically 
significant differences as determined using SPSS software (*, P ≤ 0.05; ** P ≤ 0.01).  
These experiments were carried out by Sherif El-Khamisy and are presented here with 
kind permission. 
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Figure 6.2  –  A BER defect is uncovered in quiescent mouse APTX-/- astrocytes 
treated with aphidicolin 
 
Astrocytes obtained from APTX-/- and WT littermate mice were cultured and made 
quiescent by contact inhibition and subsequent serum starvation.  After a week in 
serum starvation media, the cells were harvested and pre-treated with 50μM APH or 
DMSO in suspension at 37°C for 30 min.  The cells then incubated with 25, 50 or 
100μM MMS for 10 min at 37°C in drug containing media.  Samples were taken and 
comet tail moments were determined for 100 cells per sample using the Comet Assay 
IV software.  The data from three independent experiments was averaged (+/- SEM). 
Asterisks indicate statistically significant differences as determined using SPSS 
software (*, P ≤ 0.05). These experiments were carried out by Sherif El-Khamisy and 
are presented here with kind permission. 
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Figure 6.3  –  Dose response of FD105 hTERT human fibroblasts to γ-irradiation 
 
A  An hTERT immortalised fibroblast cell line derived from an AOA1 individual  that 
had been corrected by stable expression of human APTX (FD105 M21 hTERT) using 
a retroviral expression system and a control cell line consisting of the same parental 
AOA1 hTERT fibroblast cell line containing the empty expression vector (FD105 M20 
hTERT) were cultured in parallel and immunoblotted for APTX protein.  These cell 
lines were compared to a WT hTERT fibroblast cell line containing the empty 
expression vector (1BR M20 hTERT).  These cell lines were originally created by 
Limei Ju.    
 
B  FD105 M20 hTERT (AOA1) (light green bars) and FD105 M21 hTERT (corrected) 
(dark green bars) cell lines were cultured, harvested and treated with increasing doses 
of γ-irradiation 
in suspension. Comet tail moments were determined for 100 cells per sample using 
the Comet Assay IV software.  The data from 3 independent experiments was 
averaged (+/- SEM).   
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Figure 6.4  –  Levels of DNA synthesis in cycling and quiescent hTERT 
fibroblasts treated with APH or DMSO 
 
Levels of DNA synthesis in cycling and quiescent hTERT fibroblasts treated with APH 
or DMSO were determined using a [3H] thymidine uptake assay.  To normalise for total 
DNA content, all [3H] counts were normalised to [14C].   
A  Schematic detailing the incubation times for the DNA synthesis assay.  1x105 cells 
of AOA1 (FD105 M20) and WT (corrected)  (FD105 M21) were seeded into a 6 well 
dish.  Two wells per cell line were seeded.  The hTERTs were allowed to adhere for 
4hrs and were then incubated with 0.02μCi/ml [14C] thymidine for 48hrs before 
washing in 3x PBS and serum starving for 7 days.  56hrs before these quiescent cells 
were to be incubated with APH/DMSO, 0.5x105 cells of AOA1 and corrected were 
seeded into a second 6 well dish and allowed to adhere for 4hrs.  These cycling cells 
were then incubated with 0.02μCi/ml [14C] thymidine for 48hrs before washing in 3x 
PBS and incubating in [14C] thymidine free media for 4 hours.  Both the quiescent and 
cycling cell lines were pre-treated with either 50μM APH or DMSO for 1hr and then 
incubated with 20μCi/ml [3H] thymidine for 3hrs in the presence of drug.  The cells 
were harvested and the 3H and 14C counts were measured using a scintillation 
counter.   
 
B  Measurement of DNA synthesis is presented as [3H] count per minute (CPM) 
normalised for total DNA content using the [14C] CPM. The data from two independent 
experiments were averaged (+/- SEM). 
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Figure 6.5  –  Repair kinetics of γ-irradiation induced breaks in quiescent hTERT 
fibroblasts pre-treated with APH 
 
Human hTERT fibroblast cell lines from an AOA1 patient stably corrected with either 
human APTX ORF (FD105 M21 hTERT) or containing empty vector (FD105 M20 
hTERT) were made quiescent by contact inhibition and serum starvation for seven 
days, incubated with 50µM APH or DMSO in suspension for 1 hour at 37°C and 
irradiated on ice with γ-rays (30Gy).  The cells were allowed to repair in media 
containing APH or DMSO at 37°C for the indicated time periods.  Comet tail moments 
were determined for 100 cells per sample using the Comet Assay IV software.   
 
A  The data from 4 independent experiments was averaged (+/- SEM).  The difference 
in repair between FD105 M20 and FD105 M21 treated with DMSO at the 15min, 
30min and 60min repair time points was found not to be significant using the two-way 
anova test (p=0.062890865).  
B  Representative scatter graphs from selected time points from one experiment.   
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Figure 6.6  Total levels of SSBR proteins in cycling vs non-cycling AOA1 
fibroblasts as determined by western blotting 
 
FD105 M20 (AOA1) and FD105 M21 (corrected) hTERT fibroblast cell lines were 
cultured and were made quiescent by contact inhibition and serum starvation for a 
week.  Separate flasks of the cell lines were kept cycling in parrallel.  After a week the 
quiescent (Qu) and cycling fibroblasts (Cyc) were harvested and resuspended to a 
concentration of 2x104 cells/ml in SDS loading buffer and 4x105 cells were 
immunoblotted for various SSBR proteins.  Samples were separately run on a protein 
gel and stained with coomassie blue for use as a loading control.   
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Figure 6.7  –  Repair kinetics of γ-irradiation induced breaks in quiescent 
primary human AOA1 fibroblasts pre-treated with APH 
 
Human primary fibroblast cell lines from an AOA1 patient (FD105) and an unrelated 
WT individual (1BR) were made quiescent by contact inhibiting and serum starving for 
30 days.  The cell lines were then incubated with 50µM APH or DMSO in suspension 
for 1 hour at 37°C and irradiated on ice with 30Gy γ-rays.  The cells were allowed to 
repair in media containing APH or DMSO at 37°C for the indicated time periods.  
Comet tail moments were determined for 100 cells per sample using the Comet Assay 
IV software.  A  The data from 4 independent experiments was averaged (+/- SEM). 
Primary fibroblast cell lines with passage numbers of 4 – 8 were used in the 
experiments.  The passage numbers of the WT and AOA1 cell lines were matched in 
each experiment.  B  Representative scatter graphs from one experiment.   
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Figure 6.8  – Repair kinetics of γ-irradiation induced breaks in cycling hTERT 
fibroblasts pre-treated with APH 
 
Cycling human hTERT fibroblast cell lines from an AOA1 patient (FD105) stably 
corrected with either human APTX ORF (FD105 M21) or containing empty vector 
(FD105 M20) were incubated with 50µM APH or DMSO in suspension for 1 hour at 
37°C and irradiated on ice with 30Gy γ-rays.  The cells were allowed to repair in media 
containing APH or DMSO at 37°C for the indicated time periods.  Comet tail moments 
were determined for 100 cells per sample using the Comet Assay IV software.  A  The 
data from 4 independent experiments was averaged (+/- SEM).   
B  Representative scatter graphs from one experiment.   
Figure 6.9  – Repair kinetics of γ-irradiation induced breaks in cycling primary 
human AOA1 fibroblasts pre-treated with APH 
 
Cycling human primary fibroblast cell lines from an AOA1 patient (FD105) and an 
unrelated WT individual (1BR) were incubated with 50µM APH or DMSO in suspension 
for 1 hour at 37°C and irradiated on ice with 30Gy γ-rays.  The cells were allowed to 
repair in media containing APH or DMSO at 37°C for the indicated time periods.  
Comet tail moments were determined for 100 cells per sample using the Comet Assay 
IV software.  A  The data from 4 independent experiments was averaged (+/- SEM).  
Primary fibroblast cell lines with passage numbers of 5 – 9 were used in the 
experiments.  The passage numbers of the WT and AOA1 cell lines were matched in 
each experiment.  B  Representative scatter graphs from one experiment.   
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Figure 6.10  APH does not inhibit the gap-filling activity of Polβ in vitro 
 
A  Cartoon of the substrate used in the experiments.  The oligonucleotide duplex 
contains a 1 nucleotide gap with a 3’-OH and 5’-P.  The substrate is 32P radiolabelled 
on the 5’ terminus of the 17mer. 
 
B  A titration of recombinant human Polβ (25nM, 10nM, 5nM, 2.5nM, 1nM) was pre-
incubated with 50µM APH or DMSO for 15min at room temperature and then 
incubated with 25nM substrate at 30°C for 45min.  
 
Reactions were stopped by addition of formamide loading buffer and the products 
fractionated by 15% denaturing PAGE and detected by phosphorimaging. 
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Name Type Preferred substrate 
Uracil- N-glycosylase (UNG) Monofunctional Uracil 
 Single-strand-
elective monofunctional uracil DNA 
glycosylase (SMUG1) 
Monofunctional Uracil 
Methyl-CpG-binding domain protein 4 
(MBD4) 
Monofunctional U and T opposite G 
Thymine-DNA glycosylase (TDG) Monofunctional U and T opposite G 
N-methylpurine-DNA glycosylase (MPG) Monofunctional 3’-methyladenine,  3’-
methylguanine 
MutY homolog (MYH) Monofunctional A opposite 8-oxoG 
Endonuclease III homolog (NTH1) Bifunctional (β) Thymine glycol, 5’- formyluracil 
8-oxoguanine DNA glycosylase (OGG1) Bifunctional (β) 8-oxoG, formamidoguanine 
Endonuclease VIII-like 1 (NEIL1) Bifunctional (βδ) Formamidoadenine, thymine 
glycol, 5’-hydroxyuracil 
Endonuclease VIII-like 2 (NEIL2) Bifunctional (βδ) Spiriminohydantoin, 
guanidinohydantoin, 5’-
hydroxyuracil 
Table 1.1  –  Mammalian DNA glycosylases 
Names and substrates of mammalian DNA glycosylases (Adapted from (Robertson et al., 2009)) 
 
 
 
 
 
 
 
 
 
 
Types of damaged 
termini at a SSB 
Sources Processed by 
3’ – phosphate Sugar fragmentation following ROS damage;    cleavage of an 
AP site by a bifunctional DNA glycosylase (βδ elimination); 
repair of a Top1-SSB generated by ROS or topoisomerase 
poisons 
PNK 
3’ – phosphoglycolate  Sugar fragmentation following ROS damage APE1 
3’ – αβ unsaturated 
aldehyde 
Cleavage of an AP site by a bifunctional DNA glycosylase (β 
elimination). 
APE1 
3’ - Top1 peptide Abortive Top1 activity induced by ROS or topoisomerase 
inhibitors 
Tdp1 
5’ – hydroxyl Sugar fragmentation following damage by ROS; repair of a 
Top1-SSB generated by ROS or topoisomerase poisons 
PNK 
5’ – aldehyde Sugar fragmentation following ROS damage;     ? 
5’ – dRP Cleavage of an AP site by APE1 generated by ROS or alkylating 
damage 
Polβ 
5’ – AMP Premature ligation of an oxidative break. APTX 
Table 1.2  –  Types of damaged DNA termini at found at SSBs 
Chemistries of common damaged termini found at SSBs and the enzymes that repair them 
(Adapted from (Caldecott, 2008)).    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Disease or syndrome Gene Neurological Symptoms Extraneurological 
symptoms 
DNA SSB repair deficiency    
Ataxia oculomotor apraxia 
1 (AOA1) 
APTX Ataxia, neurodegeneration, 
oculomotor apraxia and 
peripheral neuropathy 
Hypercholesterolaemia 
and hypoalbuminaemia 
Spinocerebellar ataxia 
with axonal neuropathy 1 
(SCAN1) 
TDP1 Ataxia, neurodegeneration, 
peripheral axonal motor and 
sensory, and muscle weakness 
Hypercholesterolaemia 
and hypoalbuminaemia 
Microcephaly, early-
onset, intractable seizures 
and developmental delay 
(MCSZ) 
PNK Microcephaly, infantile-onset 
seizures, developmental delay 
and variable behavioral 
problems, especially 
hyperactivity 
Absent 
DNA damage response or 
DNA DSB repair 
deficiency 
   
Ataxia telangiectasia (AT) ATM Ataxia, neurodegeneration, 
telangiectasia and dysarthia 
Immunological defects, 
malignancy and sterility 
Ataxia telangiectasia – like 
disorder (ATLD) 
MRE11 Ataxia, neurodegeneration, 
dysarthia, oculomotor apraxia 
or microcephaly 
Mild immunological 
defects 
RAD50 deficiency RAD50 Microcephaly and mental 
retardation 
Short stature 
Nijmegen breakage 
syndrome (NBS) 
NBS1 Microcephaly Immunological defects 
and lymphoid 
malignancy, growth 
retardation 
ATR – Seckel syndrome ATR Microcephaly Severe growth defects 
LIG4 syndrome LIG4 Microcephaly Developmental/growth 
delay, severe combined 
immunodeficiency and 
lymphoma 
Human immunodeficiency 
with microcephaly 
Cernunnos/X
LF 
Microcephaly Immunodeficiency 
Radiosensitivity, 
immunodeficiency, 
dysmorphic features and 
learning difficulties 
(RIDDLE) 
RNF168 Learning difficulties and slightly 
ataxic gait 
Radiosensitivity, 
immunodeficiency and 
cancer predisposition 
Bloom syndrome BLM Absent Proportional dwarfism 
and cancer 
Werner syndrome WRN Absent Severe progeria and 
cancer 
Fanconi anaemia BRCA2 Microcephaly and 
medulloblastoma 
Bone marrow defects, 
hypoplastic thumbs with 
radial defects  
Ataxia oculomotor apraxia 
2 (AOA2) 
SETX Cerebellar atrophy, axonal 
sensorimotor neuropathy, 
oculomotor apraxia 
Elevated serum alpha-
fetoprotein 
Severe combined 
immunodeficiency and 
increased cellular 
radiosensitivity (RS-SCID) 
ARTEMIS Absent Severe combined 
immunodeficiency and 
lymphoma 
Nucleotide excision 
repair deficiency 
   
Xeroderma pigmentosum 
(XP) 
XPA–XPG Neurodegeneration and 
microcephaly 
UV sensitivity and skin 
cancer 
Cockayne syndrome (CS) CSA, CSB, 
XPB, XPD 
and XP 
Microcephaly and 
dysmyelination 
Progeria and otherwise 
variable presentation 
Trichothiodystroph (TTD) XPD, XPB 
and TTD- 
Neurodevelopmental defects 
and dysmyelination 
Brittle hair and 
otherwise variable 
presentation 
Table 1.3  –  Human syndromes associated with defects in the DNA damage response 
and repair pathways 
A list of human diseases associated with mutations in proteins involved in DNA SSB and DSB 
repair  (Adapted from (McKinnon, 2009)) 
 
 
 
 
 
 
 
 
 
 
 
 
Plasmid DNA construct Source/Reference 
pB352-hAPTX Caldecott Laboratory (Clements et al., 2004) 
pET16b-hPNK Caldecott Laboratory (Whitehouse et al., 2001) 
pLW11-hPolβ Wilson Laboratory (Sobol et al., 1996) 
pET16b-hLigIIIα Caldecott Laboratory (Taylor et al., 1998) 
pET16b- PBCV-1 ligase Shuman Laboratory (Sriskanda and Shuman, 1998) 
pET16b- PBCV-1 CΔ5 Shuman Laboratory (Sriskanda and Shuman, 1998) 
Table 2.1  –  Bacterial expression plasmid DNA constructs 
Plasmid DNA constructs used in this thesis for the overexpression of recombinant proteins in 
E.coli and their sources 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antibody Type Source Conditions for 
immunoblotting 
Anti-APTX Rabbit polyclonal Malcolm Taylor 
(Collaborator) 
1:1000 5% milk            
1 hour at RT  
Anti-PNK Rabbit polyclonal Caldecott Laboratory 1:1000 1% milk           
ON at 4°C 
Anti-XRCC1 Rabbit polyclonal Caldecott Laboratory 1:100 5% milk           
ON at 4°C 
Anti-Polβ Mouse monoclonal Abcam 1:100 1xTBST                
1 hour at RT 
Anti-LigIIIα Rabbit polyclonal Caldecott Laboratory 1:1500 3% milk                   
ON at 4°C 
Anti-PARP1 Mouse monoclonal Serotec 1:500 5% milk             
1 hour at RT 
Anti-FEN1 Mouse monoclonal Abcam 1:1000 5% milk           
1 hour at RT 
Anti-APE1 Mouse monoclonal Abcam 1:2000 5% milk           
1 hour at RT     
Anti-PCNA Mouse monclonal CRUK 1:500 1% milk              
1 hour at RT        
Anti-β-Tubulin Rabbit polyclonal Bethyl Antibodies 1:3000 1xTBST            
1 hour at RT             
Anti-Actin Mouse monoclonal Sigma 1:2000 5% milk                       
1 hour at RT        
Table 2.2  –  Primary antibodies 
Source, type and conditions for primary antibodies used for immunoblotting.   
 
 
 
 
 
 
Antibody Source Conditions for 
immunoblotting 
Anti-Rabbit HRP conjugated  DAKO 1:5000 1xTBST                           
1 hour at RT 
Anti-Mouse HRP conjugated DAKO 1:5000 1xTBST                           
1 hour at RT 
Table 2.3  –  Secondary antibodies 
Source and conditions for secondary antibodies used for immunoblotting.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recombinant protein Expression vector Incubation time Incubation 
temperature 
APTX pB352-hAPTX 3 hours 30°C 
PNK pET16b-hPNK 90 min 20°C 
LigIIIα pET16b-hLigIIIα 90 min 20°C 
Chlorella Virus DNA 
ligase  
pET16b- PBCV- Ligase/ 
pET16b- PBCV- CΔ5 
3 hours 30°C 
Polβ pLW11-hPolβ 4 hours 42°C 
Table 2.4  –  Incubation conditions for the overexpression of different recombinant 
proteins in E.coli 
Details of the bacterial expression vectors and incubation conditions employed in this thesis 
for the overexpression of recombinant proteins in E.coli. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recombinant protein  Isoelectric point (pI) of 
protein 
pH of cation exchange 
chromatography buffers 
APTX 9.27 8 
PNK 8.73 7.5 
LigIIIα 9.03 7.0 
Polβ 9.01 7.5 
Table 2.5  –  pH of the buffers used during the purification of recombinant proteins by 
cation exchange chromatography 
Details of the pH of the buffers employed in the cation exchange purification steps.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oligonucleotide Sequence 
25-mer 5’- GACATACTAACTTGAGCGAAACGGT – 3’ 
17-mer 5’- TCCGTTGAAGCCTGCTT – 3’ 
18-mer 5’- TCCGTTGAAGCCTGCTTT – 3’ 
43-mer 5’- CCGTTTCGCTCAAGTTAGTATGTCAAAGCAGGCTTCAACGGAT – 3’ 
Competitor 
oligonucleotide 
5’- P-TCTGCTAGCATCGATCCATG – 3’ 
Table 2.6  –  Sequences of the oligonucleotides used to prepare model SSB substrates 
Sequences of the oligonucleotides used to prepare model SSB substrates in vitro.  All 
oligonucleotides were ordered from Eurofins MWG Operon.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell lines Cell type Disease Genotype Source 
MT1 LCL WT WT Malcolm Taylor 
MT6 LCL AOA1 Homozygous for a genomic 
deletion of APTX 
Malcolm Taylor 
1BR Fibroblast WT WT Malcolm Taylor 
FD105 Fibroblast AOA1 Homozygous for W279X Malcolm Taylor 
1BR M20 
hTERT 
Fibroblast WT WT Created by Limei 
Ju 
FD105 M20 
hTERT 
Fibroblast AOA1 Homozygous for W279X Created by Limei 
Ju 
FD105 M21 
hTERT 
Fibroblast AOA1 
(corrected) 
Homozygous for W279X; 
corrected with stable 
integration of human APTX 
cDNA 
Created by Limei 
Ju 
Table 2.7  –  Details of the mammalian cell lines used in this study 
Details of the names, genotypes and sources of the mammalian cell lines employed in this 
thesis.   
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Ataxia oculomotor apraxia 1 (AOA1) results from mutations in aprataxin, a component of DNA strand break
repair that removes AMP from 5 termini. Despite this, global rates of chromosomal strand break repair are
normal in a variety of AOA1 and other aprataxin-defective cells. Here we show that short-patch single-strand
break repair (SSBR) in AOA1 cell extracts bypasses the point of aprataxin action at oxidative breaks and stalls
at the final step of DNA ligation, resulting in the accumulation of adenylated DNA nicks. Strikingly, this defect
results from insufficient levels of nonadenylated DNA ligase, and short-patch SSBR can be restored in AOA1
extracts, independently of aprataxin, by the addition of recombinant DNA ligase. Since adenylated nicks are
substrates for long-patch SSBR, we reasoned that this pathway might in part explain the apparent absence of
a chromosomal SSBR defect in aprataxin-defective cells. Indeed, whereas chemical inhibition of long-patch
repair did not affect SSBR rates in wild-type mouse neural astrocytes, it uncovered a significant defect in
Aptx/ neural astrocytes. These data demonstrate that aprataxin participates in chromosomal SSBR in vivo
and suggest that short-patch SSBR arrests in AOA1 because of insufficient nonadenylated DNA ligase.
Oxidative stress is an etiological factor in many neurological
diseases, including Alzheimer’s disease, Parkinson’s disease,
and Huntington’s disease. One type of macromolecule dam-
aged by reactive oxygen species is DNA, and oxidative damage
to DNA has been suggested to be a significant factor in these
and other neurological conditions (2). In particular, a number
of rare hereditary neurodegenerative disorders have provided
direct support for the notion that unrepaired DNA damage
causes neural dysfunction. Not least of these are the recessive
spinocerebellar ataxias, a number of which are associated with
mutations in DNA damage response proteins (17). The arche-
typal DNA damage-associated spinocerebellar ataxia is ataxia-
telangiectasia (A-T), in which mutations in ATM protein result
in defects in the detection and signaling of DNA double-strand
breaks (DSBs) (3). A-T-like disorder is a related disease that
exhibits neurological features similar to those of A-T, resulting
from mutation of Mre11, a component of the MRN complex
that operates in conjunction with ATM during DSB detection
and signaling (28).
Two additional spinocerebellar ataxias are spinocerebellar
ataxia with axonal neuropathy 1 (SCAN1) and ataxia oculo-
motor apraxia 1 (AOA1), in which the TDP1 and aprataxin
proteins are mutated, respectively (9, 19, 27). Both TDP1 and
aprataxin are components of the DNA strand break repair
machinery (recently reviewed in references 6 and 24). Whereas
SCAN1 is currently limited to nine individuals from a single
family, AOA1 is one of the commonest recessive spinocere-
bellar ataxias. Aprataxin is a member of the histidine triad
superfamily of nucleotide hydrolases/transferases and has been
reported to remove phosphate and phosphoglycolate moieties
from the 3 termini of DNA strand breaks (26). Aprataxin can
also remove AMP from a variety of ligands in vitro, including
adenosine polyphosphates, AMP-lysine, AMP-NH2 (adenine
monophosphoramidate), and adenylated DNA in which AMP
is covalently attached to the 5 terminus of a DNA single-
strand break (SSB) or DSB (1, 16, 23, 25). To date, aprataxin
activity is greatest on AMP-DNA, suggesting that this may be
the physiological substrate of this enzyme.
In vitro, DNA strand breaks with 5-AMP termini can arise
from premature DNA ligase activity. DNA ligases adenylate 5
termini at DNA breaks to enable nucleophilic attack of the
resulting pyrophosphate bonds by 3-hydroxyl termini, thereby
resealing the breaks. However, DNA adenylation by DNA
ligases can occur prematurely, before a 3-hydroxyl terminus is
available. Aprataxin reverses these premature DNA adenyla-
tion events, in vitro at least, effectively “resetting” the DNA
ligation reaction to the beginning (1). Whether or not 5-AMP
arises in DNA in vivo or is a physiological substrate of
aprataxin, however, is unknown. Moreover, attempts to mea-
sure DNA strand break repair rates in vivo are conflicting and
have failed to identify a consistent defect in DNA SSB repair
(SSBR) or DSB repair (DSBR) in AOA1 cells (14, 15, 20). It
is thus not clear whether or not defects in DNA strand break
repair can account for this neurodegenerative disease.
Here we have resolved the discrepancy between the require-
ments for aprataxin in vitro and in vivo by identifying the stage
at which SSBR reactions fail in vitro and by carefully analyzing
chromosomal SSBR rates in vivo. We show that short-patch
SSBR reactions are defective in AOA1 cell extracts at the final
step of DNA ligation, resulting in the accumulation of adeny-
* Corresponding author. Mailing address: Genome Damage and
Stability Centre, University of Sussex, Science Park Road, Falmer,
Brighton BN1 9RQ, United Kingdom. Phone: 44 (0) 1273 877519. Fax:
44 (0) 1273 678121. E-mail: k.w.caldecott@sussex.ac.uk.
† J.J.R. and S.F.E.-K. contributed equally to this work.
 Published ahead of print on 22 December 2008.
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lated DNA nicks, and that this defect can be rescued in AOA1
extracts independently of aprataxin by addition of recombinant
DNA ligase. We also find that treatment with aphidicolin, an
inhibitor of DNA polymerase  (Pol ) and Pol ε, unveils a
measurable defect in chromosomal SSBR in Aptx/ primary
neural astrocytes, suggesting that the adenylated nicks that
arise from the short-patch repair defect can be channeled into
long-patch repair in vivo. These data demonstrate that
aprataxin participates in chromosomal SSBR and suggest that
this process arrests in AOA1, at oxidative SSBs, due to insuf-
ficient levels of nonadenylated DNA ligase.
MATERIALS AND METHODS
Preparation of adenylated DNA substrates. Oligonucleotide duplexes contain-
ing an SSB with a 5-AMP terminus and either a 1-bp gap with a 3-phosphate
terminus or a nick with a 3-hydroxyl terminus were prepared as follows. A
25-mer (5-GACATACTAACTTGAGCGAAACGGT) was labeled by phosphor-
ylation with T4 PNK and [-32P]ATP and was annealed with a 43-mer (5-CCG
TTTCGCTCAAGTTAGTATGTCAAAGCAGGCTTCAACGGAT) and a 17-
mer with a 3-phosphate terminus (17-mer-P) (5-TCCGTTGAAGCCTGCT
T-P). The labeled 25-mer in this duplex was then either adenylated at the 5
terminus by incubation with 1 U T4 DNA ligase at 30°C for 1 h in ligation buffer
(50 mM Tris-HCl [pH 7.5], 10 mM MgCl2, 5 mM dithiothreitol [DTT], 25 g/l
bovine serum albumin, 1 mM ATP) or mock adenylated in the absence of T4
DNA ligase. The labeled adenylated 25-mer was then separated from the labeled
nonadenylated 25-mer (and from the 17-mer and 43-mer) on a 15% denaturing
polyacrylamide gel electrophoresis (PAGE) gel, excised, and eluted from the
crushed gel in elution buffer (0.5 M ammonium acetate, 10 mM magnesium
acetate, 1 mM EDTA [pH 8.0]) overnight at room temperature. The eluted DNA
was then ethanol precipitated. The labeled mock-adenylated 25-mer was purified
in parallel. The labeled adenylated 25-mer was then reannealed with the 43-mer
and either the 17-mer-P (containing a 3 phosphate) or an 18-mer (5-TCCGT
TGAAGCCTGCTTT) to produce oligonucleotide duplexes harboring an adeny-
lated SSB with either a 1-bp gap and a 3-phosphate terminus or a nick with a
3-hydroxyl terminus, respectively. To measure the repair of 3 termini by PNK
or gap filling by Pol , the 17-mer-P or a 17-mer oligonucleotide lacking a 3
phosphate, respectively, was labeled with T4 PNK (phosphatase dead) and
[-32P]ATP and was annealed to the 25-mer and 43-mer. The substrate was
either mock adenylated or adenylated as described above and was purified on a
15% native PAGE gel. The final substrate contained a 1-bp gap with a 5 AMP
and either a 3 P or a 3 OH.
Purification of recombinant human SSBR proteins. Pol  was expressed in
Escherichia coli and purified by anion and cation exchange as previously de-
scribed (29), using a 1.6-ml Poros column on a Biocad Sprint chromatography
system (Applied Biosystems, United Kingdom). His-tagged PNK and His-tagged
DNA ligase III (Lig3) were expressed in the E. coli strain BL21(DE3) for 90
min at 20°C following addition of 1 mM isopropyl--D-thiogalactopyranoside
(IPTG). PNK was purified by cation-exchange chromatography followed by im-
mobilized metal chelate affinity chromatography (IMAC) as previously described
(30). Lig3 was purified by IMAC as described previously (7), followed by cation
exchange as described previously for PNK. His-tagged aprataxin was expressed
from pB352 (8) in BL21(DE3) by addition of 1 mM IPTG and incubation at 30°C
for 3 h. Aprataxin was purified by IMAC followed by cation exchange as de-
scribed above for PNK and Lig3.
Preparation of human lymphoblastoid cell extracts. Total-cell extracts were
prepared from 5 	 106 ConR2 (wild type [WT]) or Ap5 (AOA1) lymphoblastoid
cells or from Aptx/ and Aptx/ primary quiescent mouse astrocytes by lysis in
0.2 ml 20 mM Tris-HCl (pH 7.5), 10 mM EDTA, 1 mM EGTA, 100 mM NaCl,
1% Triton X-100, and 1/100 dilution of protease inhibitor cocktail (Sigma). The
extracts were clarified by centrifugation, quantified with a Bio-Rad DC protein
assay kit using bovine serum albumin as a standard, and then aliquoted and
snap-frozen.
In vitro repair of adenylated SSB substrates by recombinant proteins. For
reactions employing recombinant human proteins, a 25 nM concentration of the
indicated 32P-labeled substrate was incubated with the indicated concentrations
of recombinant protein for 1 h at 30°C in 25 mM HEPES (pH. 8.0), 130 mM KCl,
1 mM DTT, 10 mM MgCl2, 100 M deoxynucleoside triphosphates (dNTPs),
and 1 mM ATP unless otherwise indicated. Reactions were stopped by addition
of 1/3 volume of formamide gel loading buffer, and reaction products were
fractionated on 15% denaturing PAGE gels and analyzed by a phosphorimager.
For reactions employing cell extracts, 5 g of extract from WT lymphoblastoid
cells (ConR2) or AOA1 lymphoblastoid cells (Ap5) or from Aptx/ and Aptx/
primary quiescent mouse astrocytes was incubated with a 100 nM concentration
of the indicated 32P-labeled substrate for 1 h at 30°C in 25 mM HEPES (pH 8.0),
130 mM KCl, 1 mM DTT, and, unless otherwise indicated, 10 mM MgCl2, 100
M dNTPs, and 1 mM ATP. A 1,000-fold excess of a competitor oligonucleotide
with an unrelated sequence and a 5 phosphate (5-P-TCTGCTAGCATCGAT
CCATG-3) was added to reduce degradation of the labeled substrate by non-
specific nucleases. Reactions were stopped and products analyzed as described
above.
Cell culture. (i) Human cells. 1BR3 cells are primary human fibroblasts, and
ConR and ConR2 cells are lymphoblastoid cells, all from unrelated normal
individuals. fAp1 and fAp4 cells are AOA1 primary fibroblasts, and Ap3 and Ap5
cells are AOA1 lymphoblasts. ConR, Con R2, fAp1, fAp4, Ap3, and Ap5 cells
were kindly provided by Malcolm Taylor and, except for Ap5 and ConR2, have
been described previously (8). Ap1, Ap3, and Ap4 cells harbor the homozygous
APTX mutation W279X, which results in little or no aprataxin protein or activity
(1, 8), and Ap5 cells harbor a genomic deletion of APTX (M. Taylor, unpublished
data). Cells were cultured as described previously (8).
(ii) Primary mouse astrocytes. Aptx/ mice have been described previously
(1). The generation and characterization of nestin-Cre conditional Xrcc1/
mice will be described elsewhere. All animals were housed in individually ven-
tilated cabinets and were maintained in accordance with the guidelines of the
institutional animal care and ethical committee at the University of Sussex.
Mouse astrocytes were prepared from postnatal day 3 (P3) to P4 brains. Cortices
were dissociated by passage through a 5-ml pipette, and cells were resuspended
in Dulbecco’s modified Eagle’s medium and Ham’s F-12 nutrient mixture (1:1;
Gibco-BRL) supplemented with 10% fetal bovine serum, 1	 Glutamax, 100
U/ml penicillin, 100 g/ml streptomycin, and 20 ng/ml epidermal growth factor
(Sigma). Primary astrocytes were established in Primeria T-25 tissue culture
flasks (Falcon) at 37°C in a humidified oxygen-regulated (9%) incubator. The
culture medium was changed after 3 days, and astrocyte monolayers reached
confluence 3 days later. The purity of the astrocyte cultures was confirmed by
immunofluorescence using an anti-GFAP antibody (Sigma).
Alkaline comet assays. Cells (
3 	 105/sample) were incubated with 75 M
(mouse astrocytes), 50 M (human lymphoblastoid cells), or 75 M (primary
human fibroblasts) H2O2 for 10 min on ice or with the indicated doses of methyl
methanesulfonate (MMS) for 10 min at 37°C. Where indicated, cells were then
incubated in complete medium for the indicated repair periods at 37°C. To
inhibit long-patch DNA polymerases, cells were incubated with 50 M aphidi-
colin (Sigma) in complete medium for 30 min at 37°C. Cells were then either
mock treated or treated with H2O2 or MMS as described above in the continued
presence or absence of aphidicolin, as appropriate. Chromosomal DNA strand
breaks were then measured using alkaline comet assays as previously described
(5). Statistical analyses were performed using SPSS software.
RESULTS
Aprataxin interacts with the SSBR scaffold protein XRCC1,
raising the possibility that a defect in chromosomal SSBR
underlies the neuropathology of this disease. However, evi-
dence for a defect in SSBR in aprataxin-defective AOA1 cells
is conflicting (14, 15, 20). To resolve this issue, we employed
alkaline comet assays to compare chromosomal SSBR rates in
a variety of different aprataxin-defective cell types. It should be
noted that while alkaline comet assays measure both SSBs and
DSBs, these assays primarily measure SSBs following short
periods of treatment with H2O2 or MMS, because these agents
induce several orders of magnitude more SSBs than DSBs (4,
18). In contrast to the findings of a previous report (15), we
failed to observe a significant difference in chromosomal SSBR
rates between either lymphoblastoid cells (Fig. 1A) or primary
fibroblasts (Fig. 1B) from AOA1 patients and those from nor-
mal individuals following H2O2-induced oxidative stress. Be-
cause individual genetic variability might mask differences in
SSBR rates, we also compared chromosomal SSBR in qui-
escent primary astrocytes from Aptx/ mice and isogenic
Aptx/ littermate controls. Astrocytes were chosen because
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they are neural in origin and thus better reflect the type of cells
affected in AOA1. However, SSBR rates were similar in
Aptx/ and Aptx/ astrocytes following treatment with H2O2
(Fig. 1C). Aptx/ and Aptx/ astrocytes also accumulated
SSBs at similar rates during incubation with the alkyating agent
MMS, suggesting that the rate of SSB rejoining during DNA
base excision repair is also normal in Aptx/ cells (Fig. 1D). In
contrast, astrocytes lacking the core SSBR factor Xrcc1 exhib-
ited greatly reduced SSBR rates following treatment with ei-
ther H2O2 or MMS (Fig. 1C and D). It should be noted that we
also observed normal SSBR kinetics in Aptx/ postmitotic
cerebellar granule neurons (data not shown). We conclude
from these experiments that AOA1 and other aprataxin-defec-
tive cells lack a measurable defect in the global rate of chro-
mosomal SSBR.
In contrast to the findings of cellular SSBR assays, protein
extracts from Aptx/ astrocytes and Aptx chicken DT40 cells
are unable to support short-patch repair of adenylated oxida-
tive SSBs in vitro (1). To resolve this discrepancy, we examined
whether this was also true in AOA1 lymphoblastoid cell ex-
tracts. To measure short-patch SSBR, we employed an oligo-
nucleotide duplex harboring a 1-bp gap with 3-phosphate ter-
mini, a substrate that mimics one of the commonest types of
oxidative SSB arising in cells (Fig. 2A, top). The SSB also
possesses a 5 AMP and is therefore a substrate for aprataxin.
In agreement with previous experiments with neural extracts
(1), WT extracts efficiently removed AMP from 5 termini and
repaired the SSBs, as indicated by the respective appearance of
the 32P-labeled 25-mer and the 32P-labeled 43-mer (Fig. 2A,
lanes 6 to 8). In contrast, AOA1 extracts did not (Fig. 2A, lanes
3 to 5). Importantly, SSBR was proficient in AOA1 extracts if
the initial SSB lacked 5 AMP (Fig. 2B). A number of trun-
FIG. 1. Normal rates of chromosomal SSBR in cells lacking aprataxin. (A) AOA1 lymphoblastoid cells were incubated in the absence () or
presence () of 50 M H2O2 (15 min on ice), followed by incubation in a drug-free medium for the indicated repair period at 37°C. Chromosomal
DNA strand breaks were then measured by alkaline comet assays. (B) AOA1 primary fibroblasts were treated in the absence () or presence ()
of 75 M H2O2 (15 min on ice) and processed as described for panel A. Insets in panels A and B contain the same data as in the main panels but
plotted as percent damage remaining. (C) WT, Aptx/, and Xrcc1/ primary quiescent astrocytes were incubated in the absence () or presence
() of 75 M H2O2 (10 min on ice), followed by incubation in a drug-free medium for the indicated repair period at 37°C. Chromosomal DNA
strand breaks were then measured by alkaline comet assays. (D) WT, Aptx/, and Xrcc1/ primary quiescent astrocytes were incubated in the
absence () or presence of the indicated concentration of MMS (10 min at 37°C). Chromosomal DNA strand breaks were then measured by
alkaline comet assays.
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cated oligonucleotide fragments were generated by nonspecific
nucleolytic activity in these experiments, which represented
degradation of the 3 terminus of the 32P-labeled 25-mer. How-
ever, this activity did not account for the short-patch repair
defect in AOA1 cell extracts, which was fully complemented by
the addition of recombinant aprataxin (Fig. 2A, lanes 9 to 11).
The appearance of ligated product in these experiments was
dependent on the presence of dNTPs, confirming that these
experiments measured gap repair rather than ligation across
the 1-bp gap (data not shown).
The predicted pathway for short-patch repair of SSBs har-
boring 5 AMP in WT cells is depicted in Fig. 3A. It was
considered likely that this pathway arrests in AOA1 extracts at
the very beginning, prior to 3-DNA end processing by PNK
and/or DNA gap filling by Pol , because the presence of AMP
at the 5 terminus might occlude access to the 3 terminus.
Surprisingly, however, the 3-phosphatase activity of PNK was
similar irrespective of whether the SSB possessed 5 AMP or
not, under conditions in which PNK was limiting (Fig. 3B).
Similar results were observed for DNA gap filling by Pol ,
with similar amounts of the 32P-labeled 17-mer converted into
a 32P-labeled 18-mer irrespective of the presence or absence of
5 AMP (Fig. 3C). These experiments suggested that neither
PNK nor Pol  activity is affected by the presence of 5 AMP
at these time points, and thus short-patch SSBR might fail in
AOA1 extracts at the final step of DNA ligation, resulting in
the accumulation of adenylated DNA nicks (Fig. 3D).
To confirm this hypothesis, we compared WT and AOA1
extracts for their abilities to ligate adenylated nicks. Indeed,
whereas adenylated nicks were efficiently ligated by extracts
from WT cells, they remained largely unligated in reaction
mixtures containing AOA1 cell extracts (Fig. 4A). The finding
that short-patch repair in AOA1 arrests during DNA ligation is
surprising, because adenylated nicks are normal intermediates
of DNA ligation and are normally rapidly resealed by nonade-
nylated DNA ligase (11). Normally, the nonadenylated DNA
ligase required for this purpose is created during, and tightly
coupled with, adenylation of the 5 terminus of the break by an
adenylated DNA ligase (Fig. 4B). However, in the absence of
aprataxin, DNA nicks may accumulate in a preadenylated state
and therefore require preexisting pools of nonadenylated
DNA ligase. While both nonadenylated and adenylated DNA
ligases exist in cells, the former may be very limited because
the readenylation of DNA ligases by cellular ATP is very rapid.
Consequently, we reasoned that the DNA ligation defect in
AOA1 may reflect insufficient cellular levels of nonadenylated
DNA ligase. To test this hypothesis, we examined the impact of
supplementing short-patch SSBR reaction mixtures in AOA1
cell extracts and Aptx/ mouse neural astrocyte extracts with
recombinant DNA ligase. Strikingly, addition of T4 ligase re-
stored short-patch SSBR efficiency in both AOA1 cell extracts
and Aptx/ neural cell extracts to a level similar to that ob-
served in WT extracts (Fig. 4C and D, compare lanes 6 and 10).
Importantly, complementation was more efficient in the ab-
sence of ATP than in its presence, supporting the notion that
it was the nonadenylated subfraction of T4 ligase that was
responsible for complementation (Fig. 4C and D, compare
lanes 8 and 10). Similar results were observed for AOA1 cell
extracts if T4 ligase was replaced with human DNA ligase 3,
albeit to a lesser extent (Fig. 5A).
The data described above suggest that short-patch repair of
some adenylated SSBs can occur independently of aprataxin if
sufficient nonadenylated DNA ligase is available. To confirm
this idea, we attempted to reconstitute this aprataxin-indepen-
dent SSBR pathway using recombinant proteins. As expected,
the repair of adenylated gaps by PNK, Pol , and Lig3 was
FIG. 2. Aprataxin-dependent short-patch SSBR of 5-AMP SSBs in AOA1 lymphoblastoid extracts. (A) Defective short-patch SSBR in AOA1
extracts and its complementation by recombinant aprataxin. (Top) Cartoon of the oligonucleotide duplex employed for these experiments,
containing a 1-bp gap, a 3-phosphate terminus, and a 5-AMP terminus. The 5 phosphate to which AMP is covalently linked is labeled with 32P.
The position of this label restricts the assay to measurements of short-patch repair events only. Nucleotide lengths are shown. (Bottom) Portions
(0.1 g, 1.0 g, or 5.0 g) of either WT (ConR2) or AOA1 (Ap5) cell extracts were incubated for 60 min at 30°C with a 32P-labeled 5-AMP SSB
substrate (25 nM) in the absence (left) or presence (right) of recombinant human aprataxin (APTX) (100 nM). Reaction products were
fractionated and detected as described in Materials and Methods. The 32P-labeled 25-mer containing (AMP-32P-25) or lacking (32P-25) 5 AMP
was fractionated in parallel for size markers (Mks). The position of the repaired 32P-labeled 43-mer is also indicated. Asterisks indicate nonspecific
nucleolytic products. (B) Normal short-patch repair of SSBs lacking 5 AMP in AOA1 cell extracts. (Top) Cartoon of the oligonucleotide duplex
employed for these experiments, containing a 1-bp gap, a 3-phosphate terminus, and a normal 32P-labeled 5-phosphate terminus. WT (ConR2)
or AOA1 (Ap5) cell extracts (5 g) were incubated for 60 min at 30°C with a 32P-labeled SSB substrate lacking 5 AMP (100 nM). Reaction
products were fractionated and detected as described in Materials and Methods.
VOL. 29, 2009 SHORT-PATCH SINGLE-STRAND BREAK REPAIR IN AOA1 CELLS 1357
 by on June 14, 2010 
m
cb.asm
.org
D
ow
nloaded from
 
dependent on aprataxin in the presence of ATP, conditions
under which Lig3 is largely adenylated (Fig. 5B). However, in
the absence of ATP, short-patch repair of 5-AMP SSBs oc-
curred independently of aprataxin. Taken together, these ex-
periments indicate that short-patch repair arrests in AOA1 cell
extracts at the final step of DNA ligation, due to insufficient
levels of nonadenylated DNA ligase.
Importantly, the finding that short-patch repair failed during
DNA ligation provides a possible explanation for the absence
of a measurable defect in chromosomal SSBR in AOA1, fol-
lowing oxidative stress. This is because adenylated DNA nicks
might be channeled into long-patch SSBR reactions, during
which the adenylated 5 terminus is displaced by extended
DNA gap filling and then clipped off nucleolytically, avoiding
the requirement for either aprataxin or preexisting pools of
nonadenylated DNA ligase. While our in vitro assay was not
capable of measuring long-patch repair reactions, this process
might operate efficiently at adenylated nicks within a chromo-
somal context. To examine this possibility, we compared chro-
mosomal SSBR rates in WT and Aptx/ quiescent mouse
neural astrocytes in the presence and absence of aphidicolin,
an inhibitor of the DNA polymerases Pol  and Pol ε, which
are implicated in long-patch repair reactions (10, 13, 22). Strik-
ingly, whereas aphidicolin did not measurably reduce SSBR
rates in WT astrocytes following H2O2 treatment, it signifi-
cantly slowed SSBR in Aptx/ astrocytes (Fig. 6A). Aphidi-
colin also selectively slowed short-patch base excision repair in
AOA1 cells, as indicated by the accumulation of higher steady-
state levels of chromosomal DNA strand breaks in Aptx/
astrocytes than in WT astrocytes during short incubations with
the DNA-alkylating agent MMS (Fig. 6B). The fact that SSBR
in Aptx/ cells was slowed rather than prevented by aphidi-
colin most likely reflects the fact that only a subset of H2O2-
and MMS-induced SSBs possess adenylated 5 termini. Nev-
ertheless, the presence of a measurable defect in chromosomal
SSBR in Aptx/ cells indicates that a significant fraction of
endogenous SSBs arising from oxidative stress and DNA base
damage are substrates for aprataxin.
In summary, we demonstrate here that aprataxin is required
for SSBR in vivo and suggest that short-patch SSBR is defec-
tive in AOA1 cells, at oxidative SSBs, due to insufficient levels
of nonadenylated DNA ligase.
DISCUSSION
AOA1 is one of the commonest recessive hereditary spino-
cerebellar ataxias identified to date. This disease results from
mutations in aprataxin, a component of the DNA strand break
FIG. 3. Removal of 5 AMP by aprataxin is not required for end processing by PNK or gap filling by Pol . (A) Cartoon of aprataxin-dependent
short-patch repair of adenylated SSBs in WT cells. (B) 5 AMP does not affect processing of 3-phosphate termini by PNK. An SSB substrate (25
nM) lacking or containing 5 AMP as indicated (top) was incubated either with 25 nM, 50 nM, 125 nM, or 250 nM recombinant human PNK or
without PNK () for 1 h at 30°C. Reaction products were fractionated by denaturing PAGE and detected by phosphorimaging. Note that the 5
terminus of the 17-mer is labeled with 32P in these experiments to allow detection of 3 end processing. The position of the 17-mer harboring 3
phosphate (17-P) or 3 hydroxyl (3-OH) is indicated. (C) 5 AMP does not affect gap filling by Pol . An SSB substrate (25 nM) lacking or
containing 5 AMP as indicated (top) was incubated either with 5 nM, 15 nM, 30 nM, or 100 nM purified recombinant human Pol  or without
Pol  () for 1 h at 30°C. Reaction products were fractionated by denaturing PAGE and detected by phosphorimaging. The positions of the 17-mer
and 18-mer are indicated as markers. (D) Cartoon depicting APTX-independent repair of adenylated SSBs in AOA1. Note the hypothetical
blockage of this process at the final step of DNA ligation.
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repair machinery that removes AMP from 5 termini during
short-patch SSBR reactions in vitro (1, 9, 19). However,
whether or not aprataxin is required for chromosomal DNA
strand break repair in vivo is unclear. This is because the
occurrence of DNA strand breaks with 5 AMP has not yet
been demonstrated. Moreover, attempts to detect a chromo-
somal DNA repair defect in AOA1 cells have proved conflict-
ing and unclear (14, 15, 20). To resolve the latter issue, we
carefully measured chromosomal SSBR rates in a variety of
aprataxin-defective cell lines, including genetically matched
FIG. 4. Short-patch SSBR fails in AOA1 due to insufficient levels of nonadenylated DNA ligase. (A) AOA1 cell extracts cannot efficiently ligate
adenylated DNA nicks. Total WT (ConR2) or AOA1 (Ap5) lymphoblastoid cell extracts (6.25 g) were incubated with a 32P-labeled adenylated
nicked substrate (25 nM) (top) for the indicated times at 30°C. Reaction products were fractionated by denaturing PAGE and detected by
phosphorimaging. A 32P-labeled 25-mer containing 5 AMP (AMP-25) and one lacking 5 AMP were fractionated for size markers (Mks). The
position of the 43-mer ligated product is indicated. (B) Cartoon depicting ligation of a nonadenylated DNA nick by DNA ligase. (i) An adenylated
DNA ligase molecule transfers AMP to the 5-phosphate terminus of a DNA nick, resulting in an adenylated nick and a nonadenylated ligase
molecule. (ii) The nonadenylated DNA ligase molecule rapidly catalyzes a nucleophilic attack of the pyrophosphate bond linking AMP to DNA,
resulting in nick ligation and the release of AMP. The nonadenylated DNA ligase molecule is readenylated (dashed arrow) in readiness for the
next ligation event. (C) Complementation of the SSBR defect in AOA1 lymphoblastoid extracts by recombinant T4 DNA ligase. Total WT
(ConR2) or AOA1 (Ap5) lymphoblastoid cell extracts (5 g) were incubated with a 32P-labeled 5-AMP SSB substrate (25 nM) for 1 h at 30°C
in the presence or absence of 1 mM ATP and/or 2 U of T4 DNA ligase, as indicated. Reaction products were fractionated by denaturing PAGE
and detected by phosphorimaging. The positions of the 32P-labeled 43-mer reaction product and the 32P-labeled 25-mer containing or lacking 5
AMP are indicated. M’rkers, markers. (D) Complementation of the SSBR defect in Aptx/ primary astrocyte extracts by recombinant T4 DNA
ligase. Aptx/ (/) or Aptx/ (/) mouse astrocyte extracts (5 g) were incubated with a 32P-labeled 5-AMP SSB substrate (25 nM) for 1 h
at 30°C in the presence or absence of 1 mM ATP and/or 2 U of T4 DNA ligase, as indicated. Reaction products were fractionated by denaturing
PAGE and detected by phosphorimaging. The positions of the 32P-labeled 43-mer reaction product and the 32P-labeled 25-mer containing or
lacking 5 AMP are indicated.
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WT and Aptx/ quiescent neural cells. These experiments
revealed that the overall rate of SSBR is normal in aprataxin-
defective cells. Notably, we also failed to detect reduced rates
of DSBR in AOA1 (unpublished observations).
To resolve the discrepancy between the requirement for
aprataxin for SSBR in vitro versus that in vivo, we identified
the stage at which short-patch SSBR fails in AOA1 in vitro.
Notably, 3-DNA end processing and DNA gap filling occurred
normally during SSBR in the absence of aprataxin, despite the
persistence of AMP on the 5 terminus. However, SSBR reac-
tions subsequently stalled at the final step of DNA ligation,
resulting in the accumulation of adenylated DNA nicks. This
was surprising, because adenylated DNA nicks are normal,
indeed prerequisite, intermediates of DNA ligation reactions,
requiring only nonadenylated DNA ligase to reseal the breaks.
We therefore reasoned that DNA ligation might fail in AOA1
cell extracts because of insufficient levels of nonadenylated
DNA ligase. This would be consistent with the notion that
while DNA ligases exist in both adenylated and nonadenylated
states, the former predominates in cells because of the cellular
ATP concentration. This would not pose a problem in WT
cells, in which aprataxin activity ensures that DNA nicks aris-
ing during SSBR are not preadenylated and thus are substrates
for adenylated DNA ligase. However, in AOA1 cells, DNA
nicks can arise in a preadenylated state during SSBR which
thus require nonadenylated DNA ligase. In short, we propose
that while all cells possess low levels of nonadenylated ligase,
due to the rapid adenylation of free ligase molecules by cellular
ATP, only in aprataxin-defective cells do preadenylated nicks
arise at a level that exceeds the availability of nonadenylated
ligase.
Confirmation that short-patch SSBR fails in AOA1 due to
insufficient levels of nonadenylated DNA ligase emerged from
our finding that addition of recombinant T4 DNA ligase or
human Lig3 restored short-patch SSBR in AOA1 extracts
and Aptx/ quiescent astrocyte extracts in the absence of
aprataxin. Importantly, complementation was more efficient if
ATP was omitted from the reaction mixtures, supporting the
notion that the complementing factor was nonadenylated
DNA ligase. This may also explain the apparent difference
between the abilities of T4 DNA ligase and Lig3 to comple-
ment the defect (compare Fig. 4C and 5A), since it is likely that
the relative amounts of nonadenylated ligase present in the
two DNA ligase preparations were different.
The finding that adenylated nicks accumulate during short-
patch SSBR in AOA1 provides a possible explanation for the
normal rate of chromosomal SSBR observed in this disease.
This is because adenylated nicks can be channeled into long-
FIG. 5. Complementation of the SSBR defect in AOA1 lymphoblastoid cell extracts by recombinant human Lig3 and reconstitution of
aprataxin-independent SSBR with recombinant human proteins. (A) Complementation of the SSBR defect in AOA1 lymphoblastoid cell extracts
by recombinant DNA ligase III (Lig3). Total WT or AOA1 lymphoblastoid cell extracts (5 g) were incubated with a 32P-labeled 5-AMP SSB
(100 nM) substrate for 1 h at 30°C in the presence or absence of 1 mM ATP and/or 8 nM, 24 nM, or 72 nM Lig3, as indicated. (B) Reconstitution
of aprataxin-independent SSBR with recombinant human proteins. A 5-AMP SSB substrate (60 nM) was incubated with 250 nM recombinant
PNK, 100 nM Pol , and 80 nM Lig3 in the presence or absence of 100 nM aprataxin (APTX) and 1 mM ATP, as indicated, for 1 h at 30°C.
Reaction products were fractionated by denaturing PAGE and detected by phosphorimager.
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patch SSBR. In this pathway, damaged 5 termini are displaced
as a single-stranded flap during gap filling from the 3 terminus
and cleaved off by Flap endonuclease 1 (FEN1) (reviewed in
reference 12). This process would not be detected by the short-
patch repair assays employed in the current work, because
oligonucleotide duplexes of the type employed here are not
good substrates for long-patch repair reactions and because
cleavage of the single-strand flap would remove the 32P label in
our substrates. However, to determine whether long-patch re-
pair might compensate for the loss of short-patch repair in
aprataxin-defective cells, we exploited the observation that
long-patch SSBR employs the aphidicolin-sensitive DNA poly-
merases Pol  and/or Pol ε (10, 13, 22). Because inhibition of
Pol  and/or Pol ε also prevents DNA replication during S
phase and can thus impact DNA metabolism independently of
long-patch SSBR, we employed quiescent primary astrocytes
for these experiments. Strikingly, whereas preincubation with
aphidicolin did not affect SSBR rates in WT cells, it revealed a
significant chromosomal SSBR defect in Aptx/ primary qui-
escent astrocytes following treatment with either H2O2 or
MMS. SSBR was slowed rather than prevented by aphidicolin,
perhaps reflecting the fact that only a subset of DNA strand
breaks induced by these agents possess 5-AMP termini.
Alternatively, it is possible that Aptx/ quiescent astrocytes
possess additional, partially overlapping SSBR pathways.
Nevertheless, these data demonstrate, for the first time, the
involvement of aprataxin in chromosomal SSBR in vivo.
It remains to be determined whether long-patch repair can
also compensate for defective short-patch repair in AOA1
cells, as appears to be the case in Aptx/ mouse neural cells.
However, if this is the case, why do aprataxin mutations result
in disease? One possibility is that a subset of SSBs arise at
which long-patch repair cannot operate. For example, it is
possible that aprataxin is also required to repair specific types
of damaged 3 termini (26). Long-patch repair would be un-
able to operate at such breaks, because no 3-hydroxyl primer
terminus is available for DNA gap filling. Alternatively, since
aprataxin is associated with the DSBR machinery (8), it is
possible that unrepaired DSBs might account for AOA1. It
should be noted, however, that we have so far failed to detect
a DSBR defect in AOA1 or Aptx/ cells (unpublished obser-
vations). Finally, it is possible that long-patch repair is not
operative or is attenuated in the specific cell types that are
affected in AOA1. For example, a number of replication-asso-
ciated proteins, including several of those implicated in long-
patch repair, are downregulated in certain differentiated cell
types (21). Thus, it will now be of interest to expand the
experiments described in this study to other cell types, includ-
ing those neural cell types most likely affected in AOA1.
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Abstract
AOA1 (ataxia oculomotor apraxia-1) results from mutations in aprataxin, a component of DNA strand break
repair that removes AMP from 5′-termini. In the present article, we provide an overview of this disease
and review recent experiments demonstrating that short-patch repair of oxidative single-strand breaks
in AOA1 cell extracts bypasses the point of aprataxin action and stalls at the ﬁnal step of DNA ligation,
resulting in accumulation of adenylated DNA nicks. Strikingly, this defect results from insufﬁcient levels of
non-adenylated DNA ligase and short-patch single-strand break repair can be restored in AOA1 extracts,
independently of aprataxin, by addition of recombinant DNA ligase.
AOA1 (ataxia oculomotor apraxia-1)
AOA1 is an autosomal recessive spinocerebellar ataxia syn-
drome that resembles Friedreich’s ataxia and A-T (ataxia
telangiectasia) neurologically, but which lacks extraneurolo-
gical features such as immunodeficiency and telangiectasia.
A recent study of 14 French, Italian and Algerian AOA1
patients from nine families supports the likelihood that,
although cerebellar atrophy, ataxia and sensorimotor axonal
neuropathy are common to most AOA1 patients, the
presence and severity of other features is more variable
(∼85% of patients in the case of oculomotor apraxia) [1].
Variation in clinical impact and/or severity of AOA1 is
suggested further by reported clinical overlap with other
neurological diseases/conditions, such as MSA (multiple
system atrophy) and ataxia with coenzyme Q10 deficiency
[2–4]. AOA1 accounts for 5–10% of all autosomal recessive
cerebellar ataxias and has variable age of onset (typically 1–
18 years), with a mean of ∼5 years [1,5]. Unlike A-T cells,
AOA1 cells are only mildly sensitive, if at all, to ionizing
radiation andother genotoxins, and exhibit normal cell-cycle-
checkpoint control and chromosome stability following
ionizing radiation [6]. Consistent with these observations,
elevated cancer incidence has not been reported in AOA1 pa-
tients. The gene mutated in AOA1 is designated APTX [7,8],
and the protein product of APTX is designated aprataxin.
Aprataxin contains a central HIT (histidine triad) domain
and is amember of theHITdomain superfamily of nucleotide
hydrolases/transferases. The N-terminus of aprataxin exhib-
its homology with PNK (polynucleotide kinase) [8], and
Key words: aprataxin, ataxia oculomotor apraxia, short-patch repair, single-strand break repair,
spinocerebellar ataxia.
Abbreviations used: AOA1, ataxia oculomotor apraxia-1; APLF, aprataxin- and polynucleotide
kinase-like factor; A-T, ataxia telangiectasia; DSBR, double-strand break repair; FHA, forkhead-
associated; HIT, histidine triad; Lig3α, DNA ligase IIIα; Polβ, polymerase β; PNK, polynucleotide
kinase; SSB, single-strand break; SSBR, single-strand break repair; WT, wild-type; XRCC1, X-ray
repair complementing defective repair in Chinese-hamster cells 1.
1To whom correspondence should be addressed (email k.w.caldecott@sussex.ac.uk).
like PNK encodes a divergent FHA (forkhead-associated)
domain [9]. The FHA domains of both aprataxin and
PNK facilitate constitutive interactions with protein kinase
CK2-phosphorylated XRCC1 (X-ray repair complementing
defective repair in Chinese-hamster cells 1) [6,9–14]. It is
noteworthy that a third member of this divergent FHA
domain family has been identified [denotedAPLF (aprataxin-
and PNK-like factor)/PALF (PNK and aprataxin-like FHA
protein)/Xip1] and shown to bind CK2-phosphorylated
XRCC1 [15–17]. In fact, all three FHA domain proteins are
also sequestered into the DSBR (double-strand break repair)
machinery, via FHAdomain-mediated interactionwithCK2-
phosphorylatedXRCC4 [6,15,18]. It is thus highly likely that
aprataxin, PNK and APLF play roles both in SSBR (single-
strand break repair) and DSBR. Aprataxin also associates
with PARP-1 [poly(ADP–ribose) polymerase 1] and p53,
and additionally with the nucleolar proteins nucleolin, nuc-
leophosmin and UBF-1 (upstream binding factor 1) [12,19].
The association and partial co-localization of aprataxin with
nucleolar proteins is also mediated by the FHA domain,
althoughwhether these associations are direct or indirect (e.g.
via another protein) remains to be determined. Nevertheless,
the association of aprataxin with nucleolar proteins may
indicate that SSBR and/or DSBR is particularly important
at sites of high transcriptional activity, perhaps to prevent
SSBs (single-strand breaks) from blocking gene expression.
Most of the mutations identified in AOA1 to date are
located within theHIT domain or just upstream of the C-ter-
minal zinc-finger motif, consistent with a critical require-
ment for the HIT domain for normal neurological function.
Many of these mutations greatly reduce the stability and/or
cellular level of aprataxin andmay thus be functionally null al-
leles [12,20,21]. Some mutations appear to be associated with
later disease onset and/or milder clinical features [8,22–24],
which, in some cases, appear to have less impact on aprataxin
stability and/or activity [20]. On the basis of sequence
comparisons and substrate specificity, aprataxin appears to
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represent a discrete branch of the HIT domain superfamily
[25]. Indeed, although aprataxin can hydrolyse substrates
typical of either the Fhit or Hint branch of HIT domain
proteins, releasing AMP from diadenosine tetraphosphate
or AMP-lysine respectively, its catalytic activity is very low
(kcat <0.03 s− 1) [20,25]. Aprataxin has also been reported to
process two types of damaged 3′-terminus arising at oxidative
DNA breaks, 3′-phosphate and 3′-phosphoglycolate termini,
raising thepossibility that it is an end-processing factor.How-
ever, the activity of aprataxin on such substrates is also very
low (kcat ∼0.0003–0.003 s− 1). A more likely physiological
substrate for aprataxin are 5′-AMP termini, at which AMP is
covalently linked to 5′-phosphate through a pyrophosphate
bond [26,27]. DNA strand breaks in which the 5′-terminus
is linked to AMP are normal intermediates of DNA ligation,
but if they arise before 3′-DNA end processing has occurred,
ligation is inhibited. Aprataxin can remove AMP from the
5′-terminus of DNA breaks at such ‘abortive’ DNA ligation
events, effectively ‘proofreading’ the DNA ligase reaction
[26]. In addition to the HIT domain, the C-terminal zinc
finger is important for aprataxin activity on 5′-AMP, probably
to increase the affinity and/or specificity of aprataxin for 5′-
AMP substrates [27]. Although the ability to process 5′-AMP
termini is a very elegant activity, it remains to be determined
whether or not this type of terminus arises in vivo.
AOA1 and short-patch SSBR
To clarify the nature of the SSBR defect in AOA1, we
recently reconstituted AOA1-dependent short-patch SSBR
assays in vitrowith human and rodent cell extracts [26,28]. To
measure short-patch SSBR, we employed an oligonucleotide
duplex harbouring a 1-bp gap with 3′-phosphate termini, a
substrate that mimics one of the commonest types of oxidat-
ive SSB arising in cells (Figure 1A). The SSB also possesses a
5′-AMP and is therefore a substrate for aprataxin. WT (wild-
type) extracts efficiently removed AMP from 5′-termini and
repaired the SSBs, as indicated by the respective appearance
of 32P-labelled 25-mer and 43-mer (Figure 1A, lanes 6–8). In
contrast, however, AOA1 extracts did not (Figure 1A, lanes
3–5). It should be noted that SSBR is proficient in AOA1
extracts if the initial SSB lacks 5′-AMP ([28] and results not
shown). A number of truncated oligonucleotide fragments
were generated by non-specific nucleolytic activity in these
experiments (see asterisks in Figure 1A), which is common
in lymphoblastoid extracts, and which represent degradation
of the 3′-terminus of the 32P-labelled 25-mer. However,
this activity did not account for the short-patch repair
defect in AOA1 extracts, which was fully complemented
by addition of recombinant aprataxin (Figure 1A, lanes 9–
11). The appearance of ligated product in these experiments
was dependent upon the presence of dNTPs, confirming that
these experiments measured gap repair rather than ligation
across the 1-bp gap (results not shown).
The predicted pathway for short-patch repair of SSBs
harbouring 5′-AMP in WT cells is depicted in Figure 1(B).
It was considered likely that this pathway arrests in AOA1
Figure 1 Aprataxin-dependent short-patch SSBR of 5′-AMP SSBs
in AOA1 lymphoblastoid extracts
(A) Defective short-patch SSBR in AOA1 extracts and its complementation
by recombinant aprataxin. Upper panel: cartoon of the oligonucleotide
duplex employed for these experiments containing a 1-bp gap,
3′-phosphate terminus and 5′-AMP terminus. The 5′-phosphate to which
AMP is covalently linked is labelled with 32P. The position of this
label restricts the assay to measurements of short-patch repair events
only. Numbers denote nucleotide lengths. Lower panel: 0.1, 1.0 or
5.0 μg of either WT (ConR2) or AOA1 (Ap5) extracts were incubated
for 60 min at 30◦C with 32P-labelled 5′-AMP SSB substrate (25 nM) in
the absence (left) or presence (right) of recombinant human aprataxin
(APTX) (100 nM). Reaction products were fractionated and detected
as described above. 32P-labelled 25-mer containing (AMP-32P-25) or
lacking (32P-25) 5′-AMP was fractionated in parallel for size markers
(Mks). The position of repaired 32P-labelled 43-mer (32P-43) is also
indicated. Non-speciﬁc nucleolytic products are indicated by an asterisk.
(B) Cartoon of aprataxin-dependent short-patch repair of adenylated
SSBs in WT cells. Reproduced from Molecular and Cellular Biology (2009),
29, 1354–1362, doi:10.1128/MCB.01471-08 [28], with permission c©
2009 American Society for Microbiology.
extracts at the very beginning, before 3′-DNAend-processing
by PNK and/or DNA gap-filling by Polβ (polymerase β),
because the presence of AMP at the 5′-terminus might
occlude access to the 3′-terminus. Surprisingly, however, the
3′-phosphatase activity of PNK was similar irrespective of
whether or not the SSB possessed 5′-AMP, under conditions
C©The Authors Journal compilation C©2009 Biochemical Society
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Figure 2 Removal of 5′-AMP by aprataxin is not required for
end-processing by PNK or gap-ﬁlling by Polβ
(A) 5′-AMP does not affect processing of 3′-phosphate termini by PNK.
SSB substrate (25 nM) lacking or containing 5′-AMP as indicated (upper
panel) was incubated with 25, 50, 125 or 250 nM recombinant human
PNK, or without PNK (-), for 1 h at 30 ◦C. Reaction products were
fractionated by denaturing PAGE and detected by phosphorimaging.
Note that the 5′-terminus of the 17-mer is labelled with 32P in these
experiments to allow detection of 3′-end processing. The position of the
17-mer harbouring the 3′-phosphate (17-P) or 3′-hydroxy group (3′-OH)
is indicated. (B) 5′-AMP does not affect gap-ﬁlling by Polβ. SSB substrate
(25 nM) lacking or containing 5′-AMP as indicated (upper panel) was
incubated with 5, 15, 30 or 100 nM puriﬁed recombinant human Polβ,
or without Polβ (-), for 1 h at 30 ◦C. Reaction products were fractionated
by denaturing PAGE and detected by phosphorimaging. The positions of
17-mer and 18-mer are included as markers. Reproduced from Molecular
and Cellular Biology (2009), 29, 1354–1362, doi:10.1128/MCB.01471-08
[28], with permission c© 2009 American Society for Microbiology.
in which PNK was limiting (Figure 2A). Similar results
were observed for DNA gap-filling by Polβ, with similar
amounts of 32P-labelled 17-mer converted into 32P-labelled
18-mer, irrespective of the presence or absence of 5′-AMP
(Figure 2B). These experiments suggested that neither PNK
nor Polβ activity is affected by the presence of 5′-AMP
at these time points, and thus short-patch SSBR might
fail in AOA1 extracts at the final step of DNA ligation,
resulting in the accumulation of adenylated DNA nicks.
This was surprising, because adenylated DNA nicks are
normal, indeed prerequisite, intermediates of DNA-ligation
reactions, requiring only non-adenylated DNA ligase to
reseal the breaks.We considered that DNA ligationmight fail
in AOA1 cell extracts because of insufficient levels of non-
adenylated DNA ligase. This would be consistent with the
notion that, although DNA ligases exist in both adenylated
and non-adenylated states, the former predominates in cells
because of the cellular concentration of ATP. This would not
be a problem in WT cells, in which aprataxin activity ensures
that DNA nicks arising during SSBR are not pre-adenylated
and are thus substrates for adenylated DNA ligase. However,
in AOA1 cells, DNA nicks arise in a pre-adenylated state
during SSBR and thus require non-adenylated DNA ligase.
We thus suggest that, whereas all cells possess low levels
of non-adenylated ligase, because of the rapid adenylation of
free ligase molecules by cellular ATP, only in aprataxin-
defective cells do pre-adenylated nicks arise at a level
sufficient to exceed the availability of non-adenylated ligase.
Evidence in support of this hypothesis arose when we
compared WT and AOA1 extracts for their ability to
ligate adenylated nicks. Whereas adenylated nicks were
efficiently ligated by cell extract from WT cells, they
remained largely unligated in reactions containing AOA1
cell extract (Figure 3A). To test our hypothesis further, we
examined the impact of supplementing short-patch SSBR
reactions in AOA1 cell extracts and Aptx−/− mouse neural
astrocyte extracts with recombinant DNA ligase. Addition
of T4 ligase restored short-patch SSBR efficiency in both
AOA1 and Aptx−/− neural cell extract to a level similar to
that observed in WT extract (Figure 3B, compare lanes 6 and
10). Importantly, complementation was more efficient in the
absence of ATP than in its presence, supporting the notion
that it was the non-adenylated subfraction of T4 ligase that
was responsible for complementation (Figure 3B, compare
lanes 8 and 10). The experiments described above suggested
that short-patch repair of some adenylated SSBs can occur
independently of aprataxin if sufficient non-adenylatedDNA
ligase is available. To confirm this idea, we also attempted to
reconstitute this aprataxin-independent SSBR pathway using
recombinant proteins. As expected, the repair of adenylated
gaps by PNK, Polβ and Lig3α (DNA ligase IIIα) was
dependent on aprataxin in the presence of ATP, conditions
underwhich Lig3α is largely adenylated (Figure 4). However,
in the absence of ATP, short-patch repair of 5′-AMP SSBs
occurred independently of aprataxin. Taken together, these
experiments indicate that short-patch repair arrests in AOA1
cell extracts at the final step of DNA ligation, owing to
insufficient levels of non-adenylated DNA ligase.
The finding that adenylated nicks accumulate during short-
patch SSBR in AOA1 provides a possible explanation for the
normal rate of chromosomal SSBR observed in AOA1. This
is because adenylated nicks can be channelled into long-patch
SSBR. In this pathway, damaged 5′-termini are displaced as a
single-stranded flap during gap-filling from the 3′-terminus
and cleaved off by FEN1 (flap endonuclease-1) (reviewed
in [29]). This process would not be detected by the short-
patch repair assays employed in our recentwork [28], because
oligonucleotide duplexes of the type employed here are not
good substrates for long-patch repair reactions and because
cleavage of the single-strand flap would remove the 32P label
in our substrates. However, if long-patch repair can com-
pensate for defective short-patch repair in AOA1 cells, then
why do aprataxinmutations result in disease?One possibility
is that a subset of SSBs arise at which long-patch repair cannot
operate. For example, it is possible that aprataxin is also
required to repair specific types of damaged 3′-terminus [30].
Long-patch repair would be unable to operate at such breaks,
because a 3′-hydroxy primer terminus is not available for
C©The Authors Journal compilation C©2009 Biochemical Society
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Figure 3 Short-patch SSBR fails in AOA1 due to insufﬁcient levels
of non-adenylated DNA ligase
(A) AOA1 extracts cannot efﬁciently ligate adenylated DNA nicks. Total
WT (ConR2) or AOA1 (Ap5) lymphoblastoid cell extracts (6.25 μg) were
incubatedwith 32P-labelled adenylated nicked substrate (25 nM) (shown
schematically in the upper panel) for the indicated time period at 30 ◦C.
Reaction products were fractionated by denaturing PAGE and detected by
phosphorimaging. 32P-labelled 25-mer containing (AMP-25) or lacking
(25) 5′-AMP were fractionated for size markers (Mks). The position of
43-mer ligated product (43) is indicated. (B) Complementation of the
SSBR defect in AOA1 lymphoblastoid extracts by recombinant T4 DNA
ligase. Total WT (ConR2) or AOA1 (Ap5) lymphoblastoid cell extracts
(5 μg) were incubated with 32P-labelled 5′-AMP SSB substrate (25 nM)
(shown schematically in the upper panel) for 1 h at 30◦C in the presence
or absence of 1 mM ATP and/or 2 units of T4 DNA ligase, as indicated.
Reaction products were fractionated by denaturing PAGE and detected
by phosphorimaging. The positions of 32P-labelled 43-mer reaction
product (43) and 32P-labelled 25-mer containing (AMP-25) or lacking
(25) 5′-AMP are indicated. Reproduced from Molecular and Cellular
Biology (2009), 29, 1354–1362, doi:10.1128/MCB.01471-08 [28], with
permission c© 2009 American Society for Microbiology.
DNA gap-filling. Alternatively, since aprataxin is associated
with the DSBR machinery [6], it is possible that unrepaired
double-strand breaks might account for AOA1. It should be
noted, however, that we have so far failed to detect a DSBR
defect in AOA1 or Aptx−/− cells (S.F. EI-Khamisy and K.W.
Caldecott, unpublishedwork). Finally, it is possible that long-
Figure 4 Reconstitution of aprataxin-independent SSBR with
recombinant human proteins
Reconstitution of aprataxin-independent SSBR with recombinant human
proteins. 5′-AMP SSB substrate (60 nM) (shown schematically above the
gel) was incubated with 250 nM recombinant PNK, 100 nM Polβ and
80 nM Lig3α in the presence or absence of 100 nM aprataxin (APTX)
and 1 mM ATP, as indicated, for 1 h at 30 ◦C. Reaction products were
fractionated by denaturing PAGE and detected by phosphorimaging.
Reproduced from Molecular and Cellular Biology (2009), 29, 1354–1362,
doi:10.1128/MCB.01471-08 [28], with permission c© 2009 American
Society for Microbiology.
patch repair is not operative or is attenuated in the specific
cell types that are affected in AOA1. For example, a number
of replication-associated proteins, including several of those
implicated in long-patch repair, are down-regulated in certain
differentiated cell types [31].
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Maintenance of DNA integrity is crucial for all cell types, 
but neurons are particularly sensitive to mutations in DNA 
repair genes, which lead to both abnormal development 
and neurodegeneration1. We describe a previously unknown 
autosomal recessive disease characterized by microcephaly, 
early-onset, intractable seizures and developmental delay 
(denoted MCSZ). Using genome-wide linkage analysis in 
consanguineous families, we mapped the disease locus to 
chromosome 19q13.33 and identified multiple mutations in 
PNKP (polynucleotide kinase 3′-phosphatase) that result in 
severe neurological disease; in contrast, a splicing mutation 
is associated with more moderate symptoms. Unexpectedly, 
although the cells of individuals carrying this mutation are 
sensitive to radiation and other DNA-damaging agents, no such 
individual has yet developed cancer or immunodeficiency.  
Unlike other DNA repair defects that affect humans, PNKP 
mutations universally cause severe seizures. The neurological 
abnormalities in individuals with MCSZ may reflect a role for 
PNKP in several DNA repair pathways.
We identified the autosomal recessive disorder MCSZ with the fol-
lowing features: microcephaly, infantile-onset seizures, developmen-
tal delay and variable behavioral problems, especially hyperactivity. 
MCSZ was observed in multiple pedigrees of Middle Eastern and 
European origin (Fig. 1). The first three pedigrees were Arabic 
Palestinians living in Jordan and the United States. Three other 
families with similar manifestations were Arabic (Kingdom of Saudi 
Arabia), Turkish and of mixed European ancestry (United States). 
We later found less severely affected individuals with MCSZ from 
family 7, which is also mixed European heritage and from the United 
States. Brain magnetic resonance imaging scans (MRIs) consistently 
show microcephaly with preserved brain structures, without appar-
ent neuronal migration or other structural abnormalities, and with 
no evidence of degeneration (Fig. 2). The affected individuals did 
not develop ataxia or other neurological symptoms. Routine clinical 
genetic and metabolic screening showed no abnormalities. Despite 
careful inquiry, individuals with MCSZ were not found to have a 
higher frequency of common or uncommon infections, offering no 
clinical evidence of immunodeficiency. Cells from one affected indi-
vidual showed sensitivity to irradiation in a standard colony-survival 
assay2,3. However, no affected person has developed cancer by age 
21, and heterozygous carriers have not developed early-onset cancer 
or any sign of immunodeficiency (Supplementary Note, Clinical 
Information, Supplementary Table 4 and Summary). 
Genome-wide linkage screens suggested a single common 
homozygous region on chromosome 19q in all six individuals with 
MCSZ in the consanguineous families 1–3. This same locus showed 
homozygosity in the two affected individuals from family 4 and in 
the single one from family 5 whose parents were not known to be 
related. We observed no other regions of linkage, including at known 
primary microcephaly loci. Notably, all six affected individuals in 
the three Palestinian families (families 1–3) were homozygous for 
the same 3-cM (1.5-Mb) haplotype (between markers D19S879 and 
D19S907) at chromosome 19q13.33, suggesting a common ancestor 
(Supplementary Fig. 1). Further investigation revealed a common 
town of origin for these families. Linkage analysis of families 1–4 and 
family 6 generated a combined maximum two-point lod score of 5.60 
at D19S867 with u = 0 (Supplementary Table 1) and a maximum 
multipoint lod score of 7.12 (Supplementary Fig. 2).
We sequenced 41 genes within the minimal region (Supplementary 
Fig. 2 and Supplementary Table 2), and only the PNKP gene con-
tained mutations. We found homozygous mutations in families 1–5 
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and compound heterozygous mutations in families 6 and 7 (see Fig. 3 
and Supplementary Fig. 3 for detailed analyses of all mutations). The 
three Palestinian families (families 1–3) shared a homozygous base 
pair substitution in exon 11 (G975A), resulting in the nonconservative 
amino acid change E326K. The families from the Saudi Arabia 
(family 4) and Turkey (family 5) had the same homozygous 17-bp 
duplication (17-bp dup) in exon 14 (1250_1266dup), resulting in a 
frameshift, T424GfsX48. Family 6 (European) had two heterozygous 
mutations: the same 17-bp duplication in exon 14 as the Saudi and 
Turkish families and a point mutation in exon 5 (C526T) that results 
in L176F. The moderately affected members of family 7 (European) 
showed compound heterozygosity, carrying the 17-bp duplication 
mutation in exon 14 and a 17-bp deletion in intron 15 that disrupts 
proper mRNA splicing.
To confirm that these mutations were pathogenic, we ana-
lyzed Epstein-Barr virus (EBV)-transformed lymphocytes derived 
from affected individuals from families 3 (E326K substitution) and 
7 (17-bp duplication and intron 15 deletion). The samples from the 
severely affected individual (family 3) and mildly affected individu-
als (family 7) had much lower concentrations of PNKP protein than 
did those from unaffected or heterozygous family members (Fig. 3b). 
RT-PCR analysis showed that the intron 15 deletion in family 7 disrupts 
mRNA splicing and causes skipping of exon 15; a barely detectable 
level of properly spliced mRNA remains (Fig. 3c). The low concentra-
tions of PNKP protein and the indistinguishable phenotype among 
severely affected individuals from families 1–6 suggest that all of these 
mutations impair PNKP severely or completely; in contrast, the indi-
viduals from family 7, who have a slightly milder phenotype and carry 
one noncoding mutation, may retain some PNKP activity.
Unexpectedly, despite their diverse ancestries (Saudi, Turkish 
and mixed European), all chromosomes with the 17-bp duplication 
mutation seem to share the same haplotype for 18 SNPs in or near 
the PNKP locus (Supplementary Fig. 4a). The low frequency of this 
mutated haplotype (Supplementary Fig. 4b) suggests that the 17-bp 
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Figure 1 Pedigrees of MCSZ families. Family 1 represents a 
consanguineous Palestinian pedigree in Jordan. Family 2 shows another 
consanguineous Palestinian pedigree that is reportedly unrelated to family 
1, also in Jordan. Family 3 is also consanguineous and Palestinian, but 
the family now resides in the United States. Family 4 is from the Kingdom 
of Saudi Arabia, and the parents were not known to be consanguineous. 
Family 5 is from Turkey, and the parents were not known to be related. 
Family 6 is of mixed European descent from the United States (German-
Irish). Family 7 is also of mixed European (Swedish, Italian, Irish and 
English) heritage, from the United States. The individuals from whom 
samples were obtained are indicated by the label ‘DNA’. The individuals 
from whom we established lymphoid cell lines are indicated by the label 
‘Cells’. Cells and DNA were available for all members of family 7.
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Figure 2 Brain MRIs of individuals with MCSZ. Representative MRI images are shown from families 4 (a; severely affected) and 7 (b; moderately 
affected) with aged-matched controls. MRIs of severely affected individuals from other families were similar to the representative images in a. Sagittal 
images are shown on the left (T1), axial images in the middle (T2) and coronal images on the right (T2 (a) and FLAIR (b)), with the MRI sequence 
noted above the image. The MRIs show that, despite the microencephaly (small brain), the gyral pattern is not clearly abnormal, indicating an absence 
of visible neuronal migration abnormality. The cerebellum is proportionately small compared to the cerebrum, and the subpallium (basal ganglia or 
ventral cerebrum) is proportionate to the pallium (dorsal cerebrum). There is no evidence of atrophy or glial scarring. Scale bar indicates 5 cm for both 
unaffected and MCSZ images.
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duplication in exon 14 is probably of shared origin and very old 
in all or most of these families. Nonetheless, the mutation shows an 
extremely low carrier frequency in the general population, as the 
17-bp duplication mutation was absent in 1,080 Middle Eastern or 
European-descended control chromosomes, and all other mutations 
were absent in all 280 control chromosomes screened.
The PNKP protein has been implicated in repair of both double-
strand breaks (DSBs) and single-strand breaks (SSBs)4,5, because its 
phosphatase domain removes 3′-phosphates and its kinase domain 
phosphorylates 5′-hydroxyl groups, steps that are required for DNA 
ligation6. PNKP’s forkhead domain mediates interaction with the non-
homologous end-joining (NHEJ) complex via XRCC4 or with the SSB 
and base-excision repair (BER) pathways via XRCC1 (Supplementary 
Fig. 5)4–8. PNKP has been further implicated in the repair pathway 
disrupted in an ataxic neurodegenerative disease, spinocerebellar 
ataxia with axonal neuropathy (denoted SCAN1 and involving a 
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Figure 3 PNKP mutations in individuals with 
MCSZ. (a) The diagram shows four different 
mutations identified in human PNKP genomic 
DNA, mRNA and protein, including protein 
domains (forkhead is indicated by ‘FHA’). The 
human PNKP gene consists of 17 exons (boxes) 
and encodes a peptide of 521 amino acids. 
Filled boxes represent untranslated regions and 
open boxes represent coding regions. Lines 
connecting the exons represent introns.  
(b) Protein blot for PNKP. Lanes 1 and 2 show 
samples from an individual with MCSZ (VI:3 with 
the E326K mutation) and an unaffected brother 
(VI:1), respectively, from family 3. Lanes 3 and 
4 represent individuals with MCSZ (II:1 and II:4, 
with both a 17-bp duplication (dup) and a  
17-bp intron 15 deletion (del)) from family 7. In 
contrast, lanes 5 and 6 represent the father (I:1) 
and brother (II:3) from this family, who are both 
heterozygous for the 17-bp intron 15 del. The 
band indicates a molecular weight of ~60 kDa 
(predicted size 57 kDa). Anti–β-actin is a loading 
control. (c) RT-PCR products of mRNA from 
members of family 7 show the expected size 
from the normal copy of PNKP cDNA (636 bp), 
seen in lanes 3 and 4 from unaffected carriers. 
The 17-bp dup results in a 653-bp fragment, 
seen in lanes 1, 2 and 3. The band in lanes 1, 2 and 4 corresponding to a size of 548 bp is found in samples with the intron 15 deletion lacking exon 15 
(determined from sequencing; data not shown). A small amount of normal-sized transcript is seen in lanes 1 and 2 with higher exposure (data not shown), 
indicating that a small amount of normal PNKP mRNA can be produced.
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Figure 4 Lymphocytes from individuals with MCSZ show abnormal DNA 
repair. (a) Examples of comet assay results. The intensity of the fluorescence 
is represented in pseudocolor, as the electrical field drives damaged, loose 
DNA from left to right. The image at left shows a cell with 50% tail DNA with 
the body of the nucleus (green) on the left and the tail of the comet derived 
from the damaged DNA extending to the right. The images middle and right 
show progressively less damage, with 29% and 11% tail DNA, respectively. 
(b) After hydrogen peroxide treatment with 0 min for recovery, cells show 
their maximum damage. Cells derived from individuals with MCSZ (blue 
and red) show significant impairment in their ability to repair DNA after 
hydrogen peroxide was removed, whereas cells derived from unaffected 
family members were able to repair DNA much more efficiently. (c) After 
camptothecin (CPT) treatment, there was also statistically significantly 
slower repair in cells derived from individuals with MCSZ compared with 
those from unaffected family members (green and purple). However, after 
45 min, the MCSZ-derived cells were able to repair all CPT damage, in 
contrast to hydrogen peroxide–treated cells. All cells were derived from 
family 7. Blue diamonds and red squares indicate cells from individuals 
with MCSZ carrying the exon 14 17-bp duplication and the intron 15 17-bp 
deletion (II:1 and II:4, respectively); green triangles represent an unaffected 
parent who is heterozygous for the intron 15 17-bp deletion (I:1); purple 
crosses represent an unaffected sibling with no mutation (II:2). *P = 0.05; 
**P < 0.005; ***P < 0.0005. Scale bar, 50 µm.
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mutation in TDP1) (see Supplementary Fig. 5 for additional 
details). The abnormalities in a clinical irradiation–sensitivity test 
already reflect deficiencies in NHEJ, which is required to repair 
radiation-induced DSBs. Because PNKP potentially has roles in 
additional repair pathways, we tested cells in response to other 
DNA-damaging agents.
We examined the response of cells from individuals with MCSZ to 
free radical damage from hydrogen peroxide, which predominately 
requires BER, and camptothecin, which requires TDP1 via its activity 
on topoisomerase I, using an alkaline comet assay that detects both 
SSBs and DSBs by quantifying the amount of DNA that moves from 
a nucleus after electrophoresis. Typical nuclei with various degrees 
of DNA damage are shown in Figure 4a. We determined the relative 
amount of DNA damage by measuring the ‘Percent tail DNA’ (DNA 
that has moved out of the nucleus). The relative amount of DNA dam-
age repair was quantified as the percent tail DNA after toxin exposure 
at various times of recovery (see Supplementary Table 2 for all data) 
and normalized to the maximum and minimum damage for each 
cell line in each experiment. MCSZ-derived cell lines were signifi-
cantly impaired in their ability to repair hydrogen peroxide–induced 
damage (Fig. 4b) and were also delayed in repairing camptothecin-
induced damage (Fig. 4c). MCSZ-derived cells were eventually able 
to repair the camptothecin-induced damage after 45 min, but they 
could not repair all hydrogen peroxide–induced damage even after 
90 min. These data suggest that camptothecin-induced damage may 
be easier to repair than free radical damage in the setting of PNKP 
mutations. Although individuals with MCSZ do not develop the ataxia 
that characteristically results from TDP1 mutations that also cause 
camptothecin sensitivity9,10, it may be that those we studied are too 
young (oldest 21 years) to show this characteristic, or there may be 
some mechanism compensating for the loss of PNKP.
Microcephaly can result from failure to produce enough neurons 
during development (primary microcephaly) or from degeneration 
after normal development. Individuals with MCSZ have no evidence 
of brain atrophy or clinical regression, making degeneration unlikely 
(see the Supplementary Note, Clinical Information, for further 
details). In situ hybridization indicated that human and mouse PNKP 
mRNAs are expressed in both dividing neuronal precursors in the 
cerebral cortical ventricular zone (VZ, Fig. 5a–c) and in postmitotic 
neurons of the cortical plate (CP, Fig. 5d), which is consistent 
with potential roles in both dividing and postmitotic neurons. 
In addition, we found that when we used RNAi to reduce levels 
of Pnkp in dissociated mouse neurons in vitro, there was a small 
but statistically significant increase in apoptosis in both neuronal 
 precursors and differentiated neurons (Supplementary Figs. 6 and 7 
and Supplementary Table 3) compared to cells transfected with 
control plasmids. This indicates that microcephaly could result from 
apoptosis of precursors, differentiated neurons or both cell types.
Disruption of genes encoding NHEJ repair proteins can lead to 
microcephaly in humans and/or mice, as occurs in LIG4 syndrome, 
which involves mutations in Lig4 (refs. 11–13), in severe combined 
immunodeficiency with microcephaly, or as a result of mutations 
in NHEJ1 (encoding Cernunnos)14, Xrcc4 (ref. 15), Xrcc6 (encoding 
Ku70) and Xrcc5 (encoding Ku80)16 and Prkdc (encoding DNA-PKcs)17. 
However, disruption of NHEJ function is not known to cause sei-
zures, which are a prominent clinical feature of MCSZ. In contrast, 
 disruption of the BER and SSB pathways by deletion of Xrcc1 in mice 
produced normal brain size, but the mutant mice developed ataxia, 
loss of interneurons within the cerebellum and seizure-like behav-
ior18. The intriguing similarity of phenotypes between humans with 
MCSZ who carry mutations in PNKP and mice with targeted deletion 
of Xrcc1 does suggest a potential common mechanism, demonstrat-
ing the requirement for the BER and SSB pathways in the prevention 
of seizures, potentially via an interneuron-specific requirement of the 
BER and SSB pathway. Therefore, the unique pattern of neurological 
symptoms of MCSZ may reflect a requirement for PNKP activity in 
multiple DNA repair pathways.
MeThoDS
Methods and any associated references are available in the online 
 version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
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Genetic screening. Family 1 underwent a genome-wide linkage screen using 
about 400 microsatellite markers in the ABI linkage mapping set MD v2.5 at 
an average density of 10 cM (Applied Biosystems) at the Children’s Hospital 
in Boston (Genotyping Core facility). We performed genome-wide screens 
for families 3 and 4 at the Center for Inherited Disease Research using micro-
satellite markers that were also at an average spacing of 10 cM. We carried out 
fine mapping using polymorphic microsatellite markers from the ABI linkage 
mapping set HD v2.5 at an average density of 5 cM (Applied Biosystems) along 
with additional microsatellite markers identified using the UCSC Human 
Genome Browser19 and synthesized primers (Sigma-Genosys). Two point and 
multipoint lod scores calculated using Allegro20 assumed recessive inheritance, 
full penetrance and a disease allele frequency of 0.0001. All nucleotide numbers 
are in reference to cDNA, in which A (of the ATG start site) is +1, except for 
the intronic deletion, which is in reference to the genomic sequence, in which 
A of ATG of the translational start site is +1 (all from UCSC genome browser, 
NCBI Build 36.1).
PNKP protein blotting. For PNKP, we grew EBV-transformed lymphocytes in 
DMEM with 15% (vol/vol) FCS plus normocin. We lysed 2 × 105 cells in SDS 
loading buffer at 90 °C and fractionated them by SDS-PAGE. We transferred 
the proteins to Hybond-C Extra Nitrocellulose (GE Healthcare), stained them 
with Ponceau S solution (Sigma) and washed them in TBST (25 mM Tris base, 
150 mM NaCl, 2.7 mM KCl, 0.1% Tween-20) before carrying out immuno-
blotting with anti-PNK (SK3195)21 at a dilution of 1:1,000 in 5% (wt/vol) non-
fat dried milk. We then washed the blots and probed them with goat anti-rabbit 
IgG–horseradish peroxidase (HRP) secondary antibody (DakoCytomation), 
which we detected with ECL detection reagents (GE Healthcare). The blot was 
then washed in TBST and re-probed with monoclonal anti–β-actin (Sigma) using 
rabbit anti-mouse IgG HRP (DakoCytomation) as a secondary antibody.
PNKP reverse transcriptase polymerase chain reaction. We grew EBV-
transformed lymphocytes as described above. We isolated the RNA using 
the RNeasy Mini Kit (Qiagen). We used 5 µg of total RNA for first-strand 
synthesis with oligo(dT) primers using the SuperScript III First-Strand 
Synthesis SuperMix (Invitrogen). We then used 1 µl of the product of the 
reverse transcriptase reaction was used in PCR with primers from Exon 
10 to Exon 17.
Comet assays. We carried out alkaline comet assays using the protocol from 
CometAssay ES unit (Trevigen). Briefly, we grew affected individual–derived 
EBV-transformed lymphocytes as described above. Cells were obtained before 
treatment or exposed to 100 µM hydrogen peroxide (Sigma) or 10 µM campto-
thecin (Sigma) for 30 and 60 min, respectively, at 37 °C. After exposure, we 
immediately collected the cells for the 0 min recovery time point or washed 
them once, resuspended them in growth medium and incubated at 37 °C. 
Cells were subsequently at the times indicated. We then embedded the cells 
in low-melt agarose, plated them on microscope slides, lysed them, treated 
them with alkaline solution and then electrophoresed the slides in alkaline 
solution at 1 V cm−1 (21 V) with ~300 mA for 30 min. We washed and dried 
the slides were washed and stained the DNA with SYBR green. Images of 
nuclei and tails were taken with a Nikon TE2000-E fluorescent microscope 
with CCD camera, and we determined the percent tail DNA with CometScore 
1.5 software (TriTek).
In situ hybridization. We performed human in situ hybridizations at the Human 
Developmental Biology Resource (Institute of Human Genetics, International 
Centre for Life, UK) with probes to antisense human PNKP cDNA (nucleotides 
+488–1500). We carried out mouse in situ hybridizations as described22, with 
an antisense probe derived from mouse Pnkp cDNA (+386–1566).
We calculated statistics using Microsoft Excel unless otherwise described. 
The ‘Percent DNA repair’ values in Figure 4 were determined by measuring the 
mean of the percent tail DNA in three separate wells (raw data are presented 
in Supplementary Fig. 5), using the combined percent tail DNA at 0 min 
recovery (maximum damage) and the minimum damage measured as full 
recovery for each individual cell line. We determined P values by comparing 
the baseline adjusted DNA repair level from three separate wells using a t-test 
that “compared” each MCSZ-deficient line to two normal control cell lines 
with a two-tailed distribution and homoscedastic test.
PNKP mutation analysis. We performed PNKP protein alignments using 
MegAlign (Lasergene). We examined the three-dimensional structure of mouse 
Pnkp in MacPyMOL from previously published information23. The Branch 
Point analysis was done with Human Splicing Finder version 2.3 (http://www.
umd.be/HSF/)
Determination of the 17-bp duplication haplotype in exon 14. We deter-
mined Sequenom SNP genotypes in samples from affected and control indi-
viduals at the Molecular Genetics Core Facility at Children’s Hospital Boston. 
We determined haplotypes were determined with Mendelian inheritance 
patterns for parents and offspring and with Phase haplotype-determining 
software24–26 for control samples.
PNKP RNA interference studies. pSilencer 1.0 GFP had RNAi oligos targeted 
to mouse Pnkp mRNA identified via the Broad Institute RNAi Consortium 
shRNA Library, ligated into EcoRI and ApaI sites (Mo-Pnkp RNAi prim-
ers, Supplementary Table 3; Invitrogen). We dissected the cerebral cortices 
from embryonic day 13.5 Swiss-Webster mice and dissociated them using 
the Papain Dissociation System (Worthington Biochemical). We washed 
the cells twice in HBSS buffer (HyClone, Thermo Scientific) and trans-
fected them using the Amaxa Nucleofactor 96 well shuttle system (Amaxa 
Biosystems) with either pSilencer mouse Pnkp-RNAi GFP or pSilencer GFP 
with or without pSport-human PNKP (Open Biosystems, Entrez clone 
ID BC057659). We grew the cells on poly-l-ornithine–treated (Sigma-
Aldrich) Lab-Tek chamber slides with Permox (Nalge Nunc International) in 
DMEM with 10% (vol/vol) FBS for the Pax6 studies. For the NeuN studies, 
we changed the medium of the cultures to Neurobasal complete medium 
after 4 h. We fixed the cultures with 4% (vol/vol) paraformaldehyde 24 h 
after transfection. We carried out immunostaining in PBS with 0.2% (wt/vol) 
Triton X-100 and 10% (vol/vol) goat serum with chick anti-GFP (Abcam), 
rabbit anti-cleaved caspase 3 (Asp175) (Cell Signaling Technology), mouse 
anti-Pax6 (The Developmental Studies Hybridoma Bank) or mouse anti-NeuN 
(Chemicon). We detected the primary antibodies with anti-chicken IgG Alexa 
488 (Invitrogen) and donkey anti-mouse IgG Cy3 or donkey anti-rabbit IgG 
Cy5 (Jackson ImmunoResearch). Images were obtained by looking for GFP-
positive cells with a Nikon TE2000-E fluorescent microscope and Metamorph 
imaging software. We counted the cells from digital images with the counter 
blinded as to whether the cultures were derived from Pnkp-RNAi or control 
transfections. We calculated the P values in Supplementary Figure 7 using a 
G-test of goodness of fit with 5 degrees of freedom, a two-tailed P value and 
no Williams correction27.
Mouse Pnkp RNA interference testing. We tested the mouse (Mo) Pnkp 
RNAi construct Mo-Pnkp-DsRed or the human construct Hu-PNKP-
DsRed, both expressed by the pCAG-DsRed vector28. We transfected the 
RNAi control vector (empty vector)/Mo-Pnkp-DsRed fusion protein, 
Mo-Pnkp-RNAi/Mo-Pnkp-DsRed, RNAi-control/Hu-PNKP-DsRed fusion 
and Mo-Pnkp-RNAi/Hu-PNKP-DsRed into NIH-3T3 cells with Lipofectamine 
2000 (Invitrogen) according to the manufacturer’s protocol. We counted the 
cells after 24 h in culture. Random fields were chosen by the level of GFP 
expression, and the number of cells with high GFP expression was counted, 
followed by the number of cells expressing the Ds-Red fusion protein. 
DsRed expression was nuclear, as expected from PNKP localization (data 
not shown). For protein blot analysis, we transfected NIH-3T3 cells as 
described above. After 24 h of culture, we lysed the cells using the protocol 
described above for PNKP protein blotting. After quantifying the protein 
using the BCA assay, we separated 25 µg of protein per lane by PAGE. We 
transferred the protein to a membrane, blocked it with Odyssey blocking 
buffer (Li-Cor Biosciences) and probed with mouse anti-actin (AC-15), 
rabbit anti-GFP (Molecular Probes) and rabbit anti-DsRed (Clontech). 
Primary antibody was detected with anti-mouse labeled with IRDye 700 
or anti-rabbit IRDye 800 (Li-Cor Biosciences) and detected with Li-Cor 
imaging system. In the bar graph, protein amounts are normalized to RNAi 
control conditions.
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